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The Ca2+ transient of the cardiomyocyte is key to the contractility of the heart. Its 
dysregulation has been associated with heart disease, leading to investigation of 
the regulation of Ca2+ for potential drug targets. The Sarcoplasmic Endo-Reticulum 
Ca2+ ATP-ase (SERCA) pump and its main inhibitor in heart tissue, 
phospholamban (PLN), are two promising targets that are under β-adrenergic 
control via phosphorylation of PLN by Protein Kinase A (PKA). Phosphorylation of 
Ser16 on the cytoplasmic domain of PLN results in decreased inhibition of SERCA. 
Recently, an additional member of the SERCA interactome has been discovered 
called Hematopoietic lineage cell-specific protein 1 (HCLS1) Associated Protein 
X-1 (HAX-1). Contrasting PLN phosphorylation, the interaction of HAX-1 and PLN 
increases the inhibition of PLN for SERCA, adding another layer of complexity to 
SERCA regulation and a potential new drug target. This thesis aims to investigate 
the structure-function relationship of the ternary complex, SERCA/PLN/HAX-1 
using NMR spectroscopy as the primary technique.  
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Chapter 1 Introduction 
 
1.1 Entropy and information 
Transmission of biochemical signals that are received and elicit functional 
responses results in the manifestation of life; the malfunction of which often results 
in disease. Biochemical signals are described as a flow of information, a concept 
that is central in life sciences. To quantify the amount of information contained 
within a system, an introduction of Entropy, a term coined by Rudolph Clausius, 
and its relation to Shannon Measurement of Information (SMI) is required. 
 Entropy was born from the realization that the change in Energy (U) was 
not sufficient to describe the direction of a spontaneous process; exothermicity is 
not required for spontaneity. There is a balance between minimizing the energy of 
a system as well as maximizing the number of possible states occupied. A state 





for a spontaneous process [6]. Boltzmann defined the entropy of a typical system 
at the molecular level: 
𝑆 = 𝑘𝐵ln𝑊(𝑎𝑗) 
Where kB is the Boltzmann constant and 𝑊(𝑎𝑗) =
𝐴!
∏ 𝑎𝑗!𝑗
, the possible configurations 
where A is the number of systems in an ensemble and aj ϵ A is the number of 
2 
systems in a possible state j. If all possible configurations are equally probable 
(pja=(1,…,W(aj)), the probability of a macroscopic state a is [7]: 
𝑃(𝑎) = 𝑊(𝑎𝑗)𝑝(𝑎𝑗) 
The above derivations assumed that in large ensembles there is no difference 
between the maximum entropy (most probable) and the mean value of entropy. 
Eliminating this assumption (and dropping kB for simplicity): 




𝑆̅ = −∑𝑃(𝑎𝑗) ln 𝑝(𝑎𝑗)
𝑎𝑗
+ ∑𝑃(𝑎𝑗) ln 𝑃(𝑎𝑗)
𝑎𝑗
 
And considering all configurations are of equal probability: 
𝑆̅ = −∑ ∑ 𝑝𝑗𝑎(𝑎𝑗) ln 𝑝𝑗𝑎(𝑎𝑗)
𝑊(𝑎𝑗)
𝑝𝑗𝑎=1𝑎𝑗
+ ∑𝑃(𝑎𝑗) ln 𝑃(𝑎𝑗)
𝑎𝑗
 
The first term in the above equation is of the same form as the solution that 
Shannon found in 1948 that induced interest in the field of information theory, SMI 
[7]: 




Where K is a positive constant and log2 results in the unit of bits rather than using 
the natural log as is done for convenience in thermodynamics when working with 
Boltzmann factors. H is a measurement of uncertainty in a random variable and 
can be conceptualized as the amount of information contained within a probability 
distribution [8]. With the relationship between entropy and information content 
defined, we are equipped to apply these principles biophysically. 
 
1.2 Lipid membranes 
Entropy within cells is primarily decreased by self-assembled phospholipid 
bilayers called membranes. Membranes are essential to life, a statement justified 











explicitly describing a decrease in entropy through a decrease in internal energy 
(dU), a decrease in volume (dV), or an increase in the flux of molecules across a 
barrier (dN). These amphipathic, semi-permeable surfaces corral ions, small 
molecules, and macromolecules while allowing diffusion of water, both decreasing 
explorable volume as well as increasing chemical potentials (μ) of small molecules 
[9-13]. 
 At the molecular level, the phosphoglycerides that constitute cell 
membranes are diverse in charge (positive, negative or zwitterionic), aliphatic 
chain length (most commonly 14 to 18 carbons), as well as chain saturation 
4 
(typically at the Δ9 position) [14]. Additionally, membranes are not uniform among 
species or even within the cell organelles. Furthermore, head group charge 
differentiates between the inner and outer leaflet of a single lipid bilayer based on 
the location of biosynthetic machinery [15]. This diversity contributes to the ideal 
functioning of membrane proteins, the machinery embedded in the membrane that 
allows for transportation of nutrients and waste or act as transmitters or receivers 
of information. For example, Gustavsson et al. discovered that a calcium 
transporter, the sarco-endoplasmic reticulum calcium ATPase (SERCA) has 
greater activity when in the presence of negatively charged headgroups such as 
phosphatidylserine (PS) and/or upon increasing the aliphatic chain length [16]. 
 
1.3 Membrane proteins 
As alluded to in the previous section, the formation of concentration gradients 
and the uptake of nutrients or the release of waste is not possible without channels 
or pumps for which hydrophilic ions and organic material pass through the 
hydrophobic lipid membrane. From a bird’s eye view of a lipid bilayer, one might 
imagine a sea of lipids with randomly dispersed membrane proteins “floating” 
within. Despite the importance of this fluid mosaic model of lipid and membrane 
protein interactions provided by Singer and Nicholson in 1972 [17] the next 50 
years would prove this model was inaccurate. 
Organisms express thousands of membrane proteins, and in eukaryotes, 
membrane proteins account for approximately 30% of the human proteome [18, 
5 
19]. These proteins often have an interaction energy greater than thermal 
energies, forming homo or heteromeric complexes [9]. This enables fine tuning of 
the concentration gradients of various ions and molecules. Additionally, the lipid 
membrane is home to several other organic molecules such as steroids, like 
cholesterol, vitamins, like vitamin D, and eicosanoids. Drugs like ibuprofen and 
acetaminophen inhibit the synthesis of eicosanoids to limit pain and inflammation 
[14]. Lastly, the fluid mosaic model lacks an understanding of the heterogeneity 
displayed within the lipid bilayer. Barriers created by fixed molecular assemblies 
such as the cytoskeleton of large protein complexes create partitions through 
which proteins cannot freely diffuse [20]. Furthermore, the controversial topic of 
lipid rafts, a transient bilayer domain resembling the liquid-ordered phase in which 
membrane proteins experience dampened dynamics, adds another layer of 
complexity left out by the fluid mosaic model [20]. 
Ultimately, biophysical 
research is driven to 
understand how the 
machinery of the cell 
functions, how it 
malfunctions in disease, and 
to identify, site specifically 
within the machinery, drug 
targets that can be 
leveraged to restore normal 
 
Figure 1.1: Secondary structure of 
transmembrane proteins 
A. An example of a β-barrel transmembrane 
protein: the voltage-gated anion channel (PDB: 
dK4T). B. An example of an α-helical 
transmembrane protein: sarcolipin. 
 
6 
function. Half of all drug targets are membrane proteins [21] which can be 
classified as either integral membrane proteins or peripheral membrane proteins. 
 
1.4 Integral membrane proteins 
Integral membrane proteins are amphiphiles tightly bound to membranes 
by hydrophobic interactions [14]. Due to the amphiphilic nature, most integral 
membrane proteins span the entirety of the lipid bilayer (transmembrane proteins) 
interacting with the nonpolar carbon chains and the polar phosphate head groups. 
All membrane proteins contain some portion that is water soluble; no protein is 
known to be completely buried in a membrane [22]. Due to lipid membrane 
asymmetry and the location of peptide synthesis, membrane proteins orient 
asymmetrically as well [23]. Often, if the integral membrane protein is an ion 
channel or pump, orientational asymmetry results in a coordinated redistribution of 
ions in space, leading to changes in the chemical potential and a manifestation of 
a “flow of information” [24]. 
The transmembrane domains of integral membrane proteins may consist of 
two secondary structure motifs: an anti-parallel β barrel (Fig. 1.1A.) or an α-helix 
(Fig. 1.1B.). These two motifs have strong hydrogen bonding interactions that 
outcompete those of its surroundings [25]. α-helical membrane proteins can have 
a single transmembrane helix or bundle together with up to 20 total helices where 
changes in topology can lead to protein function [26]. Isoleucine, leucine, and 
valine are the most common amino acids found in transmembrane α-helices due 
7 
to their propensity to form hydrophobic interactions with the bilayer. β-barrel 
membrane proteins create a barrier between the hydrophobic lipid bilayer, often 
forming hydrophilic pores for which soluble biomolecules can diffuse called 
channels. To date, 3.6% of the protein data bank are transmembrane proteins with 
80% of those being α-helical. 
The difficulty of membrane protein structure determination is multifarious. 
Over-expression and purification can prove to be strenuous tasks as these proteins 
tend to aggregate or precipitate out of the solution without surfactants or lipid 
membrane mimetics. Additionally, the technology behind the techniques used to 
study these proteins are years behind those used for their soluble counterparts. 
Most importantly, creating a physiologically relevant lipid bilayer mimetic is difficult 
due to the heterogeneity of the lipid membrane. Nevertheless, with the field still in 
its infancy, these challenges present an 
opportunity for rapid growth. 
 
1.5 Peripheral membrane proteins 
Peripheral membrane proteins (Fig. 
1.2) interact with the lipid bilayer 
transiently through electrostatic, 
hydrophobic and selective post-
translational lipidations, making the 
conformational energy landscape 
complex. Contributing to the intricacy, 
 
Figure 1.2: Surface proteins 
An example of a peripheral 
membrane protein: Myelin protein 2. 
 
8 
these interactions often occur in tandem: e.g., long-range electrostatic interactions 
that contribute to the localization of peripheral membrane proteins to the bilayer 
followed by a folding upon binding driven by hydrophobic interactions.  
Electrostatic interactions are primarily driven by the presence of negatively 
charged phospholipid headgroups such as phosphatidylglycerol (PG), 
phosphatidic acid (PA), phosphatidylserine (PS), and phosphatidylinositol (PI) [27]. 
Most peripheral proteins are cationic, however, ligand binding to an anionic 
peripheral protein can induce a conformational change exposing positively 
charged residues previously buried within the protein known as an “electrostatic 
switch” [28]. While electrostatic interactions are nonspecific, the specific 
headgroup profile of each membrane found within the cell (e.g. plasma membrane, 
endoplasmic reticulum (ER), mitochondrial membrane, etc.) or even of each leaflet 
can lead to recruitment of the necessary components for protein function at the 
membrane [27]. 
Hydrophobic interactions occur between residues I, L, V, G, P, A, W, F, or M 
and the lipid membrane. These interactions are used as an anchor to the 
membrane and can occur simply by a hydrophobic stretch in the primary amino 
acid sequence, or by induced conformational changes resulting in secondary 
structural moieties [29, 30]. Commonly, lipid binding requires interactions with the 
interfacial region of the bilayer (the ~15 Å region between the ~15 Å hydrocarbon 
core and the bulk water [31]) demanding a balance between hydrophobic and 
hydrophilic interactions. 
9 
The most abundant membrane surface induced secondary structural moiety is 
the amphipathic helix (Fig. 1.3A.). Amphipathic helices have been demonstrated 
to have functions beyond anchoring the protein to the membrane. They induce 
membrane deformation, fission and fusion, sense membrane curvature, coat lipid 
droplets, sense membrane composition, and can even be sensitive to stress 
conditions such as reactive oxygen species (ROS) [32]. This variety of function is 
derived from the degree to which the helix is coiled (α-helix, 3-10, 3-11, π), the 
length of the helix, and the primary amino acid sequence defining the interfacial 
properties of the amphipathic helix. Properties such as charge distribution and the 
basicity/acidity of the polar face, or the bulkiness of the sidechains can increase 
the specificity of the amphipathic helix to the biological function [32]. 
To quantify the amphiphilicity of a polypeptide to aid in amphipathic helix 
prediction, Eisenberg defined the mean helical hydrophobic moment in 1982 [33] 
as 
 
Figure 1.3: Amphipathic helices 
A. An example of an amphipathic helix with hydrophobic residues colored red and 
hydrophilic residues colored blue. B. An Eisenberg plot with each “phase” labeled 








where 𝐻𝑖⃑⃑⃑⃑  is the vector representing the hydrophobicity of residue side chain i and 
N is the total number of residues. A large value of this mean vector sum of the 
hydrophobicities predicts that the helix is amphipathic and sits perpendicular to the 
membrane normal. Eisenberg developed a type of phase diagram for the 
prediction of globular, transmembrane, and peripheral proteins by relating the 
mean helical hydrophobic moment to the mean hydrophobicity (Fig. 1.3B.). The 
ability to predict these structures has seen a heightened importance in a recent 
push to study intrinsically disordered proteins (IDPs) which sample transient 
secondary structures or undergo disorder to order transitions upon ligand binding 
to promiscuously interact with many functionally diverse ligands. 
 
1.6 Intrinsically disordered proteins 
The transfer of information from DNA to RNA to a unique, well-defined protein 
structure resulting in a unique structure-function relationship has been, and often 
still is, the motivation behind biophysical protein research. However, until Huber 
discussed the possibility of conformational flexibility and the possible significance 
of “temperature factors” and “microstates” for protein function, many assumed 
proteins could only access one state. We now know that the missing electron 
density in X-ray crystallographic studies was a result of crystal packing effects [34], 
and that intrinsic disorder within proteins is a precursor for a protein to possess a 
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wide range of binding partners resulting in different biological functions [35]. With 
a turning point in the year 2000 when Uversky discussed “natively unfolded” 
proteins under physiologic conditions, IDPs slowly revealed themselves to 
scientific inquiry [36, 37]. The most recent predictions estimate that the level of 
disorder within an organisms proteome increases with organism complexity [38]; 
55% of the human proteome is comprised of proteins with >30% predicted disorder 
[39]. 
 
Figure 1.4: Energy landscapes of IDPs vs. well folded proteins 
A. An example of an ensemble of structures for an intrinsically disordered 
protein: the spinach thylakoid soluble phosphoprotein (PDB: 2FFT). B. An 
example of a well folded protein: the E. coli maltose transporter (PDB: 2R6G). 
C. An example of an energy landscape for an intrinsically disordered protein 
(left) and a well folded protein (right). Well folded proteins have one primary 
location with low energy defining a fold, while IDPs have many shallow wells 
allowing for the protein to “hop” between conformations. 
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 IDPs differ from globular proteins beginning at the amino acid sequence. It 
is understood that charge, hydrophobicity, complexity and flexibility are unique to 
intrinsically disordered proteins selected by evolutionary pressure [35]. Initially, 
disordered regions in a protein were thought to simply be non-functional linkers 
between secondary structures, tethering the folded, functional domains spatially. 
For well-folded proteins, biological function is preserved evolutionarily by 
conserved amino acid sequences. The specific location of one of the 20 naturally 
occurring amino acids is identical through generations by natural selection. The 
entropy of one specific site in the primary amino acid sequence is therefore 
decreased and the information content of the molecule is increased (positional 
information) [24]. For IDPs, information content can also be evolutionarily 
maintained through conservation of chemical properties such as charge, 
hydrophobicity or plasticity over 10s of amino acids despite significant alterations 
in primary amino acid sequence, high conformational entropy (Fig. 1.4) , or lacking 
the ability to fold post-ligand-binding [24, 40]. This discrepancy between how 
information content is preserved within well-folded and intrinsically disordered 
proteins appears polarizing, however in reality, all proteins are on a sliding scale 
of “ordered-ness”, where even the most folded proteins experience some amount 
of flexibility and conformational dynamics [35]. 
To be evolutionarily conserved, kinetic and/or thermodynamic advantages of 
ligand binding must exist. A theory of kinetic advantage called the fly-casting 
mechanism [41] suggests that disordered proteins possess increased capture 
radius due to conformational flexibility, however, this has been a contentious point 
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when thinking about kinetic advantages of IDPs and has proven difficult to observe 
experimentally. A more probable theory is the relief of steric hindrances and an 
increase in long-range electrostatic interactions contribute to an increase in the 
probability of “meaningful” interactions between the IDP and the ligand [42, 43] 
compensating for the additional kinetic bottle neck of protein folding [44].  
Thermodynamically, the affinity and specificity of interactions with IDPs are 
often decoupled resulting in highly specific yet weak interactions [45] due to the 
entropic penalty paid upon protein folding. This seemingly paradoxical effect is 
ideal for signal regulation where interactions need to be switched off rapidly 
corresponding to cellular conditions. An example of the thermodynamic advantage 
of IDPs for ligand binding is the polyelectrostatic effect. This theory describes the 
decrease in the equilibrium dissociation constant by increasing the number of 
discrete charges throughout an entire IDP [46]. Rather than considering specific 
protein-ligand interactions, this theory accounts for multiple transient 
conformations and their global effect on minimizing the free energy of binding. 
Molecular recognition features (MoRFs) are mostly disordered until bound to a 
ligand subsequently undergoing secondary structural rearrangement. These 
interactions result in transient, micromolar affinity complexes [47] and have been 
divided into subsets based on the induced secondary structural element: α- (alpha 
helical), β- (forms beta-sheets or strands), and i-(irregular hydrogen bonding 
patterns). MoRFs have defining characteristics that can help lead to their prediction 
and discovery, such as enrichment in I F,W,L, M and Y residues. Continuing with 
the alpha-helix as an example, α-MoRFs are enriched in I,F,L, and M residues [48]. 
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Thus, the potential kinetic advantages and decoupling of specificity and affinity 
allow for a hypersensitivity to changes in the physiological environment. 
 
1.7 Cardiophysiology 
An adept model for signal transduction through membranes can be found 
within the cardiomyocyte. The heart controls the flow of matter to various parts of 
the body and vice versa. Cardiomyocytes, which make up contractile chambers of 
the heart, work in unison to pump blood throughout the cardiovascular system 
carrying nutrients such as O2. Synergistic contraction of cardiomyocytes is dictated 
through myogenic electrical signaling called excitation-contraction coupling (ECC) 
[49]. The signal originates from the sinoatrial node and while they are not reliant 
on the nervous system for conception, they are strongly influenced by the 
autonomic nervous system [49]. The electrical impulses, communicated between 
cardiomyocytes by gap junctions during systole, coordinate the contraction 
mechanism throughout the chamber. 
To understand how information is transmitted during ECC, a schematic of the 
structure of the heart is required (Fig. 1.5). The sarcolemma is the lipid membrane 
creating the barrier between extracellular and intracellular space. Membrane 
proteins that act as pumps, channels and transporters are located within this 
membrane. These membrane proteins control the flow of ions. Within the cell an 
important organelle called the sarcoplasmic reticulum (SR) resides in the 
cytoplasm. The electrical signal that “transmits information” is the flow of Ca2+, Na+, 
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and K+ ions between the extracellular space, intracellular space, and sarcoplasmic 
reticulum called the action potential. This coordinated flow of ions is controlled by 
the opening and closing of the membrane proteins starting with a resting 
membrane potential of ~-90mV. This takes place during muscle relaxation, or 
diastole, and is known as phase 4 of the action potential cycle. The membrane 
potential at this phase is primarily preserved by K+ ions permeating the membrane 
 
Figure 1.5: ECC: Calcium regulation in the cardiomyocyte action 
potential 
Ca2+ leak through the L-type Ca2+ channel induces Ca2+ release from SR via 
RYR. Binding of Ca2+ to the sarcomere initiates contraction. SERCA Ca2+ 
reuptake into the SR initiates relaxation which is regulated by PLN, PKA and 
HAX-1. 
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with assistance from membrane channels such as the sodium-potassium pump or 
the sodium-calcium exchanger. Na+ and Ca2+ can also leak through gap junctions 
via an action potential from a neighboring cell, increasing the resting membrane 
potential from -90mV to -70mV. Once a threshold membrane potential of ~-70mV 
is achieved, phase 0 begins where voltage gated Na+ channels rapidly open 
allowing Na+ into the cell through the sarcolemma to drive the membrane potential 
up to ~+20mV. In phase 1, new voltage gated K+ channels are opened secondary 
to the rapid depolarization leading to a slight repolarization of the membrane 
potential to ~+5mV. At this point, the main trigger of contraction, Ca2+, flows into 
the cytosol of the cell through voltage gated Ca2+ channels which leads to the 
plateauing of the membrane potential at +5mV throughout phase 2. The 
introduction of Ca2+ here initiates Ca2+ induced Ca2+ release of Ca2+ from the SR 
via channels called ryanodine receptors which triggers muscle contraction, or 
systole. The release of Ca2+ from the SR decreases the difference between SR 
and cytosol [Ca2+] from a 3 orders of magnitude difference during diastole, (100nM 
in cytosole, 100μM in SR) to a 1 order of magnitude difference during systole. The 
Ca2+ channels then close just as suddenly as they opened driving repolarization to 
~-90mV. Additionally, the Sarcoendoplasmic Reticulum Ca2+ ATPase (SERCA) 
pumps Ca2+ across the SR membrane, reducing cytosolic [Ca2+] and beginning 
relaxation of the cardiomyocyte. This process, known as phase 3, results in the 
voltage gated K+ channels shutting and brings the cycle full circle back at the 
starting position of phase 4, ready to repeat [50]. 
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1.8 Therapeutic targets for heart failure 
As of 2017, 5.7 million people in the U.S. alone suffered from heart failure (HF), 
and by 2030, greater than 8 million people are projected to be afflicted [51]. Current 
treatments of HF include β-adrenergic blockers, angiotensin-converting-enzyme 
(ACE) inhibitors, and gene therapeutics [52, 53]. To mitigate the effects of HF, 
several studies have shown that increasing SERCA2a activity can restore cardiac 
muscle function [54] and Hulot et al. have progressed the gene therapy approach 
to human clinical trials [55].  
As mentioned in section 1.7, SERCA is involved in the sequestering of Ca2+ 
ions to the SR. SERCA makes use of thermodynamic force (difference in chemical 
potentials between two different states) by using the concentration gradient of 
protons (chemical potential) and the energy released from ATP hydrolysis to 
transport [Ca2+] against a concentration gradient through the process of free 
energy transduction. This process initiates diastole. SERCA is a 110 kDa P-type 
ATPase comprised of 4 domains: the transmembrane domain formed by 10 helical 
segments, and the cytoplasmic domains called the actuator (A) domain, the 
phosphorylation (P) domain and the nucleotide binding (N) domain [56]. The two 
Ca2+ binding sites are located in the transmembrane domain incorporating 
residues E309 for binding site II and D800 for binding site I [57]. Ca2+ binding is a 
cooperative process in which binding of site I increases the affinity of site II for 
Ca2+. The binding of Ca2+ distinguishes the two main states of SERCA, E1 and E2, 
where the former is Ca2+ bound and the latter is Ca2+ free.  
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Various SERCA isoforms are found within the body [58]. In vertebrates, 
SERCA is encoded by three genes producing more than ten isoforms located 
uniquely throughout muscle tissue. SERCA1 is found in fast-twitch skeletal muscle. 
SERCA 2 is ubiquitously expressed and found in cardiomyocytes (2a/2c) smooth 
muscle, non-muscle cells (2b), as well as human skeletal muscle (2d). SERCA 3 
is found in endothelial and epithelial cells. SERCA expression is also 
developmentally regulated. The age-related decline in cardiomyocyte contractility 
is predicted to be linked with changes in SR function and studies have 
demonstrated that neural input or disease influence the pattern of SERCA 
expression [59]. Finally, the effect of electrical stimulation modulates SERCA 
expression as seen by Pette et al. [60-63]. Following 30 days of chronic low-
frequency stimulation (CLFR), SERCA2a was upregulated and SERCA1a protein 
was downregulated. CLFR ultimately resulted in partial inactivation of SERCA in 
 
Figure 1.6: PLN conformational equilibrium 
PLN Conformational Equilibrium. PLN interconverts between inhibitory T- and 
R-states. PKA conformationally selects the R-state to phosphorylate at Ser16 
driving the equilibrium to the non-inhibitory SERCA bound B-state. 
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the SR and a net decrease in SR Ca2+ transport. In addition to the therapeutics 
discussed above, small molecule activators and inhibitors are currently under 
investigation for the SERCA pump [56, 64-69]. 
Interestingly, CLFR upregulated the expression of a small 52 amino acid 
peptide that has been found to bind SERCA2a throughout its enzymatic cycle 
called phospholamban (PLN). PLN is another potential therapeutic target. PLN 
disease mutations have been identified for both gain- and loss-of inhibitory function 
[70-74]. The function of PLN is to inhibit SERCA and fine tune Ca2+ regulation 
within the cardiomyocyte. Additionally, PLN is under β-adrenergic control; 
hormones such as adrenaline and small molecule ligands such as caffeine bind 
the G-coupled protein receptor (GPCR) which initiates a cascade of signals for the 
formation of cyclic-AMP (cAMP) by the adenylate cyclase [75]. cAMP activates the 
cAMP-dependent protein kinase A (PKA), which phosphorylates several 
substrates altering the function of these key cardiac proteins. One of the proteins 
that is reversibly phosphorylated is PLN. Monomeric PLN is in conformational 
equilibrium between the dominant T-state and the minor R-state. In the T-state, 
the cytoplasmic domain of PLN is alpha-helical and lipid bound, while in the R-
state, the cytoplasmic domain is random coil and free in solution. PKA 
conformationally selects the R-state and phosphorylates Ser16, driving the 
equilibrium towards a non-inhibitory SERCA bound B-state. Phosphorylation 
results in a relief of inhibition of SERCA2a (Fig. 1.6).  
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Evidence suggests that phosphorylation levels of PLN at Ser16 and the 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylated Thr17 are 
decreased in human failing hearts. There are several potential therapeutic 
approaches that target PLN to increase SERCA2a activity. Down-regulation of 
PLN expression via short hairpin RNA has shown success in animal models [76-
78]. Moreover, inhibition of protein phosphatase inhibitor-1, the enzyme 
responsible for the decreased phosphorylation levels in failing human hearts [79-
82] has shown encouraging results for ameliorating the effects of heart disease 
[83-87]. 
Recently, HCLS1-associated protein X-1 (HAX-1) has been shown to be a 
regulator of cardiac contractility via interaction with PLN and SERCA [88-96]. 
Originally found to interact with hematopoietic lineage cell-specific protein-1 
(HCLS1), a substrate of receptor-coupled tyrosine kinases that has been shown to 
signal for both clonal expansion and deletion in lymphoid cells, HAX-1 was 
predicted to have cell survival functions [97]. This was mainly due to the predicted 
weak structural similarity to NIP3 and distribution within cells similar to the Bcl-2 
family members: HAX-1 is ubiquitously expressed and mainly localized to the 
mitochondria, while also found at the endoplasmic reticulum (ER) and the nuclear 
envelope. Structurally, HAX-1 has no homologous proteins [97]. This has caused 
sparse literature pertaining to structural characterization. There has been evidence 
that HAX-1 is primarily disordered and adopts secondary structure via Ca2+ binding 
[98]. Additionally computational methods have predicted a primarily disordered 
structure based on the primary amino acid sequence [99]. A putative membrane 
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binding alpha helix is located from amino acids 261-273 [100]. Heat shock protein 
90 (HSP90) has been discovered as a chaperone that interacts with HAX-1 
suggesting that this interaction plays a role in HAX-1 protein folding [92, 94]. 
The localization of HAX-1 to the mitochondria provided insight towards its 
protective mechanism [94]. Involved mainly in Ischemia/reperfusion injury that is 
characterized by a decrease in [ATP], increase in glycolysis, increase in [lactic], 
increase in cytosolic [Na+], and an increase in cytosolic [Ca2+] [101], HAX-1 was 
initially found to activate Caspase 3 and Caspase 9 [102]. These two proteins are 
integral in the initiation of an extrinsic apoptotic pathway where death receptors on 
the cell surface trigger a cascade of caspase activation ultimately resulting in 
permeabilization of the mitochondrial membrane [103-106]. HAX-1 interaction with 
Pro-caspase 9 deactivates caspase 9 blocking the cascade of signals to death 
effector caspases 3, 6 and 7 preventing apoptosis. This has led to decades of 
cancer research centered around HAX-1 [94, 107-127]. Therapeutic studies 
suggest that the cardiac protective mechanism of action for pravastatin may be 
maintaining the mitochondrial expression of HAX-1 [108]. Additionally, 
chemoresistance is associated with the overexpression of HAX-1, which when 
knocked down, resensitizes the previously drug-resistant breast cancer cells to 
chemotherapy [128]. Additionally, HAX-1 has been found to bind microRNAs 
(miRNAs) which are essential tumorigenesis and chemoresistance regulators 
implicated in the resensitization of breast cancer cells to the chemotherapy drugs 
such as doxorubicin as well as cisplatin [129, 130]. Suppression of HAX-1 induced 
by miRNAs are emerging as an encouraging therapeutic for resensitization beyond 
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breast cancer cells now studied in esophageal squamous cell carcinoma, 
colorectal cancer cells as well as bladder cancer cells [131-133]. 
Kranias et al. have pioneered the research driven towards understanding the 
role of HAX-1 in Ca2+ regulation [71, 72, 82, 84, 85, 87-96]. HAX-1 has been found 
to interact with both SERCA2a as well as PLN [88, 90]. The minimum binding 
region of HAX-1 for PLN is located at amino acids 203-245 while the minimum 
binding region of PLN for HAX-1 is located at amino acids 16-22. Knock out mice 
have demonstrated that HAX-1 only localizes to the SR membrane in the presence 
of PLN. Upon phosphorylation of PLN, the HAX-1 inhibitory affects were abolished 
[91]. HAX-1 interaction with PLN accounts for roughly half of the inhibition originally 
thought to be solely due to PLN [95]. Most recently, HSP-90 has been discovered 
as a quaternary member of the SERCA/PLN/HAX-1 complex by Kranias et al. and 
SERCA2a’s interactome has expanded once again thanks to her efforts [92, 94]. 
Interestingly, mitochondrial Ca2+ uptake can account for cardiomyocyte relaxation 
when the sarcolemmal mechanisms are inhibiting, suggesting HAX-1 may play a 
role at the membrane of each organelle for Ca2+ regulation within cardiomyocytes 
[134]. 
1.9 Objectives 
It has been proposed that HAX-1 increases SERCA inhibition via disruption of 
PLN pentamers, however the structural changes of HAX-1 associating to the 
membrane and binding monomeric PLN leading to increased inhibition of SERCA 
are not yet understood. I hypothesized that HAX-1 associates with the membrane 
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as well as with PLN codependently to alter PLN dynamics. To test this hypothesis, 
I used NMR spectroscopy in conjunction with other biophysical and biochemical 
techniques to probe HAX-1, PLN, SERCA and the SERCA/PLN/HAX-1 complex. 
Specifically, I aimed to answer the following questions: 
• How can HAX-1 be expressed, purified, and functionally assayed for in vitro 
biophysical characterization? 
• What is the structure of HAX-1 in solution and in the presence of lipid 
membranes?  
• How is SERCA function and PLN regulation affected by HAX-1 and how 
can a SERCA/PLN/HAX-1 complex be formed to perform NMR studies 
under fully functional conditions? 
The answers to these questions would increase the understanding of the 
molecular basis of regulation of SERCA by the PLN/HAX-1 complex. This would 
contribute to the overall goal of the lab to understand the structural basis of muscle 
relaxation via Ca2+ regulation and could provide important information to target the 
SERCA/PLN/HAX-1 complex in the treatment of heart failure. 
 
1.10 NMR spectroscopy 
While X-ray crystallography or cryo-electron microscopy can provide atomic 
resolution structures of proteins both alone and in complex with various binding 
partners, for such a dynamic protein like HAX-1, tag free structural data is most 
readily available via nuclear magnetic resonance (NMR). To understand the 
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molecular basis of regulation of SERCA by the PLN/HAX-1 complex, both solution- 
and solid-state NMR are the ideal techniques to probe the conformational plasticity 
of HAX-1 both bound to membranes and in solution. 
 
1.10.1 Basics of NMR 
The elementary description of spectroscopy hinges upon the notion that a 
molecule sits at a particular energy state, labelled by the quantum numbers that 
define the allowed quantized energy states of a particular physical property, and 
hops between this initial state and excited states of higher energy upon absorbing 
electromagnetic energy equal to the energy difference between the excited state 
and the initial state [135, 136]. While it is true that this is what is observed upon 
making a measurement, in reality the molecule can exist in a superposition of any 
number of these states prior to measurement. 
The NMR technique observes the spectrum produced by energy states of an 
intrinsic quantity of atomic nuclei, called spin, upon excitation with an 
electromagnetic field of radio wave frequency [135]. Spin, like mass or charge, is 
an inherent property of the nuclei determined by the subatomic particles that make 
up the atom and is closely related to the quantity angular momentum that is 
possessed by a rotating object [136]. The difference being that angular momentum 
requires an object to be rotating, while origination of spin does not; spin simply 
exists confirmed through experimental evidence [137] 
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Classically, the total angular momentum of a rotating diatomic molecule is 
defined by quantum number J in integer values: 
𝐿𝑡𝑜𝑡 = (𝐽(𝐽 + 1))
1
2ħ 
and gives some idea as to how fast the molecule is rotating [136]. The rotational 
energy of each state, (EJ) is proportional to the square of Ltot: 
𝐸𝐽 = 𝐵𝐽(𝐽 + 1) 
where B is the rotational constant that is small for large masses and vice versa. 
While the above equations provide information about how fast the molecule is 
rotating, the azimuthal quantum number M gives an idea about the angle and 
direction of the rotation: 
𝑀𝐽 = −𝐽, −𝐽 + 1,… , 𝐽 
These definitions remain the same for spin, but introduce a new variable to 
differentiate the two physical phenomena: 
𝑆𝑝𝑖𝑛 = (𝑆(𝑆 + 1))
1
2ħ 
While particles with integer S are “allowed” by quantum mechanical treatment 
of the angular momentum of an atom (the eigenvalues of spherical harmonics 
always result in integer values describing the spatial form of the hydrogen atom 
orbitals), another experimentally proven phenomenon, lacking any physical 
framework, exists: certain atoms can have half integer quantum numbers. 
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This discovery was first made by Enrico Fermi and follows Fermi-Dirac 
statistics, hence particles with spin ½ integer are named fermions [138]. The 
competing theory of Bose-Einstein statistics follows integer spin values, hence 
particles with integer spin values are called bosons. The fundamental particles that 
compose a particle determine whether it is a fermion or a boson. There are three 
types of particles that make up the universe: leptons, quarks, and force particles. 
Leptons are low mass particles coming in six different flavors, electrons being one 
of them. Quarks are relatively heavy, also coming in 6 varieties and are spin ½. 
Force particles mediate the action of the different particles with each other. The 
most widely known force particle is the photon. Atomic nuclei are made up of 
neutrons and protons which are composed of 3 quarks each resulting in a net spin 
½ (2 quarks with spin +1/2, one with spin -1/2). The combination of these fermions 
in parallel (+1/2++1/2) or antiparallel (-1/2++1/2) configurations ultimately 
determines the net spin of 
the atomic nuclei. 
Fortunately, for NMR, the 
Pauli exclusion principle 
means the electron 
angular momentum 
almost always cancels out 
so the total angular 
momentum is a result of 
 
Figure 1.7: Spin degeneracy 
Spin ½ states without a magnetic field applied (left) 
and Zeeman splitting with a magnetic field applied 
(right). 
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molecular rotation and nuclear spins. 
A spin state is (2I+1)-fold degenerate. Because each spin state (or angular 
momentum quantum state) has a magnetic moment associated with it, to break 
this degeneracy a magnetic field is applied. This provides the spectrum of 
observable states. Consideration of only the allowed states (whether it is a boson 
or a fermion, there are discrete, quantized energy levels) is adequate for other 
forms of spectroscopy such as IR or UV spectroscopy. Because these 
spectroscopies observe vibrational or electronic energies, the rapid and frequent 
collisions that occur within solution cause mixed states lifetimes to be very short 
[135]. Additionally, manipulating mixed states requiring higher energy 
electromagnetic fields (compared to radio waves used in NMR) such as IR 
(vibrations) and UV (rotations and vibrations) requires very short, intense pulses. 
These pulses, while possible, are not always conducive to temperature sensitive 
samples such as those found in the body [135]. Because these mixed states can 
be manipulated in a time-dependent manner in NMR, there consists a unique 
library of experiments. 
While a full quantum mechanical treatment of the mixed states is required for 
complete understanding of NMR, the vector model provides a way to visualize the 
superposition of states vital to the understanding of NMR experiments. Because 
magnetic energy depends on the interaction between the magnetic moment (𝜇) 
and the magnetic field (?⃗⃑?) we can visualize the lowest energy arrangement when 
𝜇||?⃗⃑?. Spin and magnetism are very closely linked 
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?̂? = 𝛾?̂? 
where γ is the gyromagnetic ratio and ?̂? is the angular momentum of spin s. 
Because spins have angular momentum and a magnetic moment, rather than 
aligning parallel with the magnetic field, they precess around the magnetic field 
according to 
𝜔0 = −𝛾𝐵0 
where ω0 is the larmor frequency in radians/s. The precessing magnetic moment 
vector can be visualized in cartesian coordinates where B0 is along the z-axis. The 
magnetic moment can be manipulated by R.F. pulses along any of the three axes 
at any angle representing mixtures of quantum states. 
 Relaxation from excited spin states does not occur through rotations and 
collisions of molecules. The precession of nuclei about 𝐵0⃑⃑⃑⃑⃗ is affected, however, 
through other sources of magnetism (electric currents, magnetic moments of 
electrons, and magnetic moments of other nuclei). The circulation of electrons 
within an orbital create electric currents that generate magnetic fields and affect 
the precession of the spin. The effect from these small fluctuating magnetic fields 
is small (changes the tilt angle by 10-4 degrees in a 500 MHz spectrometer), 
however, leads to ?⃗? sampling its entire range of motion. While sampling, there is a 
bias towards aligning with 𝐵0⃑⃑⃑⃑⃗. This effect on an excited spin state whose 
magnetization has been rotated 90 degrees by an R.F. pulse to the x-y plane 
results in relaxation to the ground state (precessing around the z-axis). While 
precession of nuclei is on the order of ns, this transverse relaxation process 
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requires timescales on the order of s and is the source for most of the spectrometer 






 Returning to the excited spin state of a 90-degree rotation of the nuclei, a 
second relaxation phenomena must be considered. Once the R.F. pulse is 









Since each nuclei experiences a slightly different local magnetic field due to the 
chemical environment, the precession of each individual nuclei begins to precess 
out of phase leading to transverse relaxation. For small molecules in solution, T1
 ~T2. For large molecules like proteins or for solids, T2 can be on the order 
of ms. 
Rotating magnetic moments generate rotating magnetic fields that allow for 
observation of nuclear spins in a sample. Through Maxwell’s equations it is known 
that changing a magnetic field is associated with an electric field [136]. 




If a coil is placed near the sample, the electric field sets the electrons in motion 
as an electrical current. The analogue signal generated by the spins is called a 
free induction decay (FID) and is downconverted (the raw signal oscillated too fast 
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for ADCs) and digitized by comparing it to a reference signal of a known frequency 
chosen by the spectroscopist. The FID has the form 
𝑠𝐹𝐼𝐷 = cos(𝜔0𝑡) 𝑒
−𝑡/𝑇2 
Comparing the raw signal to the reference signal results in 
cos ((𝜔0 − 𝜔𝑟𝑒𝑓)𝑡) 𝑒
−𝑡/𝑇2 
A complication now arises as the cosine function does not differentiate between 
positive and negative values of the differences in frequencies. To solve this issue 
the receiver out puts two signals (real and imaginary components): 
𝑠𝐴(𝑡)~ cos ((𝜔0 − 𝜔𝑟𝑒𝑓)𝑡) 𝑒
−𝑡/𝑇2 
𝑠𝐵(𝑡)~ sin ((𝜔0 − 𝜔𝑟𝑒𝑓)𝑡) 𝑒
−𝑡/𝑇2 
where 
𝑠(𝑡) = 𝑠𝐴 + i𝑠𝐵 
Each output is connected to its own ADC which measures the voltage level 
repeating at varying time points. For solid samples, the sampling bandwidth is 
around 250 ns, where for molecules in solution, the sampling bandwidth is around 
4 μs. The digitized signal is then Fourier transformed to the frequency domain to 
obtain the spectrum of the spins in the sample. 
 Beyond the vector model, NMR spectra hold information only interpretable 
when considering the quantum mechanics of a nuclear spin. This requires solving 
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the time-dependent-Schrödinger equation. For NMR, the motions of the electrons 
and their interactions (magnetic and electrical influences) are averaged out under 
the assumption that spin energies are assumed to be too small to effect electronic 
motions. The orientation dependence of the energy of a spin in an electromagnetic 






𝑒𝑙𝑒𝑐is the nuclear electric energy and ?̂?𝑗
𝑚𝑎𝑔
is the nuclear magnetic energy. 
For nuclei, there is no electric dipole moment and for spin ½, all electric multipole 
moments vanish: 
?̂?𝑗
elec = 0 
The nuclear magnetic energy is manipulated by the surrounding magnetic field. If 
a 3-dimensional field is considered at the site of the spin: 
?̂?𝑗 = 𝛾𝑗 ?̂?𝑗 
?̂?𝑗
mag
= ?̂?𝑗 ∙ 𝐁 
The magnetic field that the spin experiences is influenced by external and 
internal spin interactions. The external fields are B0 described by ?̂?𝑗
𝑠𝑡𝑎𝑡𝑖𝑐 and the 
applied R.F. fields described by ?̂?𝑗
𝑅𝐹(𝑡) throughout the pulse sequence as well as 









{cos(𝜔ref𝑡 + 𝜑p)𝐼𝑗𝑥 + sin(𝜔ref𝑡 + 𝜑p)𝐼𝑗𝑦} during r. f. pulse







𝛾𝑗𝐵RFsin𝜃RF| is the nutation frequency. 
The internal spin Hamiltonian of spin ½ nuclei consists of purely magnetic 
interactions (quadrupolar electronic interactions exist only for spin>½) much 
weaker than the external interactions. Chemical shift, direct dipole-dipole 
couplings, J-couplings and spin-rotation interactions are classes of interactions 
that make up the internal spin Hamiltonian. 
 
1.10.2 Chemical shift 
The chemical shift is the indirect magnetic interaction between B0 and the 
nuclei mediated by electrons. The external field induces electronic currents in the 
electron clouds surrounding atomic nuclei which in turn generates a local magnetic 
field that is typically four orders of 
magnitude weaker than B0 (Fig. 
1.8): 
𝐁𝑗




induced = 𝜹𝑗 ∙ 𝐁𝟎 
and 𝜹𝑗is a 3x3 matrix that takes into 
account that the induced field is 
 
Figure 1.8: Chemical shift 
The magnetic field (B0) induces a current 
in the electrons creating an induced 
magnetic field Bjinduced. 
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typically in a different direction than B0. For each nuclei there exists a principal set 
of axes at which the external field can be applied where the induced field is parallel 
to the external field. The average of the diagonal principal values along the 












which determines the frequency at which peaks appear in solution NMR. If all three 
principal values are equivalent, the chemical shift tensor is isotropic and is a 
sphere. If two of the values are equivalent the tensor is uniaxial and if all three 
differ the tensor is biaxial and resemble an ellipsoid. Chemical shift anisotropy 








 is the principal value 
that deviates the most from 𝛿𝑗
iso. 
Most likely, B0 does not align 
with the principal axes values: 
?̂?𝑗
CS ≅ −𝛾𝑗𝛿𝑍𝑍
𝑗 (𝜃)̅̅ ̅̅ ̅̅ ̅̅ ̅𝐵0𝐼𝑗𝑧 




depends on the molecular 
orientation (𝜃). In solids, the 
 
Figure 1.9: Direct dipole-dipole coupling 
Spin j coupled to spin k and its orientational 
dependence (θ) results in splitting of the 
signal equal to the magnitude of djk (adapted 
from R.R. Gil, et al.). 
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molecular orientation does not sample uniformly, but instead is more probable to 
have a specific orientation so the motional averaged 𝛿𝑍𝑍
𝑗 (𝜃)̅̅ ̅̅ ̅̅ ̅̅ ̅: 
𝛿𝑍𝑍
𝑗 (𝜃)̅̅ ̅̅ ̅̅ ̅̅ ̅ = ∫d𝜃𝛿𝑍𝑍
𝑗 (𝜃) p(𝜃) 
where p(𝜃) is the probability of the molecule to be found in the range of 𝜃 and d𝜃. 
 
1.10.3 Direct dipole-dipole coupling 
The second class of internal magnetic interactions is direct dipole-dipole 
coupling. This is the direct magnetic interactions of nuclear spins with each other: 
?̂?𝑗𝑘
𝐷𝐷 = 𝑏𝑗𝑘(3(𝐼𝑗 ∙ 𝑒𝑘𝑗)(𝐼𝑘 ∙ 𝑒𝑗𝑘) − 𝐼𝑗 ∙ 𝐼𝑘) 





3  which is the magnitude of the vector between the two spins 
depending on the distance, r. Considering the secular approximation and defining 
the orientation with respect to B0 in spherical coordinates [140] the magnitude 





(3cos2𝜃𝑗𝑘 − 1) 
when 3cos2𝜃𝑗𝑘 − 1 = 0, secular dipolar coupling vanishes. In solid-state NMR this 
is known as the magic angle (54.74°). In isotropic liquids, secular dipolar coupling 
averages to zero: 
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∫ d𝜃𝑗𝑘sin𝜃𝑗𝑘(3cos




where sin𝜃𝑗𝑘 gives all orientations equal probability. 
 
1.10.4 J-coupling 
The third class of internal magnetic interactions is indirect dipole-dipole 
coupling, or J-coupling, which persists in isotropic liquids. This interaction is similar 
to the chemical shift in that it is mediated by electrons, however, instead of 
providing a local magnetic field from the electron environment, J-coupling, provides 
a local magnetic field from electrons circulating through the chemical bond itself: 
?̂?𝑗𝑘
iso = 2𝜋𝐽𝑗𝑘𝐼𝑗 ∙ 𝐼𝑘 
where 𝐽𝑗𝑘 is a 3x3 matrix describing the scaler coupling (the average of the 
diagonal elements of the J-coupling tensor. Unlike the chemical shift, J-coupling is 
independent of magnetic field and anisotropic J-coupling is small enough to be 
ignored. 
 
1.10.5 Spin rotation 
The rotation of a molecule can generate circulating electric charges due to 
the charged nuclei and electrons. This generates a magnetic field, however, the 
secular component averages to zero. The non-secular part can be found to have 
an impact by causing relaxation in liquids. 
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1.10.6 Signal detection 
|𝛼⟩ and |𝛽⟩ are eigenstates of the z-component of the angular momentum 
for spin ½ and so are well defined. However, measuring the x- or y-component of 
the angular momentum leads to unpredictable measurements due to the quantum 
nature of reality. The measurement results in |𝛼⟩ or |𝛽⟩ with a probability of 50%. 
The spin, however is not restricted to only |𝛼⟩ or |𝛽⟩. It can occupy a superposition 
of states in which 
|𝜓⟩ = 𝑐𝛼|𝛼⟩ + 𝑐𝛽|𝛽⟩ 
Where 𝑐𝛼 and 𝑐𝛽 are the complex superposition coefficients. These coefficients 
have the restriction 
⟨𝜓|𝜓⟩ = 1 
How these states evolve with respect to time comprises the field of spin dynamics. 




= |𝜓⟩(𝑡) = −i?̂?|𝜓⟩(𝑡) 
And the equation of motion of a spin in an external field is 
d
dt
|𝜓⟩(𝑡) = −i𝜔0𝜏𝐼𝑧|𝜓⟩(𝑡) 
a simple differential equation with the solution 
37 
|𝜓⟩(𝑡𝑏) = 𝑒
−i𝜔0𝜏𝐼𝑧  |𝜓⟩(𝑡𝑎) 
Where 𝑒−i𝜔0𝜏𝐼𝑧 = ?̂?𝑧(𝜔0𝜏) = ?̂?𝑧(𝜙), the rotation operator. Throughout spin 
dynamics, the eigenstates remain the same except for a phase factor, while the 
superposition of states change with time. 
To quantifiably predict, via the expectation value of a given operator ?̂?, the 
time evolution of the superposition of states, or coherences, the spin density 
operator formalism is employed. This treatment begins with the realization that the 




















where the diagonal elements represent the population of |𝛼⟩ or |𝛽⟩ and the off-
diagonal elements are coherences. If we would like to measure Q for multiple spins 
occupying different states, the most likely result is given by 
⟨𝜓|?̂?|𝜓⟩ = 〈?̂?〉 = Tr{|𝜓⟩⟨𝜓|?̂?} 
However, summing |𝜓⟩⟨𝜓| for every spin is impractical, so the density operator is 
defined 
?̂? = |𝜓⟩⟨𝜓|̅̅ ̅̅ ̅̅ ̅̅ ̅ 
and 
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〈𝑄〉 = Tr{?̂??̂?} 
The coherences represent the transverse spin magnetization. Because 
coherences are complex numbers, they have a phase and an amplitude. The 
thermal equilibrium distribution between |𝛼⟩ and |𝛽⟩ can be reliably guessed via 
the Boltzmann distribution, allowing for the prediction of the ensemble of spins at 
any given time after. If R.F. pulses are applied, it is a simple treatment of the 
density matrix with the appropriate sandwich rotation matrices. 
 
1.10.7 Relaxation 
Diminishment of the FID requires a treatment for the prediction of the 
relaxation of the magnetization back to thermal equilibrium. Contributing factors to 
the relaxation rate constants are dipolar, chemical shift anisotropy and quadrupolar 
interactions and vary with molecular rotational tumbling rates (𝜏𝑚). The origin of 
nuclear spin dynamics begins with the quantum mechanical master equation: 
d
d𝑡
𝜎(𝑡) = −i[H𝑠, 𝜎(𝑡)] − ?̂̂?{𝜎(𝑡) − 𝜎0} 
where H𝑠 is the spin Hamiltonian and 𝜎(𝑡) is the reduced density operator. 𝜎(𝑡) is 
used to find the expectation values of a set of operators that only interact with 
nuclear spins. 𝜎(𝑡) is a matrix consisting of diagonal elements (populations) and 
off diagonal elements (coherences). ?̂̂? is the relaxation super-operator that drives 
the density operator towards its equilibrium value by accounting for dissipative 
interactions with the lattice; an operator that accounts for the interactions ignored 
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by the selected set of spin operators [142]. ?̂̂? is an operator that operates on 
operators and subsequently requires a transformation from Hilbert space, spanned 
by state functions, to the Liouville space, spanned by the corresponding linear 
operators. For example, consider the commutator superoperator Ĥ̂. The 
eigenvalues for Ĥ (εr) are equal to the energy states of the system; therefore, the 
eigenvalues for Ĥ̂ are 
𝜔𝑟𝑠 = 𝑟 − 𝑠 
containing the differences between energy states of the system [142]. Defining the 




𝐌𝑗(𝑡) = 𝛾𝐌(𝑡) × 𝐁(𝑡) − 𝐑𝑗{𝐌(𝑡) − 𝐌0} 
where 𝐁(𝑡) is the external magnetic field and 𝐌𝑗 is the bulk magnetization of the 






















However, this description is limited to systems without spin-spin coupling. Semi-
classical relaxation theory accounts for the spin-lattice interactions by attributing 
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where 𝐴(𝑞) are operators that act exclusively on the spin system. A correlation 
function characterizes these random processes: 
g(𝑞,𝑞
′)(𝜏) = 𝐹(𝑞)(𝑡)𝐹(𝑞
′)∗(𝑡 + 𝜏)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ 
Experimentally, the autocorrelation function forms the basis for the 
relaxation of nuclei: 
𝔾(𝑡) = 〈𝐵𝑥(𝑡)𝐵𝑥(𝑡 + 𝜏)〉 = 〈𝐵𝑥
2〉e−|𝜏|/𝜏𝑐 
defining the fluctuation of the local field (𝐵𝑥) for a time (τ) that decays based on the 
correlation time (τc) [136]. Two times the Fourier transform of the correlation 
function defines the frequency at which the local field fluctuates (spectral density) 
which the Lipari-Szabo model defines as 




where C(t) is the correlation function defined by the product of the overall motion 
(CO(t)) and internal motion (CI(t)). The internal motion is defined by the timescale 
of the motions, called the effective correlation time (τe), and the order parameter: 
𝐶I(𝑡) = 𝛰
2 + (1 − 𝛰2)𝑒−𝑡/𝜏𝑒 
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where 𝜏 = 𝜏𝑒 + 𝜏M [143]. Through Maxwell’s relations, the free energy derived from 
the experimentally determined partition function through the relaxation of atomic 
nuclei can then be used to find any thermodynamic parameter of the system [6]. 
 
1.10.8 Solid state NMR 
The isotropic 
tumbling of molecules in 




times on the ns 
timescale are essential 
for the narrow linewidths 
of solution-state NMR. 
Even detergent-
 
Figure 1.10: Tensor diagram for O-ssNMR 
Pictorial representation of the chemical shift principle 
components with respect to the orientation of the 
amid plane. (adapted from Gustavsson et al.). 
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solubilized membrane proteins are isotropic in solution allowing for solution-state 
NMR experimentation. Narrow linewidths produce high resolution spectra to easily 
observe atomic resolution, site specific information. The source comes from the 
motionally averaged dipolar couplings averaging to zero. The addition of lipid 
vesicles increases correlation times 1,000 fold to several μs [144], leading to broad 
powder patterns representing all possible orientations of the molecule. This limits 
solution-state NMR experimentation with lipid mimetics to detergent micelles only. 
Solid-state NMR (ssNMR) is the gold standard for NMR on membrane 
proteins in the presence of lipid bilayers. ssNMR consists of two main techniques: 
oriented ssNMR (O-ssNMR) and magic angle spinning (MAS) ssNMR. O-ssNMR 
magnetically aligns all the molecules in the sample using the spectrometers 
magnetic field. This removes the powder pattern and results in each nucleus giving 
rise to only one peak. Each peak is orientation dependent. The lipid bilayer mimetic 
that orients the sample is called a bicelle which is composed of short chain and 
long chain lipids forming a liquid crystalline phase that spontaneously align. The 
alignment of a sample provides information otherwise unobservable by solution-
state NMR. For example, the physical description of the amide nitrogen chemical 
shift is as follows: 
𝛿𝐼 = (𝛿33 − 𝛿11)sin
2𝛽cos2(𝛼 − 17) + (𝛿11 − 𝛿22)sin
2𝛽 + 𝛿22 
Where α and β are defined according to Fig. 1.10 and the principal values of the 
chemical shift tensor are 64 ppm, 77 ppm, and 217 ppm respectively [145]. 
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3 cos2 𝜃𝐻𝑁 − 1
2
) 
Where ΘHNis the angle between the N-H bond vector and the magnetic field, B0, 
and rHN is the distance from the amid nitrogen to the amid proton, produces a two-
dimensional spectrum acquired by separated local field (SLF) experiments [140]. 
One such experiment is the Polarization Inversion Spin Exchange at the Magic 
Angle (PISEMA) experiment, in which the expected 3.6 residues per αhelical turn 
can be observed in a wheel like pattern called the polarity indexed slant angle 
(PISA) wheel [146, 147]. The size and location of the wheel are correlated to the 
angle between the helical axis and the normal of the bilayer. In conjunction with 
the location of the resonances in the helical wheel provide topological information 
on tilt angle and rotation angle of a transmembrane helix. MAS gets its name from 
the removal of dipolar couplings via mechanical orientation of the sample at an 
angle of 54.7°, as mentioned in section 1.7.3, and spinning at rates up to 120 kHz. 
Because the dipolar coupling term depends on 
𝐷𝐼𝑆 ∝
3 cos2 𝜃𝐻𝑁 − 1
2
 
Which is equal to zero when 
𝜃𝐻𝑁 = 54.7° 
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Averaging the secular contributions of the dipolar coupling by spinning the sample 
around 𝜃𝐻𝑁 at high rates removes the dipolar coupling creating narrow linewidths 
in solid-state spectra [140].  
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Abstract 
Membrane proteins mediate a plethora of cellular functions and represent 
important targets for drug development. Unlike soluble proteins, membrane 
proteins require native-like environments to fold correctly and be active. Therefore, 
modern structural biology techniques have aimed to determine the structure and 
dynamics of these membrane proteins at physiological temperature and in liquid 
crystalline lipid bilayers. With the flourishing of new NMR methodologies and 
improvements in sample preparations, magic angle spinning (MAS) and oriented 
sample solid-state NMR (OS-ssNMR) spectroscopy of membrane proteins is 
experiencing a new renaissance. Born as antagonistic approaches, these 
techniques nowadays offer complementary information on the structural topology 
and dynamics of membrane proteins reconstituted in lipid membranes. By spinning 
biosolid samples at the magic angle ( = 54.7o), MAS NMR experiments remove 
the intrinsic anisotropy of the NMR interactions, increasing spectral resolution. 
Internuclear spin interactions (spin exchange) is reintroduced by RF pulses, 
providing distances and torsion angles to determine secondary, tertiary as well as 
quaternary structures of membrane proteins. OS-ssNMR, on the other hand, 
directly detects anisotropic NMR parameters such as dipolar couplings (DC) and 
anisotropic chemical shifts (CS), providing orientational constraints to determine 
the architecture (i.e., topology) of membrane proteins relative to the lipid 
membrane. Defining the orientation of membrane proteins and their interactions 
with lipid membranes is of paramount importance since lipid-protein interactions 
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can shape membrane protein conformations and ultimately define their functional 
states. In this Accounts, we report selected studies from my group integrating MAS 
and OS-ssNMR techniques to give a comprehensive view of the biological 
processes occurring at cellular membranes. We focus on the main experiments for 
both techniques, with an emphasis on new implementation to increase both 
sensitivity and spectral resolution. We also describe how the structural constraints 
derived from both isotropic and anisotropic NMR parameters are integrated into 
dynamic structural modeling using replica-averaged orientational-restrained 
molecular dynamics simulations (RAOR-MD). We showcase small membrane 
proteins that are involved in Ca2+ transport and regulate cardiac and skeletal 
muscle contractility: phospholamban (PLN, 6 kDa), sarcolipin (SLN, 4 kDa), and 
DWORF (4 kDa). We summarize our results for the structures of these 
polypeptides free and in complex with the sarcoplasmic reticulum (SR) Ca2+-
ATPase (SERCA, 110 kDa). Additionally, we illustrate the progress toward the 
determination of the structural topology of a six transmembrane protein associated 
with succinate and acetate transport (SaTP, hexamer 120 kDa). From these 
examples, the integrated MAS and OS-ssNMR approach, in combination with 
modern computational methods, emerges as a way to overcome the challenges 




Membrane proteins are involved in vital cellular events, mediating intra- and 
inter-cellular communication.[149] Their structure and function are regulated by 
diverse lipid membranes that constitute various cellular compartments. The 
heterogeneous membrane environment is a significant barrier for classical 
structural biology methods, and the characterization of membrane proteins at 
atomic resolution remains an outstanding challenge. Currently, X-ray 
crystallography is the method of choice for determining the structural features of 
membrane proteins in their ground states. The majority of membrane protein 
structures deposited in the protein data bank (PDB) have been determined by X-
ray in detergent preparations. However, detergents are a rough approximation of 
native membranes and are somewhat problematic, as they introduce structural 
distortions and deviations from a proteins’ native state.[150, 151] The outstanding 
progress in cryogenic electron microscopy (cryo-EM) has facilitated the structure 
determination of membrane proteins in nearly native-like states.[152] However, 
both X-ray and cryo-EM fall short in the characterization of lipid-protein interactions 
as well as in the determination of membrane protein orientation relative to the lipid 
membranes (i.e., topology). More importantly, these methods cannot probe the 
timescale of the functional dynamics of membrane proteins.  
Solid-state NMR (ssNMR) methods are now reaching a level of sophistication, 
enabling the characterization of membrane proteins’ structure, dynamics, and 
interactions.[153] In the past, ssNMR of membrane proteins relied on two distinct 
techniques: magic angle spinning (MAS)[154] and oriented sample (OS)[155] 
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ssNMR. While the first approach removes the anisotropy from the NMR physical 
observable by spinning at the magic angle to obtain high-resolution spectra,[156] 
the latter exploits anisotropic NMR parameters to obtain the orientation of 
membrane proteins’ helical or -sheet domains.[157] While MAS NMR techniques 
are ideal for measuring distances and torsion angles of a protein’s backbone, OS-
ssNMR directly measures the orientation of amide groups relative to the 
membrane bilayers. Specifically, this method provides tilt and rotation angles of 
membrane protein domains with respect to the bilayer normal. A significant 
advantage of ssNMR spectroscopy over X-ray and cryo-EM is the site-specific 
characterization of a protein’s motion, including the timescale at which these 
motions occur, as well as the depiction of the different energetic and functional 
states. Following in the footsteps of solution-state NMR,[158] ssNMR is emerging 
as an atomic resolution technique uniquely suited for detecting conformationally 
excited states,[159-161] high-energy conformations that exemplify intermediates 
of protein folding reactions, active and inactive states, or alternate conformations, 
which could be targeted by more specific allosteric drugs.  
In the following synopsis, we describe the milestones that our group has reached 
in the past decade. By all means, this survey is not exhaustive and does not cover 




2.2 Membrane mimetic systems for high-resolution ssNMR 
spectroscopy 
The functional reconstitution of membrane proteins in membrane mimetic 
systems is an essential step for the structural and functional characterization by 
ssNMR. Detailed protocols have been outlined by Das et al.[162] For MAS, we 
reconstitute recombinant membrane proteins in lipid vesicles via detergent-
mediated preparations. For OS-ssNMR studies, we have been using two main 
procedures, involving either mechanically or magnetically aligned membrane 
preparations.[162] Both reconstitution protocols have their merits and limitations. 
Mechanically aligned systems are prepared by spreading the lipid-protein mixtures 
on solid supports (typically glass plates), and with iterative hydration/dehydration 
cycles, both lipids and proteins align in a lasagna-like stacking of phospholipid and 
protein layers. These preparations are detergent-free and can be obtained using 
mixed lipid compositions to approximate native membranes. Magnetically oriented 
preparations include lipid bicelles,[163] and more recently, nano- and macro-
discs.[164] Lipid bicelles were among the first systems to be utilized for magnetic 
alignment of membrane proteins.[165] Bicelles are formed by one or more lipid 
types (long-chain component) and a detergent that solubilize the lipids (short-chain 
component). Depending on the ratio between the long- and short-chain 
components, anisotropic bicelles adopt a discoidal shape or a Swiss cheese 
phase.[166] Unlike mechanically aligned membrane systems, the composition of 
bicelles has more restrictions as many lipids prevent the formation of stably aligned 
phases for NMR measurements.[167] Also, the presence of proteins modifies the 
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phase diagram of bicelles, and the conditions to obtain uniform orientation are 
often very narrow. 
Another hurdle is represented by detergents (e.g., 1,2-dihexanoyl-sn-glycero-3-
phosphocholine, DHPC) that may interact with membrane proteins competing out 
lipids and causing the disruption of the bicellar phase.[151] Nonetheless, 
membrane proteins reconstituted in bicelle preparations possess more favorable 
conditions for ssNMR spectroscopic analysis.[168] The dynamics of bicelles 
 
Figure 2.1: MAS and OS-ssNMR studies of single pass membrane proteins 
PLN and SLN 
A. Structure and membrane orientation of PLN obtained from a combination of 
isotropic and anisotropic restraints. B. 13C,13C-DARR spectrum of PLN in lipid 
vesicles. C. SE-SAMPI4 spectrum of PLN in oriented lipid bicelles. D. Structure 
and orientation of SLN in lipid membranes calculated using both MAS and OS-
ssNMR data. E. 13C,13C-DARR spectrum of SLN in lipid vesicles. F. SE-SAMPI4 
spectrum of PLN in oriented lipid bicelles. Note that the oriented spectrum of SLN 
was obtained using paramagnetic doping and in the absence of Yb3+ (unflipped 
bicelles). 
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lengthen the transverse spin relaxation (T2) of proteins, resulting in sharper and 
more intense resonances. As a consequence, it is possible to obtain highly-
resolved two-dimensional (2D) separated local field (SLF) spectra. More 
importantly, membrane proteins reconstituted in bicellar preparations make 
possible the acquisition of 3D SLF experiments, i.e., polarization inversion spin 
exchange at the magic angle (PISEMA) and SAMPI4, and residue-specific 
sequential assignments via proton driven spin diffusion (PDSD). 
 
2.3 To spin or not to spin? 
Since its incipit, ssNMR of membrane proteins has been carried out using MAS 
techniques.[169] OS-ssNMR has been relegated to an ancillary role due to the 
more demanding sample preparations. However, the redundancy of the primary 
sequences of helical membrane proteins and the inherent conformational 
heterogeneity hampers the complete sequential assignments and structure 
determination. To date, the majority of the structures solved by NMR of membrane 
proteins are backbone structures of small and medium-sized membrane proteins 
obtained by OS-ssNMR.[153] A few research groups have pioneered the 
combination of the two techniques to determine distances, torsion angles as well 
as orientational restraints.[170-175] The marriage of these techniques, often 
performed in similar membrane preparations, is very powerful. Both isotropic and 
anisotropic parameters can be combined to describe the ‘gymnastics’ of 
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membrane proteins, hopping from one state to another (Fig. 2.1). MAS techniques 
easily capture changes in the secondary structures. However, topological changes 
are more difficult to identify using isotropic NMR parameters. Transmembrane 
(TM) helix signaling occurs via intramembrane topological changes of helical 
domains, such as translation, piston, 
pivot (tilting), or rotation motions.[176, 
177] While translation or piston-like 
motions can be monitored using inter-
helical distances, tilt and rotation 
motions are often silent to the MAS 
analysis, but can be easily mapped 
using OS-ssNMR techniques. An 
example is the effects of a single 
mutation on the TM helix of DWarf 
Open Reading Frame (DWORF) (Fig. 
2.2). The proline to alanine mutation of 
this small protein affects not only the 
helical content, but also its tilt and 
rotation angles relative to the lipid 
membrane. These topological changes 
are silent to MAS techniques, but they 
can be readily characterized by SLF 
experiments (Fig. 2.2). Although 
 
Figure 2.2: Effects of single 
mutation on the topology of 
DWORF in lipid membranes 
A. SE-SAMPI4 spectra of wild-type 
DWORF (blue) and P15A mutant (red) 




(POPC) bicelles. B. Structural models 
of DWORF backbone obtained from 
replica-averaged orientational 
restrained molecular dynamics 
(RAOR-MD). Distinctive helical 
domains associated with the N-
terminus (green) and C-terminus 
(blue) are fitted to PISA models. 
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rotationally aligned MAS experiments for determining the topology of membrane 
proteins have been developed, they require fast rotational diffusion of proteins 
within lipid membranes and are often challenging for membrane proteins 
interacting strongly with lipids.[178, 179] 
 
2.4 Advanced MAS and OS-ssNMR techniques 
In the past decades, there have been several breakthroughs in MAS of 
membrane proteins. The first and most significant advancement involves the use 
of dynamic nuclear polarization (DNP)[180], which enhances the nuclear 
polarization via dipolar interactions with unpaired spin electrons, giving rise to high 
sensitivity spectra. In a few cases, this technique has dramatically improved the 
NMR spectra, and for selected membrane proteins, DNP has accessed information 
that was difficult to achieve using classical spectroscopic methods.[181] Also, 
protein perdeuteration[182] and paramagnetic doping[183] have contributed to 
speeding up NMR data acquisition. Our contribution has been in the development 
of novel pulse sequences with higher sensitivity for both MAS and OS-
ssNMR.[184, 185] Our strategy is to recover orphan spin operators that are 
discarded during the execution of conventional pulse programs. We called these 
experiments POE for Polarization Optimized Experiments (Fig. 2.3).[185] The 
essential element of POE is the simultaneous cross-polarization (SIM-CP) that 
enables the transfer of polarization from the 1H bath to two (or more) heteronuclei 
13C and 15N. Dual acquisition MAS spectroscopy (DUMAS)[186, 187] was the first 
implementation of POE. In the DUMAS scheme, 13C- and 15N-edited 2D (or 3D) 
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experiments are simultaneously registered in a single experiment using two 13C 
acquisition periods per scan. In our laboratory, 2D CC and NC correlation spectra 
are routinely acquired using DUMAS-based CXCX-NCA and Double Quantum 
Single Quantum (DQSQ)-NCO pulse sequences. After an initial analysis of CC and 
NC fingerprints, one can move on to more robust sequential assignment protocols, 
e.g., a 3D DUMAS NCACX-CANCO experiment. 
The sequential walk of carbonyl chemical shifts is obtained by matching the NCA 
planes of NCACX and CANCO data sets. In 3D DUMAS, a bidirectional SPECFIC-
CP enables the polarization transfer from 15N to 13Cα and vice versa. For selecting 
the NC bidirectional transfer, we use a four-step phase cycle on 15N (+x, -x, +x, -
x) and 13C (+x, +x, -x, -x) radio frequency (RF) spin-locks.[188] This phase cycle 
selects the N to Cα or C to N transferred polarization and eliminates the 13C and 
15N residual polarization pathways. To recover both transferred and residual 
polarization pathways of SPECIFIC-CP, we have developed the Multiple 
ExperIments via Orphan SpIn operatorS (MEIOSIS) approach that records four 2D 
spectra using two acquisitions per scan. The RF phases of SPECIFIC-CP spin-
lock pulses are Hadamard-encoded, which enables the decoding of both 
transferred and residual polarization pathways leading to simultaneous acquisition 
of four multidimensional spectra. Similarly, a 3D MEIOSIS pulse sequence was 
developed for acquiring 3D CCC or CA(N)COCX correlation together with two 
other 3D spectra, NCACB and NCOCX, as shown for succinate and acetate 
transport membrane protein (SatP) (Fig. 2.3). We have also exploited residual 
polarization to concatenate up to eight two-dimensional experiments using Multiple 
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acquisitions via sequential transfer of orphan spin polarization (MAeSTOSO) 
approach. The MAeSTOSO approach can be very useful for acquiring 2D CXCX 
and N(C)C spectra with Dipolar Assisted Rotational Resonance (DARR) mixing 
periods for both long- and short-range correlations. All of these pulse sequences 
were tested with both crystalline preparations of globular proteins and single and/or 
multi-span membrane proteins such as sarcolipin (SLN), phospholamban (PLN), 
and SatP.[189] POE can also take advantage of the afterglow phenomenon, 
introduced by Traaseth and co-workers,[190] which can be incorporated into 
Transferred Echo DOuble Resonance (TEDOR)-NCX-based pulse 
sequences.[189] The 3D version of TEDOR-NCACX-NCOCX enables the 
simultaneous measurement of CC DARR restraints in the 1st acquisition and the 
TEDOR NC distance restrains in the 2nd acquisition. This subtype of POE enables 
 
Figure 2.3: MAS Polarization Optimized Experiments (POE) on the six 
transmembrane SaTP protein transporter reconstituted in lipid membranes 
A. 2D DUMAS experiments for the simultaneous acquisition of DARR (200 ms) 
and NCA experiments. B. MEIOSIS experiment with the simultaneous acquisition 
of three 3D experiments: NCACB, CA(N)COCX, and NCOCX. 
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one to record two different experiments, the first for resonance assignment and the 
second for distance measurements. More recently, POE were developed to 
include fast MAS experiments for the acquisition of ten experiments 
simultaneously.[191, 192]  
  Parallel to the improvements of MAS spectroscopy, our group has 
developed sensitivity enhancement (SE) 
SLF and heteronuclear correlation 
(HETCOR) experiments.[184] SE-SLF 
experiments increase the signal-to-noise 
ratio (S/N) by √2.[193, 194] We routinely 
use SE-SLF for 2D experiments to 
determine the topology of membrane 
proteins’ backbones with respect to the 
bilayer normal. Recently, our laboratory 
has utilized paramagnetic relaxation 
enhancement (PRE) for the fast 
acquisition of SE-SLF experiments. By 
doping bicelles with 5% 1,2-dimyristoyl-sn-
glycero-3-phosphoethanolamine-N-
diethylenetriaminepentaacetic acid copper 
salt lipid (Cu2+-DMPE-DTPA), we found 
that it is possible to accelerate the 
acquisition of multidimensional SE-SLF 
 
Figure 2.4: Example of 3D SLF 
experiments performed on SLN 
aligned in lipid bicelles 
A. 3D SE-SAMPI4-PDSD 
spectrum of [U-15N]-SLN in 
bicelles doped with 5% Cu2+-
chelated lipids. B. 3D strip plots at 
specific dipolar coupling values 
from the 3D SE-SAMPI4-PDSD 
spectrum. The solid lines indicate 
[i, i+1] cross peaks. 
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experiments up to 3 times. The improvements in sample stability combined with 
SE techniques and PRE made it possible to acquire 3D experiments for sequential 
residues assignments in magnetically oriented bicelle samples (Fig. 2.4).[195] A 
significant drawback of the application of paramagnetic doping to multidimensional 
SE-SLF pulse sequences is the temperature variations during the experiments, 
which is due to to the relatively short pulse delay (~ 1 s). These temperature 
oscillations not only affect the thermal stability of membrane proteins, but also 
disturb the magnetic alignment of the bicellar system. To address this issue, we 
designed heat-compensated SE-SLF pulse sequences (hcSE-SLF).[196] By 
removing the heterogeneity of the resonances in the spectra, the hcSE-SLF pulse 
sequences provide approximately 20% increase in sensitivity relative to SE-SLF 
experiments. The use of PRE is now being combined with Dual Acquisition 
orIented ssNMR spectroscopy (DAISY), a technique that records 2D SLF and SLF-
Proton Driven Spin Diffusion (PDSD) OS-ssNMR spectra, simultaneously [188]. 
 
2.5 Structure calculations using ssNMR restraints 
There are several approaches to implement isotropic and orientational restraints 
in the structure determination of membrane proteins. MAS experiments provide 
structural restraints, primarily isotropic chemical shifts and distances derived from 
DARR (or PDSD), chemical shift perturbation (CSP), and PREs, similarly to 
solution-state NMR. In most of the calculation protocols distances, angles, and 
chemical shift index (CSI) are implemented as harmonic restraints.[197] However, 
distances and angular restraints for membrane proteins are often very sparse and 
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may result in ill-defined structures, with the register of TM helices poorly defined. 
This problem is common to solution NMR structures of membrane proteins in 
detergent micelles.[150] For OS-ssNMR, Opella and Nevzorov introduced 
structural fitting procedures that would offer the best fit of chemical shift anisotropy 
(CSA) and dipolar coupling (DC) to calculate backbone orientations.[198] A more 
efficient procedure was introduced by Marassi and co-workers,[199] where the 
orientational restraints were treated as harmonic restraints and minimized using a 
simulated annealing algorithm. Together with the Cross, Marassi, Opella, and 
Hong groups, we recognized the importance of using a hybrid approach that would 
include not only the physical parameters obtained by MAS or solution NMR, but 
also orientation dependent parameters obtained by OS-ssNMR.[172, 200] In our 
original calculations, we included in the force field a depth of insertion potential 
developed by DeGrado’s group that restrains the conformational freedom of 
membrane proteins within a low dielectric slab. This limits their conformational 
space to more physical minima defined by the hydrophobicity and electrostatics of 
membrane proteins. Using this protocol, we were able to determine the high-
resolution structures of SLN and PLN (monomeric and pentameric assembly).[172, 
174, 175, 200] Later on, we implemented distance, angular, and orientational 
restraints in a simulation system with explicit water and lipid environments.[201, 
202] The explicit environment provides an improved description and a more 
accurate search of the membrane protein conformational phase space.[201, 202] 
Restrained molecular dynamics samplings have been shown to be applicable to a 
many biological systems, ranging from relatively rigid structural states to 
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heterogeneous conformational ensembles of proteins, including those adopting 
multiple topological states. Given the ensemble-averaged nature of the 
experimental ssNMR data, the latter case is accounted for by imposing the 
structural restraints as an average over independent simulations (replicas) 
evolving simultaneously in the so-called replica-averaged approach. These 
restrained simulations are able to give a view on the collective protein backbone 
motions at picosecond-to-millisecond timescales. To this extent, we were able to 
accurately describe the heterogeneous conformational ensembles of PLN both in 
its monomeric[201] and pentameric[202] states. The conformational equilibrium of 
PLN matched with the distinct states that were observed by both MAS and OS-
ssNMR. 
 
2.6 Topological allostery: transmembrane signaling via dynamic 
interactions 
Unlike their soluble counterparts, membrane proteins are embedded in lipid 
bilayers where hydrophobicity is no longer a dominant force stabilizing ternary and 
quaternary structure.[203] Concomitant with the allostery occurring throughout an 
extensive network of interactions, signal transduction throughout TM domains 
must be communicated throughout a structure held together by weaker van der 
Waals forces, side-chain packing motifs (i.e., leucine zippers), specific interactions 
with lipids and physical constraints imposed by the dimensions of lipid 
bilayers.[204, 205] Indeed, hydrogen bonding plays a significant role in stabilizing 
larger α-helical bundles,[25] but how external signals are transduced throughout 
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transmembrane helices is still unknown. As 
mentioned above, rigid-body motions of the 
helical domains (i.e., topological changes) 
are among the possible structural transitions 
that characterize TM dynamic signaling. In 
the current literature, there are many 
examples of rigid-body transitions such as 
those occurring in mechanosensitive 
channels, G protein-coupled receptors 
(GPCRs), etc.[203] Distance and angular 
restraints are insufficient to define these 
global topological changes. In contrast, SLF 
experiments are extremely sensitive to small 
TM changes in rotation and tilt that propagate 
from one to the opposite leaflet of the lipid 
membranes. Among the most outstanding 
examples are the topological changes 
mapped by Traaseth and co-workers for 
EmrE using OS-ssNMR.[206] In this case, 
the topological changes of EmrE were so 
pronounced to enable the detection of 
exchanging topologies in the SLF spectra. 
Another example is the topological 
 
Figure 2.5: Two-state topological 
equilibrium of monomeric PLN 
A. Observation by MAS of two 
conformational states of PLN: the 
ground T-state and the excited R-
state. B. 2D [15N-1H] SE-SAMPI4 
spectrum of PLNAFA with (blue) and 
without (red) phosphorylation in 
flipped DMPC/POPC bicelles. The 
insets show the two-state equilibrium 
for a selective 15N-Phe labeled 
PLNAFA. C. T-state (PDB 2KB7) and 
R-state (PDB 2LPF) of PLNAFA.  
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transitions of PLN in lipid membranes. (Fig. 2.5) PLN possesses two major 
regions: a hydrophobic TM domain that inhibits the sarcoplasmic reticulum Ca2+-
ATPase (SERCA), and a cytoplasmic domain that tunes the extent of inhibition via 
phosphorylation by protein kinase A (PKA) and calmodulin-dependent protein 
kinase II (CaMKII).[207] Our original 
topology of monomeric and pentameric 
PLN were obtained in mechanically 
aligned lipid bilayers.[172, 200] Under 
these conditions, the backbone 
resonances in the SLF spectra were so 
broad that we could not fully appreciate 
the presence of two different populations 
of resonances for the TM domain. In 
contrast, the spectra in lipid bicelles 
display a major and a minor population 
with slightly different tilt and rotation 
angles (Fig. 2.5), mirroring the two 
populations (R and T states) identified for 
the cytoplasmic region by MAS 
spectroscopy (Fig. 2.5A.).  
Upon phosphorylation of Ser16 by 
PKA, we observed a shift of the ground 
population toward the lowest populated 
 
Figure 2.6: Structural 
determination of the SERCA-PLN 
complex by ssNMR 
Mapping the binding between the 
dynamic N-terminus was achieved 
previously by PRE experiments 
followed by MAS [13C-1H] rINEPT 
and [13C-13C] DARR measurements 
(adapted from PNAS 2013). 
Residues marked by red spheres 
were found to experience 
unambiguous PRE-induced line 
broadening, yellow spheres 
ambiguous and blue sphere 
unambiguously no-PRE quenched. 
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state, which becomes the dominating state. These changes are very pronounced 
for Asn30 and Asn34, whose hydrogen bond interactions stabilize the E2 (Ca2+-
free) state of SERCA. Since the inhibition of SERCA by PLN occurs via allosteric 
interactions between the TM domain of the regulator and the Ca2+ binding site of 
the ATPase (Fig. 2.6), the topological changes of the TM domain allosterically 
modulate the extent of inhibition of the enzyme (topological allostery).[208] It is 
possible that different SERCA modulators expressed in non-cardiac cells, i.e., 
regulins, might display different topologies reflecting their various biological 
activities. Therefore, the topological and allosteric diversity in regulins may 
modulate the ATPase affinity for Ca2+ ions, thereby differentially affecting calcium 
cycling.[209]  
 
2.7 Characterization of motions via ssNMR 
The characterization of the site-specific motions and more importantly the 
timescale of conformational changes are among the most important contributions 
of NMR to structural biology.[210] However, the analysis of the dynamics of 
membrane proteins in lipid bilayers is still a significant challenge. Hong and co-
workers are using the dipolar-coupling chemical-shift correlation (DIPSHIFT) as a 
means to determine the dynamics of proteins and peptides.[169] Although it is 
possible to characterize the backbone dynamics for a few selected cases, the 
heterogeneity of membrane proteins spectra represents a significant hurdle. Our 
group has been relying on a semi-quantitative analysis of the segmental motions 
using a combination of CP and refocused Insensitive Nuclei Enhanced by 
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Polarization Transfer (rINEPT) experiments.[159] Since the intensity of 
polarization obtained from these experiments depends on the dynamics of the 
proteins, the comparison of these spectra gives an overall view of the complex 
motions of membrane proteins. In 
particular, the membrane-associated 
protein domains are mapped via CP 
based experiments that rely on DCs, 
whereas the dynamic residues that 
undergo fast dynamics average out 
anisotropic interactions and retain longer 
T2 relaxation properties, which enables 
the mapping of these residues via J-
coupling based INEPT transfer 
experiments.[211] We typically start with 
1D 15N CP and rINEPT experiments to 
look at the extent of dynamics by 
comparing the backbone spectral 
intensities. Due to the presence of 
intense lipid signals, 1D 13C rINEPT 
experiments are usually less informative 
for a semi-quantitative analysis of mobile 
residues. However, a more detailed 
characterization can be made by using 
 
Figure 2.7: MAS ssNMR 
experiments on HAX-1, an 
intrinsically disordered protein of 
279 amino acids 
A. Schematic of the predicted 
structural and functional domains of 
HAX-1. B. rINEPT spectra (right) 
normalized to CP spectra (left) of 
PLNAFA in complex with HAX-1203-245, 
the PLN binding region (PBR) of 
HAX-1 and full length HAX-1. C. 
Overlay of IDP HAX-1 spectra, 
obtained from MAS RI-HSQC (red), 
and solution NMR [1H,15N]-HSQC 
(black). D. 13C-13C DARR 
experiments of HAX-1 in lipid 
vesicles. 
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13C-detected 2D 13C-13C DARR and INEPT-TOtal through Bond correlation 
SpectroscopY (TOBSY) experiments that map immobile and dynamic residues, 
respectively. To these experiments, we recently added 1H-detected sensitivity 
enhanced refocused INEPT heteronuclear single quantum correlation (RI-HSQC) 
experiments for probing sparse conformational states with populations as low as 
1%.[212] These experiments can be hybridized into new pulse sequences to map 
rigid and dynamic domains simultaneously.[213] 
 
2.8 Interactions of intrinsically disordered proteins (IDPs) with lipid 
membranes 
Although both MAS and OS-ssNMR have been extensively used to study 
dynamic small peptides interacting with membranes, studies on the interactions 
between IDPs and the membrane bilayer are still limited. In collaboration with the 
De Simone laboratory, our group has carried out a series of studies on the 
interactions between α-synuclein (α-Syn) and membrane model systems.[202, 
214, 215] α-Syn in solution exists as a disordered polypeptide, adopting a random 
coil ensemble of conformers. Upon interactions with lipid membranes, α-Syn 
adopts a helical conformation.[216] However, the membrane-binding region has 
been virtually invisible to solution-state NMR analysis. We used INEPT-based 
experiments to image the ‘dark side’ of α-Syn and identify the residues directly 
involved with the membrane interactions and possibly responsible for the pre-
fibrillar aggregates that have been hypothesized to constitute the toxic species. 
More recently, we used a combination of CP and rINEPT experiments to determine 
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the interaction of hematopoietic-
substrate-1 associated protein X-1 or 
HAX-1 with PLN (Fig. 2.7).[100] HAX-1 
is a 279 amino acid intrinsically 
disordered protein (IDP) that is thought 
to interact with PLN, modulating the 
inhibition of SERCA. Indeed, our data 
confirm this hypothesis, but further 
suggest these interactions occur via an 
amphipathic helix located on the C-
terminus of HAX-1 that interacts with lipid 
membranes (Fig. 2.7). This helix may be 
crucial for localizing HAX-1 near the 
SERCA/PLN complex as well as 
promoting a rigid, more inhibitory state of 
PLN. 
 
2.9 Conclusions and perspectives 
As for the entire field of structural biology,[217, 218] NMR is relying on multiple 
approaches to fully characterize the structure and dynamics of membrane proteins. 
Neither MAS nor OS-ssNMR possess the silver bullet; instead, the synergistic 
nature of these different approaches is emerging. Both MAS and OS-ssNMR are 
compatible with lipid compositions and ratios similar to physiological membranes 
 
Figure 2.8: Integrated MAS and 
OS-ssNMR spectroscopy of SaTP 
in lipid membranes 
A. X-ray structure of SaTP (PDB 
5ZUG)[1]. B. Predicted MAS NCA 
spectrum (left) using the ShiftX2 
Server[3] versus experimental NCA 
spectrum (right). C. Predicted SE-
PISEMA spectrum obtained from 
MD simulation versus experimental 
SE-PISEMA spectrum (right). 
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in liquid crystalline phases, which represents a significant advantage over the other 
structural biology approaches. Under these conditions, membrane proteins, if 
properly reconstituted, are active and undergo conformational transitions that 
mimic their cellular function. From a spectroscopic viewpoint, MAS NMR methods 
are progressing rapidly. However, multidimensional spectroscopy of OS-ssNMR is 
still in its infancy. Our group is able to run double resonance 2D and 3D [1H,15N] 
experiments routinely on selected samples. The quantum leap will be possible 
when triple resonance 3D [1H,13C,15N] experiments will become available for the 
unambiguous assignments of membrane proteins. The next frontier is the 
conjugation of these ssNMR methodologies to determine the structure of multi-
span membrane proteins. Fig. 2.8 shows the application of MAS and OS-ssNMR 
to a six TM protein (SaTP) involved in the transport of succinate and acetate. Both 
the simulated spectra and the experimental fingerprints for both MAS and OS-
ssNMR are rather promising, and the sensitivity of these experiments supports the 
feasibility of the structure determination. These results suggest that the future of 
ssNMR is bright. Although improvements in sample preparations, hardware, and 
pulse sequences must be in place, critical information on challenging biological 
systems can be obtained for the time being.  
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Abstract 
Protein-protein interactions (PPIs) regulate a plethora of cellular processes and 
NMR spectroscopy has been a leading technique to characterize them at the 
atomic resolution. Technically, however, PPIs characterization has been 
challenging due to multiple samples required to characterize the hot spots at the 
protein interface. Here, we review our recently developed methods that greatly 
simplify PPI studies, minimizing the number of samples required to fully 
characterize residues involved in the protein-protein binding interface. This original 
strategy combines asymmetric labeling of two binding partners and the carbonyl-
carbon label selective (CCLS) pulse sequence element implemented into 
heteronuclear single quantum correlation (1H-15N HSQC) spectra. The CCLS 
scheme removes signals of the J-coupled 15N-13C resonances, recording 
simultaneously two individual amide fingerprints for each binding partner. We show 
the application to the measurements of chemical shift correlations, residual dipolar 
couplings (RDCs) as well as paramagnetic relaxation enhancements (PRE). 
These experiments open an avenue for further modifications of existing 
experiments facilitating the NMR analysis of PPIs.  
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3.1 Introduction 
Biological processes rely primarily on protein-protein interactions (PPIs) to 
mediate cellular function [220]. Historically biochemical techniques (co-
immunoprecipitation, yeast-two hybrid, pull-down assays, etc.) measuring 
parameters intrinsic to the whole complex have been used to characterize these 
PPIs [221, 222]. Recently, advances in nuclear magnetic resonance (NMR) 
spectroscopy have provided the means to characterize PPIs at atomic resolution, 
offering fine details of individual macromolecules participating within the complex 
[223-225]. In addition to allowing the characterization of these complexes at atomic 
resolution, NMR is well suited for studying dynamic, transient (~100 μM KD), and 
lowly populated states of complexes [226-228]. 
The mapping of PPIs using several observables such as chemical shift 
perturbation (CSP), residual dipolar couplings (RDC), intra- and inter-molecular as 
well as solvent paramagnetic relaxation enhancement (PRE) [229-231], cross-
saturation (CS), and nuclear Overhauser effects (NOEs) has been well established 
[224]. These methods nevertheless fall short when studying large complexes due 
to the inherent attenuation of transverse relaxation times (T2) resulting in a 
reduction of both signal intensity and resolution. Despite methods such as TROSY 
[232], deuteration [233, 234], and selective labeling [235, 236] addressing these 
concerns, multiple samples are still required to distinguish one species from 
another. Recently, several new NMR experiments based on simultaneous, 
interleaved detection of up to three NMR active species with distinct isotopic 
labeling have provided the opportunity to map the effect of PPIs on individual 
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components within a macromolecular complex. While there are outstanding 
reviews on protein-protein interactions [237-243], here we focus on our recently 
developed method that exploits spin-echo filtering-based experiments with 
strategic protein labeling schemes to characterize protein-protein complexes. 
 
3.2 Results 
3.2.1 Mapping two binding partners fingerprints simultaneously 
Traditional approaches to map PPIs at an atomic level involve repeat 
experiments with reverse labeling patterns such that the interaction is probed from 
both binding partners. Prior to the introduction of the spin-echo filtering experiment 
by Bax et al. [244], three-bond homonuclear 1H-1H J couplings had been used to 
derive backbone and side-chain conformational restraints [245-250]. This new 
experiment relied on measuring the magnetization loss due to unresolved J 
coupling and utilized an interleaved detection method, where two spectra are 
recorded simultaneously, but differ by 180° pulse positions on the 15N channel. 
The spin-echo filtered experiment introduced by Bax is the building block for the 
Carbonyl Carbon Label Selective (CCLS) 1H-15N HSQC pulse sequence [251], 
which requires specific isotopic labeling to simultaneously map the chemical shift 
perturbations from two binding partners. The CCLS 1H-15N HSQC pulse sequence 
utilizes spin-echo filtering with a short magnetization transfer period between 15N 
and 13C’ in order to detect 1H-15N correlations adjacent to the NMR inactive (12C’) 
carbonyl groups (Fig. 3.1A.). Building on the constant time (CT) HSQC, the CCLS 
1H-15N HSQC necessitates the acquisition of two spectra, a reference spectrum 
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and a suppression spectrum, in an interleaved manner. The reference spectrum is 
acquired using the pulse sequence reported in Fig 3.1A., with the 180° pulse on 
13C’ during the 15N CT evolution period applied at position a as proposed by Vuister 
et.al. [244], allowing for the removal of 13C’-15N coupling. The suppression 
spectrum is acquired with the 180° 13C’ pulse at position b, leaving 13C-15N J 
coupling active and converting the transverse in-phase magnetization of 15N spins 
linked to 13C’ to antiphase magnetization. This antiphase magnetization contains 
components in both the x- and y-direction. The π 1H and 13C pulses applied at the 
end of the 15N evolution convert the y-component, 4HzNyC’z, to an unobservable 
multiple quantum coherence, 4HyNzC’y, while the x-component, 4HyNzC’y, is 
dephased by the G2 gradient (Fig. 3.1A.). As a result, signals from 1H-15N groups 
coupled to 13C’ are suppressed, while signals from 1H-15N groups coupled to 12C’ 
are unaffected. The suppression spectrum can then be subtracted from the 
reference spectrum leaving the U-15N, 13C species observable (Fig. 3.1B.).  
We tested the sensitivity of the CCLS method by comparing a reference CCLS-
HSQC spectrum and a conventional HNCO spectrum of the 20-kDa protein U-13C, 
15N-Ubiquitin at 10, 20, 30, and 40°C corresponding to average T2 values of 27, 
33, 40, and 47 ms, respectively [251]. The slower tumbling rates at lower 
temperatures lead to longer rotational correlation times (τC) and faster relaxation 
resulting in broader linewidths. We found the reference CCLS-HSQC experiment 
was more sensitive compared to the HNCO experiment for lower temperatures, 
demonstrating that the shorter time delay (TNC) allows for increased sensitivity for 
large proteins or protein-protein complexes. The sensitivity enhancement gained 
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from optimal TNC values compensates for the decrease in S/N observed upon 
subtraction of the suppression spectrum from the reference spectrum. 
Furthermore, we applied this technique to resolve assignment ambiguities on the 
41 kDa catalytic subunit of cAMP-dependent protein kinase A (PKA-C) [252, 253]. 
PKA-C is the prototypical Ser/Thr kinase and, until relatively recently, had 
remained unexplored by NMR due to its size and presence of conformational 
exchange effects on the μs-ms timescale [254-257]. Advances in pulse sequence 
design and sample preparation have since made it possible to investigate this 
system using NMR [258-261]. We successfully implemented the CCLS-HSQC 
pulse sequence to assist in the assignment of multiple catalytically relevant 
residues of PKA-C. Furthermore, recent work from our group demonstrates the 
ability of this pulse sequence to simultaneously detect PKA-C in complex with an 
endogenous inhibitor, the heat-stable protein kinase A inhibitor (PKIα) [253, 262], 
giving the possibility to detect the mutual effect of PKA-C and PKIα interaction (Fig. 
3.1C. - unpublished data). Together these applications underscore the ability of 
CCLS to simultaneously detect PPIs and emphasizes the performance of this 
pulse sequence with high molecular weight systems. 
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Figure 3.1: CCLS pulse sequence 
A. Schematic of the CCLS-HSQC pulse sequence. It can be assumed unless 
otherwise indicated that all rectangular pulses are applied along the x-axis. 90° 
and 180° flip angles are represented by narrow bars and wide bars, respectively. 
The carrier frequency for 1H is set on resonance with water at 4.77 ppm; the carrier 
frequency for 15N is set in the center of the amide region at 121.8 ppm; the 13C 
offset is set to 174.8 for the C’ region. The reference spectrum is recorded with the 
shaped pulse for 13C’ (open rectangle) at position a while the suppression 
spectrum is recorded with this pulse in position b. A 3-9-19 watergate pulse 
scheme is used in the reverse INEPT transfer. GARP1 decoupling with a field 
strength of 1kHz is used during acquisition of 15N. Delay durations: Δ = 2.4 ms; δ 
= 0.11 ms; TNC’ = 16.5 ms. Phase cycling: φ1 = x,-x, φ2 = x,x,-x,-x, φrec = x,-x. A 
second FID is acquired for each increment by changing the φ1 phase to y,-y in 
order to accomplish States quadrature detection for the 15N indirect dimension. 
The φ1 and φrec phases are also incremented by 180° every other 15N increment 
for States-TPPI acquisition. The gradients use the Wurst shaped z-axis gradients 
of 1 ms. Gradient strengths (G/cm): G1: 5, G2: 7, G3: 17. The CCLS-HSQC pulse 
sequence is based on the fast HSQC experiment [263] to preserve water 
magnetization. 
B. Example spectra representing the reference spectrum, the suppression 
spectrum, and the resulting subtraction spectrum followed by insets from the PKA-
C/PKIα complex displaying the separation of resonances from each species. The 
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blue and red species are present in the reference CCLS-HSQC, while the 
suppression spectrum contains only red species. Subtraction of the suppression 
from the reference spectrum results in a third spectrum containing only the blue 
species. 
C. CCLS-HSQC experiment on the 50 kDa PKA-C/PKIα complex. The reference 
spectrum (left, purple) displays resonances from both U-15N labeled PKA-C as well 
as U-15N, 13C labeled PKIα (S/N = 40). The suppression spectrum (middle, blue) 
suppresses signal from the 13C’ labeled PKIα showing only peaks from 12C’ labeled 
PKA-C (S/N = 50). Upon subtraction of the suppression spectrum from the 
reference spectrum, a subspectrum is obtained containing only peaks from PKIα 
(right, red) (S/N = 15). 
 
3.2.2 Fingerprinting three binding partners using one sample 
Masterson et al. applied the CCLS pulse sequence element to deconvolute PPIs 
in a ternary mixture simultaneously [264].The dual carbon label selective (DCLS) 
1H-15N HSQC experiment requires three labeled binding partners, with the first 
species U-15N labeled, the second 15N, 13C’ labeled, and the third U-13C, 15N 
labeled. The deconvolution of these spectra follows the same spin-echo filtering 
theory as CCLS, with additional filtering of Cα coupled spins (Fig. 3.2A.). Cα 
suppression requires a longer TNCα delay due to both inter- and intra-residue 1H-
13Cα J coupling [265]. Increasing the TNCα delay nullifies protein backbone 
conformation dependency of 1JNCα and 2JNCα as it completely suppresses signal 
from 1JNCα while inverting the residual signal intensities of 2JNCα. 
This and the previously introduced pulse sequence rely on selective labeling of 
individual binding partners. Asymmetric selective labeling schemes to study PPIs 
in a multiple component sample are increasing in popularity [266-269] both for 
solution and solid-state NMR spectroscopy. For instance, Anglister and coworkers 
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have demonstrated the application of asymmetric deuteration in combination with 
transferred nuclear Overhauser spectroscopy to study intermolecular nuclear 
Overhauser effects (NOEs) of large, fast exchanging protein complexes [270-272]. 
With respect to CCLS and DCLS, selective labeling of 13C’ can be accomplished 
in recombinant proteins using either 15N- and 13C’-labeled amino acids or 1-13C 
pyruvate and 13C-labeled NaHCO3 as the sole carbon sources [273-277]. Selective 
13Cα labeling is achieved by using 2-13C glucose as the sole carbon source [274].  
The DCLS experiment requires the acquisition of three interleaved experiments 
in parallel (Fig. 3.2B.). A reference data set is collected observing all three species 
simultaneously, followed by the first suppression data set where amide resonances 
adjacent to 13C’ are undetected, identical to the CCLS suppression spectrum. 
Lastly, a second suppression data set is collected where amide resonances 
coupled to 13Cα are not detected. Deconvolution of the spectra is obtained by a 
linear combination of the data set. Subtraction of the second suppression spectrum 
from the reference spectrum provides a subspectrum containing only resonances 
from the U-13C, 15N labeled species. The subtraction of the first suppression 
spectrum from the second suppression spectrum provides an additional 
subspectrum containing only resonances from the U-15N, 13C’ labeled species. In 
this manner, subspectra are obtained from a single sample for each individual 
component of the ternary mixture and all resonances can be resolved. As a proof 
of concept Masterson et al. applied this labeling scheme and pulse sequence to 
three non-interacting proteins, maltose binding protein (MBP), Kemptide, and 
ubiquitin. By applying DCLS, the authors obtained subspectra corresponding to 
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each individual component of the ternary mixture displaying the potential of this 
approach to study protein-protein interactions with a single sample. 
 
Figure 3.2: DCLS pulse sequence 
A. Schematic of the DCLS-HSQC pulse sequence. It can be assumed unless 
otherwise indicated that all pulses are applied along the x-axis. 90° and 180° flip 
angles are represented by narrow bars and wide bars, respectively. The reference 
spectrum is recorded with the shaped pulse for 13C (open rectangle) at position a 
while the 13C’ suppression spectrum is recorded with this pulse in position b and 
the 13Cα suppression spectrum is recorded with the 13Cα shaped pulse in position 
c. A 3-9-19 watergate pulse scheme is used in the reverse INEPT transfer. GARP1 
decoupling with a field strength of 1kHz is used during acquisition of 15N. The 
carrier frequency for 1H is set on resonance with water at 4.7 ppm; the carrier 
frequency for 15N is set in the center of the amide region at 120 ppm; the 13C offset 
is set to 56 ppm. Selective 13C’ (13Cα) sine shaped pulses are centered at 174 (56 
ppm) and a null 113 ppm away. Delay durations: Δ = 2.4 ms; δ = 0.11 ms; TNC’ = 
16.4 ms; TNCα = 24.5 ms. Phase cycling: φ1 = x,-x, φ2 = x,x,-x,-x, φrec = x,-x. A 
second FID is acquired for each increment by changing the φ1 phase to y,-y in 
order to accomplish States quadrature detection for the 15N indirect dimension. 
The φ1 and φrec phases are also incremented by 180° every other 15N increment 
for States-TPPI acquisition. The gradients use the Wurst shaped z-axis gradients 
of 1 ms. Gradient strengths (G/cm): G1: 5, G2: 7, G3: 17.  
 
B. Example spectra representing the reference spectrum, the two suppression 
spectra, and the resulting subtraction spectra. The red, green and blue species are 
present in the reference DCLS-HSQC (i), while the first suppression spectrum (ii) 
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contains resonances from the red species and the second suppression spectrum 
(iii) contains resonances from the red and green species. Subtracting spectrum iii 
from i results in only resonances from the blue species and subtracting spectrum 
iii from ii yields only resonances from the green species. This linear subtraction 
scheme results in spectra with each component in the mixture isolated 
 
3.2.3 Measuring Residual Dipolar Coupling (RDC) of complexes using one 
sample 
Residual dipolar coupling (RDC) allows orientation specific data to be derived via 
dipole-dipole interactions. The orientation restraints provided by RDC have proven 
useful in protein structure determination, nucleic acid structure, domain orientation, 
and more recently PPIs [278, 279]. We implemented CCLS and DCLS to 
sensitivity-enhanced TROSY or anti-TROSY spin-state selection to record the 
simultaneous measurement of RDCs [278, 280-283] for the relative orientations of 
multiple proteins within a single sample (Fig. 3.3A.-B.). RDC measurements are 
susceptible to experimental condition variations, which alter alignment tensors 
making difficult the direct correlations of orientational constraints obtained from 
different samples. Our approach, together with specific isotopic labeling, 
eliminates the need for multiple samples thus removing errors associated with 
sample inconsistencies [278]. 
Similar to DCLS (Fig. 3.3C.), we applied this pulse sequence to a non-interacting 
mixture of U-2H, 15N MBP, 15N-Ser5, 13C’-Ala4 Kemptide, and, U-13C, 15N ubiquitin 
[284]. Following the same linear subtraction scheme reported for DCLS, we were 
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able to measure RDCs for each individual component in a ternary mixture. 
Importantly, these RDC values were in agreement with back calculated values 
determined from already solved crystal structures of MBP [285] and ubiquitin [286], 
confirming that the backbone conformational space of these proteins, along with 
their relative alignment tensors, were sufficiently defined. 
 
Figure 3.3: CCLS/DCLS RDC 
A. and B. Schematic of the gradient-selected TROSY-based pulse sequence for 
binary A. or ternary B. mixtures of proteins. It can be assumed unless otherwise 
indicated that all pulses are applied along the x-axis. 90° and 180° flip angles are 
represented by narrow bars and wide bars respectfully. The reference spectrum is 
recorded with the shaped pulse for 13C (open rectangle) at position a while the 13C’ 
suppression spectrum is recorded with this pulse in position b and the 13Cα 
suppression spectrum is recorded with the 13Cα shaped pulse in position c. The 
carrier frequency for 1H is set on resonance with water at 4.77 ppm; the carrier 
frequency for 15N is set in the center of the amide region at 121.8 ppm; the 13C 
offset is set to 56 ppm. Selective 13C’ (13Cα) sine shaped pulses are centered at 
174.8 ppm (56 ppm). Delay durations: Δ = 2.4 ms; δ1 = 1.5 s; TNC’ = 16.5 ms; TNCα 
= 23.5 ms. Phase cycling: φ1 = x,-x, φ2 = -x,  φ3 = -y, φrec = x,-x. Gradient strengths 
must be adjusted following the relationship G2 = G1·(γN/γH), where γN and γH are 
the gyromagnetic ratios of 15N and 1H, respectively. A second FID is collected for 
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each increment by changing the φ2 and φ3 to x and y respectively and by inverting 
the sign of the G2 gradient in order to accomplish States quadrature detection for 
the 15N indirect dimension. The φ1 and φrec phases are also incremented by 180° 
every other 15N increment for States-TPPI acquisition. The gradients use the Wurst 
shaped z-axis gradients of 1 ms. Gradient strengths (G/cm): G3: 3, G4: 13, G5: 4, 
G6: 5. To measure 1JHN coupling and NH RDC (in aligned media), a second 
spectrum, featuring the anti-TROSY component, is acquired by changing the φ3 
phase to y.  
C. Example spectra representing the reference spectrum, the suppression 
spectrum, and the resulting subtraction spectrum. The blue and red species are 
present in the reference CCLS-HSQC, while the suppression spectrum contains 
only red species. Subtraction of the suppression from the reference spectrum 
results in a third spectrum containing only the blue species. 
D. Example spectra representing the reference spectrum, the two suppression 
spectra, and the resulting subtraction spectra. The red, green and blue species are 
present in the reference DCLS-HSQC i, while the first suppression spectrum ii 
contains resonances from the red species and the second suppression spectrum 
iii contains resonances from the red and green species. Subtracting spectrum iii 
from i results in only resonances from the blue species and subtracting spectrum 
iii from ii yields only resonances from the green species. This linear subtraction 
scheme results in spectra with each component in the mixture isolated. 
 
3.2.4 Measuring long-range distances and transient complexes using CCLS for 
Paramagnetic Relaxation Enhancements (PRE) 
Paramagnetic relaxation enhancements (PRE) have been used extensively to 
obtain long-distance restraints for structure calculation and to study PPIs for both 
stable and transient complexes [287-292]. In the standard PRE experiment that 
involves two interacting proteins, the intra- or inter-molecular effects of a 
paramagnetic center are detected for only one of the binding partners in each 
independent NMR experiment (Fig. 3.4A.i.). To accurately probe these 
interactions, a minimum of four samples with differing spin label positions as well 
as reversed labeling schemes are required. Recently, we incorporated the CCLS 
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pulse sequence in the traditional 1HN-Γ2 (1HN-Γ2-CCLS) [289] that, together with an 
asymmetric labeling scheme, enables the detection of both intra- and inter-
molecular paramagnetic relaxation enhancements (PREs) simultaneously using 
only one sample [229] (Fig. 3.4B.). In this newly proposed strategy, one of the two 
binding partners must be U-15N labeled and the second U-15N, 13C labeled (Fig. 
3.4A.ii.). We also tested the proposed pulse sequence on the non-covalent, 
transient dimerization of ubiquitin. Specifically, we studied the complex formed 
between U-15N, 13C wild-type ubiquitin and the U-15N-spin labeled K48C mutant. 
We were able to discriminate intra- and inter-molecular interactions detecting the 
structural and dynamics changes intrinsic to ubiquitin upon dimerization (Fig. 
3.4C.). The Γ2 rates obtained with the new pulse sequence were confirmed to be 
identical to standard experiments. This work demonstrates that the Γ2-CCLS PRE 
experiment is suitable for identifying structural changes occurring in both binding 
partners upon formation of transient and permanent interactions using a reduced 
number of samples. 
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Figure 3.4: CCLS-PRE 
A. Schematic of the standard experiment for the detection of intra- and inter-
molecular PRE. In this case four different samples are needed. The first sample 
for the intra-molecular PRE is prepared with an asymmetric labeling scheme using 
the first binding partner uniformly 15N labeled with a conjugated spin label (SL) and 
the second is NMR silent (unlabeled). A sample with a reversed labeling scheme 
is necessary to detect the intra-molecular PRE for the second binding partner (top 
panel A). For the inter-molecular PRE, two additional samples are required: one 
NMR silent with the conjugated SL and a second NMR active (e.g., 15N or 13C 
labeled) (lower panel A). Simultaneous detection of inter- and intra-molecular PRE 
using 1HN-Γ2-CCLS experiment. One species is uniformly 15N labeled while the 
other is 13C and 15N labeled (b) and this allows the simultaneous detection of intra- 
and inter-molecular PREs. As reported before, reverse positioning of the SL is 
required for obtaining a complete characterization of the complex. 
B. The 1H-Γ2-CCLS pulse sequence for PRE Γ2 measurements. The narrow and 
wide bars represent 90 and 180 hard pulses, respectively. The three 13C 180 
shaped pulses are 256 s long Q3 pulse, the first two and the last one shaped 
pulses are applied to 13C and 13CA, respectively. The 13C 180 shaped pulse may 
be at either position a or b. When it is at position a, the 1JNC is decoupled and 
reference spectra are acquired. When it is at position b, the 1JNC is present and 
13C-suppressed spectra are acquired. The flipping angles and phases of the 
pulses in 3919 are 20.8x, 62.2x, 131.6x, 131.6-x, 62.2-x, and 20.8-x, 
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respectively, and the interval between pulses is 188 s (= 1/d, d is the distance in 
Hz between center and next null). T = 16.5 ms,  = 2.6 ms. G1=(1 ms, 25.0 G/cm), 
G2=(0.3 ms, 5.0 G/cm), G3=(0.3 ms, 8.0 G/cm), G4=(1 ms, 15.0 G/cm), G5=(1 
ms, 10.0 G/cm). Phase cycling scheme is 1= (x, -x), 2=(x, x, -x, -x), 3=4(x), 4(-
x), rec=(x, -x, x, -x, -x, x, -x, x). The quadrature detections in t1 dimension are 
acquired via States-TPPI of 1. Constant time mode is used to measure 2, that is 
𝛤2 = 𝑙𝑛 (𝑆1/𝑆2)/(𝜏2 − 𝜏1), where 𝑆1 and 𝑆2 are signal intensities of a peak 
measured with 𝜏 = 𝜏1 and 𝜏 = 𝜏2, respectively. 22 spectra are acquired in an 
interleave mode via changing relaxation delay  (minimum 2 ms) and changing the 
13C 180 shaped pulse from position a to b, respectively 
C. Intra- and inter-molecular PRE measurements of 15N-UbiK48C obtained with the 
1H-Γ2-CCLS experiment. 1HN-2 rate plot calculated for K48C mutant conjugate 
with MTSL in presence of UbiWT (upper panel C). 1HN-2 rate plot calculated for WT 
ubiquitin in presence of UbiK48C-MTSL (lower panel C). 
 
3.2.5 Improving sensitivity with the G5 pulse 
Advances in NMR methodology (TROSY, deuteration, selective labeling) have 
allowed for studies of protein-protein complexes approaching 1 MDa [293, 294]; 
however, these studies lack the ability to distinguish one species from another 
without the preparation of multiple samples. A recent technological advance that 
can improve nearly any pulse sequence is the universal triply compensated π 
pulses for high field spectrometers [295, 296], which we have incorporated into the 
CCLS pulse sequence (Fig. 3.5). All inversion and refocusing pulses in the 1H and 
15N channel were replaced with G5 pulses except the 15N refocusing pulse in 
middle of 3-9-19 water suppression. We were able to improve the signal intensity 
from 6% to 23% compared to the regular CCLS version. These experiments were 
performed on the Bruker 900 MHz AVIII spectrometer at 298K, and this 
enhancement will only be more significant in GHz spectrometers. 
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3.3 Conclusion and perspectives 
Here, we demonstrate the CCLS/DCLS pulse sequences enable the study of 
PPIs through simultaneous inter-leaved detection of all components in a single 
sample. As we have illustrated, the CCLS and DCLS pulse sequence blocks can 
be applied to a multitude of well-established experiments (RDC and PRE). 
Extrapolating from this integration into existing NMR experiments, could NOESY 
be the next step? The possibility of observing multiple species in a single sample 
for NOESY experimentation is viable as Anglister et al.[270] has reviewed 
difference spectroscopy and its application to 2D NOESY experiments. However, 
the pulse sequences are long thereby limiting sensitivity which the CCLS/DCLS 
pulse blocks show promise toward combating. Thus, reflecting upon the versatility 
of the CCLS/DCLS pulse block and the associated advantages afforded, we 
envisage the insertion into other existing NMR experiments to study a wide range 
of multicomponent systems. 
 
Figure 3.5: CCLS G5 pulse implementation 
A. CCLS 1H-15N HSQC reference spectrum of 15N, 13C UbiWT and U-15N UbiK48C 
mutant. B. Overlay spectra of the UbiWT alanine 46 peak demonstrating a 23% 
signal intensity improvement with the G5 pulse. C. Overlay spectra of the UbiK48C 
alanine 46 peak demonstrating an 18% signal intensity improvement with the G5 
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pulse. D. Overlay spectra of the glycine 75 peak demonstrating a 6% improvement 
with the G5 pulse. 
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Solid-state NMR (ssNMR) is an ideal tool to study structure and dynamics 
of membrane proteins in their native lipid environment. In principle, ssNMR has no 
size limitations. However, this feature is rarely exploited as large membrane 
proteins display severe resonance overlap. In addition, dismal yields in 
recombinant bacterial expression systems limit severely spectroscopic 
characterization of membrane proteins. For very large mammalian membrane 
proteins, extraction from the original organism remains the most viable approach. 
In this case, NMR-observable nuclei must be introduced post-translationally, but 
the approaches developed so far are rather scarce. Here, we detail the synthesis 
and engineering of a reactive 13C-ethylmethanethiosulfonate (13C-EMTS) reagent 
for the post-translational alkylation of cysteine sidechains of a 110 kDa 
sarcoplasmic reticulum Ca2+-ATPase (SERCA) extracted from rabbit skeletal 
muscle tissue. When reconstituted into liposomes, it is possible to resolve the 
resonances of the engineered ethyl groups by magic-angle spinning (MAS) 2D 
[13C,13C]-DARR experiments. Notably, the ethyl-group modification does not 
perturb the function of SERCA, yielding well-resolved 13C-13C fingerprints that are 
used to image its structural states in the catalytic cycle and filtering out 
overwhelming naturally-abundant 13C nuclei signals arising from the enzyme and 
lipids. We anticipate that this approach will be used together with 19F NMR to 
monitor conformational transition of enzymes and proteins that are difficult to 
express recombinantly.  
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4.1 Introduction 
        Solid-state NMR (ssNMR) is a powerful technique for investigating structure 
and dynamics of membrane proteins, which unlike solution NMR, does not rely on 
perturbing detergents for their functional reconstitution [298]. With no upper size 
limit, ssNMR is accessible to the largest membrane proteins embedded in their 
native lipid-bilayer environment, but poorer resolution, combined with unique 
signal arising from hundreds to thousands of amino acids, produce spectra far too 
overlapped for meaningful interpretation. Furthermore, large membrane proteins 
may be extraordinarily difficult to obtain by heterologous expression from E. coli, 
or other common hosts, in a correctly folded state and in milligram quantities 
required for ssNMR. Although a few successful attempts have been reported for 
cell-free expression and yeast expression systems, the extraction from the host 
organism often remain the only viable option. In such cases, sparse, selective and 
segmental labelling methods built on recombinant expression to reduce spectral 
overlap [219, 236, 299-303] are inapplicable and NMR-observable nuclei must be 
introduced post-translationally. Fortunately, there is an extensive toolbox for post-
translational modification of proteins, exploiting the chemistry of residues such as 
cysteine, lysine, tyrosine, arginine, glutamate, aspartate, serine, threonine, 
methionine, histidine, tryptophan as well as N- and C-termini [304, 305]. However, 
only a few to date have been utilized by the ssNMR community.  
In this chapter, we detail protocols for the synthesis of a 13C-
ethylmethanethiosulfonate (13C-EMTS) reagent [306] and its use for ethylating 
cysteines of a 110 kDa sarcoplasmic reticulum Ca2+-ATPase (SERCA) 
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transmembrane enzyme isolated from rabbit skeletal muscle tissue. The 13C-
EMTS reagent is analogous to the methylating reagent 
methylmethanethiosulfonate (13C-MMTS) introduced by Kay and co-workers [307], 
but does not require deuterated recombinant proteins to increase signal intensity. 
Importantly, this approach eliminates the background from lipids and naturally-
abundant 13C-nuclei in 1H-13C correlation spectra. Instead, the 13C-13C dipolar 
coupling of ethyl-tagged cysteines (Cys-S-13CH2-13CH3) provides a double-
quantum filter previously demonstrated to yield background-free and well-resolved 
solid-state 13C-13C Dipolar-Assisted Rotational Resonance (DARR) experiments 
[306, 308]. This reagent reacts with cysteine (Fig. 4.1A.) by well-known chemistry 
between nucleophilic thiols and alkyl alkanethiosulfonates, which is appealing for 
its applicability under mild reaction conditions, i.e., aqueous solutions and 
physiological pH. EMTS reagent enables fast reaction times, stoichiometric 
conversion of cysteine without requiring excess reagent, and reversibility upon 
addition of common thiol reagents such as dithiothreitol and β-mercaptoethanol 
[309]. More importantly, it does not perturb the enzyme’s function. 
SERCA has 24 cysteines, of which six solvent-exposed residues are 
preferentially labelled throughout both the cytoplasmic nucleotide-binding (N) and 
phosphorylation (P) domains (Fig. 4.1B.). When using a five-fold molar excess of 
13C-EMTS, the ATPase activity is fully retained [306] and the 13C-13C DARR 
spectra give compelling fingerprints of the different structural states throughout the 
enzymatic cycle [310]. 
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4.2 Protocols for using 13C-EMTS 
4.2.1 Synthesis and purification of the 13C-EMTS reagent 
The synthesis of 13C-EMTS is described at 9.2 mmol scale, which 
accounting for a total yield of 
75%, produces 35 mL of 200 
mM stock–enough for over 
18,000 NMR sample 
preparations using the 
protocol described in the 
following section. The scale 
was chosen to match the 
quantities of 13C2-
bromoethane available 
commercially, but can be 
significantly reduced. In our 
hands, we have successfully 
used this scheme at 0.7, 2, 
and 3.5 mmol scales to 
produce sufficient amounts 
for ssNMR studies. 13C-EMTS 
is obtained by a nucleophilic 




A. Reaction scheme for ethylating 
cysteine with 13C-EMTS reagent. B. Structural 
representation of ethylated cysteines (green 
spheres) and non-ethylated cysteines (white 
spheres) projected onto SERCA in the calcium-
bound E1 state (E1∙2Ca2+, PDB 1SU4) [2]. 
Nucleotide-binding (N, yellow), phosphorylation 
(P, red) and actuator (A, green) domains are 
shown as well as Ca2+ sites (red spheres). 
Expanded region shows ethyl-modified 
cysteines (patch to convert cysteine to ethyl-
cysteine for CHARMM molecular dynamics 
simulation are available on request). System 
was built using the CHARMM-GUI webserver 
[4, 5] and includes 400 POPC lipids. 
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13C2-bromoethane (Error! Reference source not found.A.) as shown previously 
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here to make the protocol more efficient.  
 
Figure 4.2 
A. Reaction scheme and B. apparatus for synthesis of 13C-EMTS. synthesis. C. 1H 
and D. 13C NMR spectrum of 13C-EMTS in CDCl3 acquired in a Varian 600 MHz 
spectrometer at 298°K. 1H spectrum was acquired using 8 scans and 30° pulses. 
13C spectrum was collected using 512 scans with power-gated decoupling. 
 
First, additional care must be taken to ensure the reaction is carried out 
under anhydrous conditions as bromoethane’s C-Br bond is hydrolysable to 
ethanol and HBr in the presence water. Therefore, better yields were obtained 
using dry solvent and avoiding atmospheric exposure. Older reports of this 
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reaction, however, compromise yields by using 5% water for dissolving sodium 
methanethiosulfonate [311-313]. To circumvent this issue, a phase transfer 
catalyst that shuttles ionic sodium methanethiosulfonate into the organic phase 
can be used. In our protocol, we use tetra-n-butyl ammonium bromide (TBAB). 
Second, the solvent of choice has a dramatic effect on the final yield of the reaction. 
Highest yields were obtained using CH3CN as a solvent. CH3CN is a polar aprotic 
solvent and is favorable for SN2 reactions as it increases the strength of the 
nucleophile due to weak solvation. Higher yields were also obtained when a 
catalytic amount of KI was added to the reaction. Iodide generated from KI 
displaces the bromine in bromoethane, which results in a better leaving group. 
Lastly, several phase-separated extractions were used to purify the final product 
from ionic by-products.  Using the apparatus depicted in Fig. 4.2B. as a guide, the 
reaction protocol is as follows: 
1. Combine dry reagents sodium methanethiosulfonate (1354 mg, 10.1 mmol), 
TBAB (10 mg, 0.03 mmol), and potassium iodide (10 mg, 0.06 mmol) in a two-
necked 50 mL round-bottomed flask (RBF). 
2. Attach a condenser column to the RBF. A standard Liebig condenser would be 
sufficient, but a higher efficiency condenser, such as a Friedrichs or a Jacketed 
Coil condenser, is recommended. Cheaper and more-common Dimroth or 
Davies condensers may also be acceptable. 
3. Seal joints with Glindemann polytetrafluoroethylene (PTFE) rings to prevent 
volatile 13C-bromomethane from escaping the reaction apparatus. Vacuum 
96 
grease may also be used, but risks contamination especially after prolonged 
heating. 
4. Plug the top of the condenser with a rubber septum and insert a syringe needle 
through it (Fig. 4.2B.). The septum will serve to minimize the amount of volatile 
13C2-bromoethane escaping and keep the reaction vessel remains mostly 
under nitrogen, while the needle will prevent pressure build-up. Attach a tubing 
adapter to the side neck and fasten with a keck clip. Flush the apparatus with 
dry nitrogen for 5 minutes. Notice that there’s no need to continuously flush 
nitrogen during the reaction. The reaction can also be run using a nitrogen 
reflux apparatus, but sufficient results were obtained with the described 
method. 
5. De-gas anhydrous CH3CN (15 mL) either by bath-sonication for 20 min or 
sparging with dry nitrogen for at least 5 min, then use it to dilute 13C2-
bromoethane (680 µL, 9.18 mmol) and add to reaction vessel via the side neck. 
The reaction mixture should appear as a cloudy white suspension.  
6. Cap the side neck with a ground-glass stopper, PTFE joint seal and Keck clip. 
7. Start a slow flow of water through the condenser (just faster than dripping) and 
turn on the heating mantle with a low setting. Reflux for at least 20 hours. The 
suspension will remain cloudy due to unreacted starting materials and 
formation of inorganic salts. 
8. NMR may be used to confirm completion of the reaction. This may be done by 
briefly opening the side neck and drawing 100 µL of the reaction with a glass 
syringe and transferring to an NMR tube. Dilute to 700 µL with CDCl3 containing 
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TMS standard and acquire 1D 1H and 13C NMR spectra. Example 1H and 13C-
spectra of pure 13C-EMTS are depicted in Fig. 4.2C. and Fig. 4.2D., 
respectively. Chemical shifts of unreacted 13C2-bromoethane and 13C-EMTS 
product are summarized in Table 4.1. 
9. Filter the solution using medium ground glass filter, then wash the solids in filter 
with 20 mL of CHCl3. Collect the filtrate and transfer to a separatory funnel.  
10. Add 75 mL of 1 M MgSO4 (in water) to convert any CHCl3-soluble I2 formed to 
water-soluble I3-. The organic layer stays on the bottom and the aqueous rises 
to the top. Collect the organic layer and repeat the extraction a total of three 
times using fresh 75 mL 1M MgSO4 each time. Combine the aqueous layers 
and back extract with 20 mL CHCl3.  
Table 4.1: Chemical shifts of unreacted 13C2-bromoethane and 13C-
EMTS product 
Chemical shifts were referenced to a tetramethylsilane (TMS) standard. 
Note that doublet 1H signals arise from 1JCH coupling with 13C carbons. 
Nuclei 1H δ (ppm) Multiplicity 13C δ (ppm) Multiplicity 








Doublet of triplets 28.02 Doublet 
     








Doublet of triplets 30.93 Doublet 






11. Combine organic extractions and dry by adding anhydrous MgSO4 powder until 
no clumping is observed. No more than 10 g should be required. Filter through 
a medium-glass filter directly into a pre-weighed 100 mL RBF. Rinse the 
remaining product from solid powder with 5 mL of anhydrous CHCl3.  
12. Remove organic solvent using a rotary evaporator with low heat (~30 °C). High 
heat may risk decomposition of 13C-EMTS. The remaining product will be a 
colorless oil but may also be slightly yellow due to trace amounts of I2 
remaining. Trace I2 impurity should not impede the ethylation reaction but could 
affect the activity of some enzymes. If this is an issue, then these traces may 
be removed by more phase-separated extractions in step 11. 
13. Once all solvent is removed acquire 1D 1H and 13C NMR spectra in 0.7 mL 
CDCl3. No CH3CN solvent should remain, which will produce a singlet at 2.10 
ppm 1H spectra; and singlets at 116.43 ppm and 1.89 ppm in 13C spectra [314]. 
The lack of CH3CN peaks will also indicate that CHCl3 was removed as it has 
a lower boiling point. 
14. Weigh RBF flask and calculate the net mass of 13C-EMTS and yield (MW of 
142.003 g/mol). At this scale, the theoretical yield is 1303.59 mg, but expect an 
actual yield of around 75%. 
15. Dissolve 13C-EMTS into DMSO, quantitatively transfer to a 50 mL conical tube 
and dilute to 200 mM with DMSO using the graduations on the tube.  Store at 
-20 °C. Aliquoting into smaller (polypropylene) tubes is recommended to limit 
repeated freeze-thawing of the main stock. The lifetime of the reagent has not 
been determined but has been stable for months in storage in our experience. 
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4.2.2 Ethylation and reconstitution of membrane proteins into lipid bilayers 
     The details regarding the purification of the SERCA are highly specific to this 
system and outside the scope of this review but may be briefly described in two 
stages.  Firstly, skeletal muscle was dissected from a freshly euthanized rabbit and 
crude sarcoplasmic reticulum (SR) extracted by several rounds of blending and 
centrifugation [315], then stored in sucrose buffer at -80C in sucrose buffer (20 
mM MOPS, 0.3 M sucrose, 1 mM NaN3, pH 7.0). Secondly, aliquots of crude SR 
were thawed, SERCA solubilized from the SR membrane into C12E8 detergent and 
purified in a single step by affinity to a Reactive Red resin [316]. Purified SERCA 
was then stored in aliquots of elution buffer (0.5 mg/mL SERCA, 0.1% C12E8, 1 
mM CaCl2, 1 mM MgCl2, 20 mM MOPS, 20% glycerol, 8 mM ADP, pH 7.00, 0.25 
mM) at -80C and thawed again at 4C prior to use. Activity was confirmed by 
coupled-enzyme assay as a function of calcium concentration [317]. The following 
steps may be more generalizable to any membrane protein and scaled to pack into 
a thin-walled 3.2 mm Varian MAS rotor (see Fig. 4.3A.): 
1. Dialyze 7.5 mg of SERCA (15 mL) twice into 1 L of dialysis buffer (20 mM 
HEPES, 100 mM KCl, 5 mM CaCl2, 1 mM MgCl2, 1 mM NaN3, 5% glycerol, 
0.25 mM C12E8, pH 7.0). The first dialysis is done over 3 hrs and the second 
overnight, both at 4C using 6-8 kDa MWCO dialysis tubing (Fisher Scientific). 
DTT must be removed as much as possible to avoid consumption of the 13C-
EMTS reagent. C12E8 detergent is included above its critical micelle 
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concentration (CMC) of 0.1 mM [318] to prevent SERCA denaturation during 
dialysis. Ca2+ and Mg2+ are included to stabilize SERCA in the Ca2+-bound E1 
state. 
2. Transfer dialyzed SERCA to a 50 mL conical centrifuge tube with a small 
magnetic stirrer, dilute to 30 mL with dialysis buffer and bring to room 
temperature. 
3. Add 13C-EMTS reagent (200 mM) at a 5:1 molar excess of SERCA and 
incubate for 2 hrs at room temperature. The molar ratio of the reagent used 
must by optimized to the tolerance of the protein of interest. For SERCA, this 
ratio has been previously determined at small scale by analyzing activity over 
various molar excesses of 13C-EMTS reagent by enzyme-coupled ATPase 
assays [317]. At 5:1, there is no loss in SERCA activity with solvent-exposed  
 
Figure 4.3  
A. Rotor schematic. B. Sample packing scheme for MAS-ssNMR 
 
cysteines 364, 471, 498, 561, 636 and 674 the most susceptible to ethylation. 
At this stage, a trypsin digest followed with liquid-chromatography electrospray 
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ionization tandem mass spectrometry (LC-ESI-MS/MS) may be used to identify 
labelled residues. 
4. Solubilize 9 mg d54-DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) into 
1 mL of dialysis buffer and 20 mg of C12E8 detergent (i.e., 80 µL of aqueous 
25% w/v stock purchased from Anatrace), add to ethylated SERCA and 
incubate 30 min at room temperature with stirring. Vortex and bath-sonicate to 
fully solubilize lipids and cool on ice if mixture becomes too viscous to transfer 
by pipette. Deuterated lipids are recommended to suppress long-relaxing 
signal from dynamic methyl groups that will create noise along the indirect 
dimension of DARR spectra. 
5. Remove detergent by adding 1.5 g of Bio-Beads SM-2 (Bio-Rad) over amounts 
of 0.25 g, 0.25 g, 0.5 g and 0.5 g, with 30-minute intervals of stirring at room 
temperate after each addition. Bio-Beads have an absorptive capacity for C12E8 
of 190 mg/g, for which it is recommended that they are added in successive 
amounts to allow smooth passage through the micelle to vesical transition and 
minimize losses of lipid [319]. The sample will become turbid due to formation 
of proteoliposomes. 
 
4.2.3 Rotor packing 
     The following describes a simple method to pack sample into a thin-walled 3.2 
mm Varian MAS rotor. This protocol may be substituted for one that utilizes 
specialized rotor packing equipment from commercial suppliers. 
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1. Aspirate proteoliposomes (from Section 2.2, Step 5) from Bio-Beads by syringe 
with a 25 G needle and transfer to a 40 mL centrifuge tube. Centrifuge at 12,000 
rpm for 30 min at 4°C using a Beckman JA-25.50 rotor. 
2. Discard supernatant and resuspend pellet into 2 mL of sample buffer (20 mM 
HEPES, 100 mM KCl, 5 mM CaCl2, 1 mM MgCl2, 1 mM NaN3, 2.5% glycerol, 
pH 7.0). 
3. Transfer to a centrifuge tube (compatible for a Beckman TLA-100.3 rotor) and 
centrifuge at 40,000 rpm for 30 min at 4°C. 
4. Discard supernatant and remove as much residual buffer as possible by 
tapping the tube inverted over a paper towel. 
5. Nest the inverted tube inside a 15 mL conical centrifuge tube (Fig. 4.3B.) and 
centrifuge 4,000 RPM for 20 min at room temperature using a Beckman 
SX4400 swinging-bucket rotor. 
6. Very carefully, cut off the bottom of the tube as close to possible to the pellet 
using a sharp razor blade. 
7. Fix the pellet inverted inside a 1 mL pipette tip inserted into the top of the rotor. 
Place the assembly inside a 50 mL conical tube and screw on lid (Fig. 4.3B.). 
If the 1 mL pipette tip does not fit the entrance of the rotor, then nesting the 1 
mL tip inside a smaller 200 µL will work, but the top of the 1 mL pipette tip may 
have to be cut shorter to fit inside the 50 mL tube. The rotor should have a drive 
cap and bottom spacer already inserted. 
8. centrifuge 4,000 RPM for 20 min at room temperature using a Beckman 
SX4400 swinging-bucket rotor. 
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9. Insert top spacer and seal rotor with top cap 
 
4.3 Solid-state NMR spectroscopy 
4.3.1 Hardware requirements 
 
Figure 4.4 
A. Schematic of a standard 1D [13C,1H]-CP experiment. B. 1D [13C,1H]-CP spectra 
of 13C-cysteine-ethylated SERCA at variable temperatures. Spectra were acquired 
with 1000 scans (51 min per experiment); 3 sec recycle delays; 2.5 µs 90° pulse 
on 1H; 2 ms CP contact time; CP field strength of 59 kHz on 1H (with 80-100% 
linear ramp) and 35 kHz on 15N; 100 kHz spectral width for 13C; 100 kHz 
heteronuclear SPINAL decoupling applied over an acquisition time of 20 ms; and 
processed with 100 Hz exponential line broadening. C. Schematic of a 2D [13C,1H]-
FSLG-HETCOR pulse sequence. D. 2D [13C,1H]-FSLG-HETCOR spectrum 
acquired at 2°C and with parameters from 1D [13C,1H]-CP experiments, except 
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using 480 scans (26 hr experiment time); 100 µs CP contact time; 5207.66 Hz 
spectral width and 32 points for the indirect 1H dimension; and FSLG 1H 
homonuclear decoupling. Shaded regions in panel B. and D. specify expected 
signal from 13C-ethylated cysteines. 
 
To further demonstrate the use of 13C-EMTS labelling, we acquired MAS ssNMR 
spectra of tissue-extracted SERCA in the calcium-bound E1 state (E1·2Ca2+) 
prepared according to Section 2. Detection of 13C-ethylated protein is achievable 
without the need of highly-specialized ssNMR equipment. For example, all spectra 
presented in this review were acquired on a simple setup including a 700 MHz 
Varian spectrometer equipped with a low-E Black Fox 3.2 mm HXY MAS (designed 
by Peter Gor’kov, National High Magnetic Field Laboratory, Tallahassee, FL) probe 
operating at a MAS rate of 12 kHz for all experiments. All spectra were externally 
refenced to adamantane [320] and processed using NMRPipe [321]. 
 
4.3.2 Cross-polarization and general considerations 
Cross-polarization (CP) is a basic element in solid-state NMR pulse sequences 
and optimized here for detection of 13C-ethyl-tagged cysteines by using standard 
1D [13C-1H]-CP sequences (Fig. 4.4A.). The ethyl tag will produce distinguishable 
signals in the regions of 31-35 ppm (CH2) and 14.5-15.5 ppm (CH3) in CP spectra 
(Fig. 4.4B.). During the CP block, magnetization is transferred via dipolar 
couplings from the high-γ and highly-abundant 1H nuclei to the low-γ 13C nuclei 
during a Hartman-Hahn-matched spin-lock period on both nuclei–with the net 
result being an enhancement in signal on the directly-detected 13C nuclei in 
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proportion to the ratio of gyromagnetic ratios (γ) γH/γC and faster recycle delays 
allowed as T1 relaxation is driven by the faster-relaxing 1H spin [322]. The 
Hartman-Hahn condition is optimized by varying the radio-frequency power levels 
(B1) until nutation frequencies (ω) on 1H and 13C are equivalent or matched to a 
spinning sideband to achieve maximal 13C signal. The optimal contact time must 
also be determined and depends on the rate of magnetization transfer, which is 
proportional to the strength of 13C-1H dipolar coupling in the sample; and decay of 
magnetization due to T1ρ relaxion, which is accelerated by molecular motions on 
timescale of ω [323]. The spin-lock field on one of the nuclei is generally ramped 
for better efficiency of magnetization transfer, where linear ramped-amplitude CP 
(RAMP-CP) [324] and adiabatic passage Hartmann-Hahn CP (APHH-CP) [325, 
326] methods are common. High-power 1H-decoupling is also applied to increase 
resolution during the acquisition period, and T1 evolution periods for 2D 
experiments, as MAS at moderate spinning rates (< 25 kHz) are only partially 
eliminate line-broadening from dipolar coupling and chemical shift anisotropy 
(CSA). For this, Small Phase Incremental Alternation (SPINAL-64) [327] and Two 
Pulse Phase Modulated (TPPM) [328] methods are usually employed. Due to the 
high-power applied for decoupling, acquisition times are shortened as much as 
possible to reduce unnecessary wear on the probe and sample heating. Recycle 
delays between acquisitions are typically set on the order of 3 s and are limited to 
T1 relaxation. Recycle delays of membrane-protein systems maybe reduced 
substantially with paramagnetic relaxation enhancement (PRE) by doping samples 
with paramagnetic ions [329] and lipid (Cu2+-chelated) [195]. Note that high-power 
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1H decoupling may cause probe damage and excessive sample heating. Faster 
MAS frequencies, however, will allow the use of low-power decoupling and recycle 
delays to be reduced as low as 0.1 ms for super-fast acquisition [330]. 
 
4.3.3 Sample temperature 
Sample temperature must also be considered in early stages of optimization. Low 
temperatures preserve the sample integrity, enhancing magnetization and 
rigidifying the system. This will enhance the efficiency of the CP transfer via 
stronger dipolar coupling interactions but may also reduce resolution due to 
inhomogeneous exchange broadening from lipid and protein dynamics, particularly 
at temperatures below the gel-fluid phase transition of lipids. Higher temperatures 
may provide better resolution, however, the flexible nature of the 13C-ethyl tag, 
especially when attached to dynamic domains, may risk complete loss of signal. 
When CP-based experiments become insensitive, INEPT-based (Insensitive 
Nuclei Enhanced by Polarization Transfer) [331] experiments may be used to 
detect highly dynamic regions [332, 333].  An array of 1D [13C,1H]-CP experiments 
(Fig. 4.4B.) show that signals arising from the 13C-ethyl tag, are retained over a 
temperature range of -18°C to 30°C, but with no observable change in resolution. 




4.3.4 Optimization and acquisition of [13C,13C]-DARR spectra 
By visual inspection of 4.4A, it is clear that the 13C-ethyl tag is not the only signal 
observed in a simple 1D [13C,1H]-CP experiment. This is expected as the ethyl tag 
only introduces 10 to 12 13C-nuclei buried in the background of 4876 naturally-
abundant (1.1% for 13C) carbons of SERCA (110 kDa and 994 residues) plus 
carbons from endogenous lipids bound to enzyme. This is especially problematic 
for the [13C,1H]-Frequency-Switched Lee-Goldburg (FSLG) HETeronuclear 
CORrelation (HETCOR) experiment [334, 335] displayed in Fig. 4.4C. In Fig. 
4.4D., background noise entirely swamps the signals expected from the 13CH2 
groups of the ethyl tag, and the signal-to-noise ratio is too low to detect 13CH3  
groups in the background-free region of the spectrum. Subsequently, 13CH2-13CH3 
dipolar coupling within the ethyl tag may be exploited in a 2D [13C,13C]-DARR 
experiment (Fig. 4.5A.) to reduce this background by 100-fold. In this experiment, 
13C-13C spins are recoupled under MAS conditions during a mixing time with 1H 
RF field (DARR) at a multiple of the spinning rate applied to recover 13C-1H dipolar 
interactions driving polarization transfer [308]. Note that we found that [13C,13C]-
DARR experiments were suitable under our moderate MAS rates, although, other 
homonuclear recoupling methods may also be applicable, including Proton-Driven 
Spin Diffusion (PDSD) [336], Phase-Altered Recoupling Irradiation Scheme 
(PARIS) [337] and Second-order Hamiltonian among Analogous Nuclei Generated 
by Heteronuclear Assistance Irradiation (SHANGHAI) [338]. Furthermore, 
Constant-Time-DARR (CT-DARR) experiments [339] may also be used to improve 
resolution in the directly-detected 13C dimension, but in our experience this 
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A. Schematic of 2D [13C,13C]-DARR pulse and B. 1D [13C,13C]-DARR pulse 
sequence highlighting a selective 1 ms Gaussian pulse on CH3 carbons at 15 ppm. 
C. Array of selective 1D [13C,13C]-DARR spectra of 13C-ethylated SERCA acquired 
at 20°C with variable DARR mixing times show build-up of intensity of CH2 signal. 
Each 1D spectrum was acquired with parameters from 1D [13C,1H]-CP 
experiments detailed in the caption of Figure 4.4, but with a 12 kHz field on 1H 
during DARR mixing and 5000 scans (4 hr each experiment). Spectra were 
processed with 100 Hz exponential line-broadening. D. 2D [13C,13C]-DARR spectra 
acquired at 2°C (blue) and 20°C (red) with 300 ms DARR; 60 t1 increments and 5 
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kHz spectral width on the second 13C dimension; and 1000 scans (52 hr 
experiment time for each spectrum). 2D spectra were processed with 20 Hz 
Lorentzian line-sharpening and 20 Hz Gaussian line-broadening. Shaded region 
highlights residues of the P-domain as previously assigned [306]. 
 In addition to optimizing [13C,1H]-CP parameters as discussed in the 
previous section, the length of mixing times must also be optimized for 2D 
[13C,13C]-DARR experiments. Obviously, optimization by an array 2D experiments 
is expensive from an NMR time viewpoint. Therefore, similar to initial reports [308], 
we took advantage of the large separation of 13CH2 and 13CH3 shifts to optimize 
parameters using selective 1D [13C,13C]-DARR experiments (Fig. 4.5B.). The 
sequence differs to the 2D sequence (Fig. 4.5A.) in that the magnetization of 13CH3 
is selectively inverted after CP, the t1 chemical shift evolution period is removed 
and build-up of 13CH2 signal is observed over an array of DARR-mixing times. For 
our sample at 20°C, we found that 300 ms provided optimal cross-peak intensity 
using an array of 4 hr long 1D experiments (Fig. 4.5C.). 
 At the scale described in Section 2.2, with 7.5 mg of SERCA reconstituted 
into 9 mg of d54-DMPC, a 2D [13C,13C]-DARR spectrum can be acquired overnight 
with good signal-to-noise ratio. In both spectra acquired at 2°C and 20°C over 2 
days (Fig. 4.5D.), the filtering ability of the 13C-ethyl tag is exemplified by the 
observation that only labeled carbons are observed in the off-diagonal regions and 
that separation of 13CH2 and 13CH3 resonance places cross-peaks well away from 
the intense diagonal. Furthermore, resolution is afforded mostly by the greater 
chemical shift dispersion of the 13CH2 dimension. Five resolved signals are 
observed in spectra acquired at 2°C, while only four at 20°C, probably owing to 
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faster conformational dynamics. In our case, higher resolution is not observed at 
higher temperature, likely due to the need to apply line-broadening to increase 
signal-to-noise ratio and time-constraints to acquiring additional points along the 
indirect dimension. 
 
4.3.5 Assignment of labeled cysteins 
Since site-specific mutations are unfeasible, the assignment 13C-ethylated 
cysteine resonances in DARR spectra is non-trivial task. The approach to be 
pursued will likely take advantage of chemical, structural and functional features 
unique to the protein of interest. At the very least, tryptic digests of 13C-ethylated 
protein will help identify which cysteines have been labeled. Furthermore, as done 
previously [306], a large excess of iodoacetamide may be added following 
incubation with 13C-EMTS to identify partially-reacted and non-reacted cysteines 
through detection of carbamidomethylated (CAM) peptides. Specific assignments 
may be made by well-informed PRE-experiments. For example, the ethylated-
cysteines in the N-domain (nucleotide binding domain) of SERCA were 
unambiguously assigned previously [306] by selective quenching upon addition of 
a paramagnetic ADP-TEMPO ligand (ADP = adenosine diphosphate; TEMPO = 
2,2,6,6-tetramethyl-1-piperidinyloxy) and selective spin-labelling of C674 with 
iodoacetamide TEMPO [340]; while 13C-ethylated P-domain (phosphate-binding 
domain) cysteines closest the membrane are generally assigned by quenching by 
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a DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) lipid engineered with a 
TEMPO headgroup. 
 
4.4. Conclusions and perspectives 
In this chapter, we reported the protocols for utilizing 13C-EMTS to post-
translationally introduce 13C-ethyl tags to the 110 kDa SERCA Ca2+-pump, 
extracted from the skeletal muscle of rabbits, for ssNMR characterization in lipid 
membranes. Similar post-translational methods based on 13C-methyl labelling 
have enabled solution NMR characterization of large systems including the 180 
kDa α7 ring of the 20S proteasome [307], the 300 kDa ClpP protease [307], the 
100 kDa ClC-ec1 chloride channel [341] and a 240 kDa NADPH-cytochrome P450 
oxidoreductase-nanodisc complex [342]. 13C-methyl labeling, however, requires 
extensive deuteration of the surrounding protein to enhance signal intensity of the 
label and eliminate background in 2D [1H,13C]-spectra [307], or deuteration of the 
label to filter out background using 2H-13C scalar coupling-edited experiments [343] 
that cannot be applied to ssNMR due to short coherence lifetimes. Furthermore, 
good resolution is required to resolve poorly-dispersed methyl peaks. For MAS-
ssNMR, the use of 13C-EMTS overcomes several major practical issues, including: 
1) the use of 13C-13C dipolar coupling to eliminate background from naturally 
abundant 13C nuclei in protein and lipid carried through from extraction; 2) wider 
chemical shift dispersion of 13CH2 to provide much-needed additional resolution; 
and 3) not at any stage being limited to obtaining protein by heterologous 
112 
expression. This labelling strategy, therefore, enables the structural states of large 
membrane proteins, obtained directly from their host organism, to be fingerprinted 
by ssNMR. Furthermore, this 13C-ethyl tag may also be adapted to other MAS 
experiments to extract additional structural and topological information [344]. 
The synthetic protocol described in Section 4.1 may also be modified to 
introduce other useful nuclei, such as 2H and 19F that have no issues with 
background in biological systems. These reaction schemes can be carried out 
using commercially available bromoalkane precursors. For example, order 
parameters extracted from 2H quadrupolar couplings can report structure and 
dynamics of the target proteins [345, 346] and may also be introduced by post-
translational site-selective protein α-deuteration [347]. 19F also has a large γ 
providing greater sensitivity and ability to measure long-range distances between 
probes, but requires specialized probes either equipped high-power 1H and 19F 
channels, or fast-MAS to remove 1H-19F-dipolar interactions to improve resolution 
[348]. In solution NMR, post-translational modification with CF3 tags has enabled 
the conformational dynamics of G protein-coupled receptors (GPCRs) to be 
studied [349]. Subsequently, a number reagents have been utilized in solution 
NMR to post-translationally modify cysteines with 19F nuclei [350-354]. 19F may 
also be introduced to tyrosine either electrochemically [355, 356] or chemically 
using acetyl hypofluorite [357]. Furthermore, glutamines may also be 
enzymatically modified with 19F [358].  
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Another residue prone to post-translational methylation is lysine, which 
undergoes reductive methylation in the presence of 13C-formaldehyde yielding a 
tertiary amine. Lysine has also been modified with 19F-tags with reagents designed 
to preserve charge and hydrophilicity of the protein [359, 360]. Partial 
(monomethylation) or complete methylation (di-methylation) of lysines is possible 
by titrating the amount of 13C-formaldehyde [361, 362]. Lysine methylation can 
yield tremendous insights into protein structure and dynamics [343, 363]. Lysines 
have high occurrence (6-7%) in soluble and solvent-exposed membrane proteins. 
Often, these residues are located nearby or within active sites and can report on 
protein function. In general, lysine methylation is structurally non-perturbing. 
However, when these residues participate to the chemistry of enzymes, capping 
their charged side chain may result in a significant reduction or loss of activity as 
it was found for SERCA (data not shown). Nonetheless, there are several reports 
on the successful application of reductive methylation of lysines [364-368] and 
efforts toward developing protocols for monoethylation have provided enhanced 
spectral quality and narrower line-widths [343]. This method, however, has had its 
largest utilization for liquid-state NMR spectroscopy, where the fast tumbling rates 
of globular proteins and their internal flexibility of solvent-exposed lysine enhance 
the sensitivity of the methyl groups [341]. For ssNMR, however, lysine methyl 
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Abstract 
Phospholamban (PLN) is a mini-membrane protein that directly controls the 
cardiac Ca2+-transport response to -adrenergic stimulation, thus modulating 
cardiac output during the fight-or-flight response. In the sarcoplasmic reticulum 
membrane, PLN binds to the sarco(endo)plasmic reticulum Ca2+-ATPase 
(SERCA), keeping this enzyme's function within a narrow physiological window. 
PLN phosphorylation by cAMP-dependent protein kinase A or increase in Ca2+ 
concentration reverses the inhibitory effects through an unknown mechanism. 
Using oriented-sample solid-state NMR spectroscopy and replica-averaged NMR-
restrained structural refinement, we reveal that phosphorylation of PLN’s 
cytoplasmic regulatory domain signals the disruption of several inhibitory contacts 
at the transmembrane binding interface of the SERCA-PLN complex that are 
propagated to the enzyme’s active site, augmenting Ca2+ transport. Our findings 
address long-standing questions about SERCA regulation, epitomizing a signal 




Miniproteins are translated from small open reading frames of 100-300 
nucleotides in length and constitute a neglected portion of the human 
proteome[369]. Most miniproteins are membrane-embedded and act as regulators 
or ancillary proteins to enzymes or receptors [370-372]. Among the most critical 
miniproteins is phospholamban (PLN), a bitopic membrane polypeptide that 
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regulates the function of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
in cardiac muscle [373]. PLN directly controls cardiac output by maintaining 
SERCA’s activity within a tight physiological window [374]. SERCA is a ten-
transmembrane (TM) pump that promotes diastole by removing Ca2+ from the 
sarcoplasm and restoring high Ca2+ concentrations in the sarcoplasmic reticulum 
(SR) in preparation for the next systole [374]. As with other P-type ATPases, 
SERCA is fueled by ATP and cycles between two major conformational states E1 
and E2, of high and low Ca2+-affinity, respectively [375]. In cardiomyocytes, PLN 
is expressed in 4-fold molar excess of SERCA, suggesting that this endogenous 
regulator is permanently bound to the enzyme in a 1:1 stoichiometric ratio [376]. 
PLN binds the ATPase via intramembrane protein-protein interactions, lowering its 
apparent Ca2+ affinity and stabilizing the E2 state of the pump [374, 377]. 
SERCA/PLN inhibitory interactions are relieved upon β-adrenergic stimulation, 
which unleashes cAMP-dependent protein kinase A (PKA) to phosphorylate PLN's 
cytoplasmic domain at Ser16, enhancing Ca2+ transport by SERCA and 
augmenting heart muscle contractility [378]. Ablation, point mutations, or 
truncations of PLN have been linked to congenital heart disease[377]. Despite 
multiple crystal structures of SERCA alone[375] and several structural studies of 
PLN free and bound to SERCA [379-381], the inhibitory mechanisms of PLN and 
its reversal upon phosphorylation or Ca2+ increase are still unknown. Mutagenesis 
data and molecular modeling suggested that SERCA regulation occurs through 
electrostatic and hydrophobic interactions between the helical transmembrane 
(TM) region of PLN and the binding groove of the ATPase formed by TM2, TM6, 
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and TM9 [382]. Upon phosphorylation, or binding SERCA, however, the helical TM 
domain of PLN does not undergo significant changes in secondary structure [184, 
383, 384]. As a result, X-ray crystallography [384] and other structural techniques 
(e.g., EPR or NMR) have not offered significant mechanistic insights into the 
regulatory process. 
Here, we reveal the elusive signal transduction mechanism responsible for 
phosphorylation-induced activation of the SERCA/PLN complex using a 
combination of oriented-sample solid-state NMR (OS-ssNMR) spectroscopy and 
dynamic structural refinement by replica-averaged orientational-restrained 
molecular dynamics simulations (RAOR-MD) [201, 385]. The analysis of 
anisotropic 15N chemical shifts (CSs) and 15N-1H dipolar couplings (DCs) of PLN 
alone and in complex with SERCA in magnetically aligned lipid bicelles unveiled 
collective topological changes of PLN’s inhibitory TM domain in response to Ser16 
phosphorylation. Specifically, the local perturbations of phosphorylation were 
allosterically transmitted via an order-disorder transition of the juxtamembrane 
helical residues involved in several inhibitory interactions with SERCA. This 
intramembrane regulatory mechanism represents a potential paradigm of the 
structural basis of SERCA activity modulation by other regulins (e.g.,  sarcolipin, 




5.2.1 The TM domain of PLN undergoes a topological two-state equilibrium 
In lipid membranes, PLN adopts an L-shaped conformation, with a 
membrane-adsorbed, amphipathic regulatory region (domain Ia, M1 to T17) 
connected by a short loop (Ile18 to Gln22) to a helical inhibitory region (domains 
Ib, Gln23 to Asn30; and domain II, Leu31 to Leu52), which crosses the SR 
membrane [386, 387]. In its storage form, PLN is pentameric [387-389] and de-
oligomerizes into active L-shape monomers [386]. The dynamic cytoplasmic 
region undergoes an order-disorder transition between tense (T) and relaxed (R) 
states, with the latter promoted by Ser16 phosphorylation [184, 383, 390]. Upon 
binding SERCA, domain Ia transitions to a more-rigid and non-inhibitory bound (B) 
state, becoming more populated upon phosphorylation [184, 383]. How does 
Ser16 phosphorylation signal the reversal of inhibition to the TM region? Since the 
inhibitory TM region is ~ 45 Å away from Ser16 and ~ 20 Å from the SERCA’s Ca2+ 
binding sites, we speculated that both phosphorylation (of PLN) and Ca2+ binding 
(to SERCA) must transmit conformational and topological changes across the 
membrane, thus allosterically modulating SERCA's function. 
 Residue-specific anisotropic NMR parameters such as CSs and DCs are 
exquisitely suited to describe topological transitions such as tilt, bend, and torque 
of TM proteins in lipid bilayers near-physiological conditions [391, 392]. Their 
analysis by OS-ssNMR requires that membrane-embedded proteins are uniformly 
oriented relative to the static magnetic field (B0). Therefore, we reconstituted PLN 
free and in complex with SERCA into magnetically aligned lipid bicelles [393].  
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Figure 5.1: Topological equilibrium of PLN and pPLN free and bound to 
SERCA in lipid bilayers detected by OS-ssNMR 
A. 2D [15N-1H] SE-SAMPI4 spectra of PLNAFA and pPLNAFA reconstituted into 
aligned lipid bicelles. The fitting of resonance patterns with PISA wheels for an 
ideal helix is superimposed. B. Expanded regions of PLNAFA 15N-labeled at N, L, 
F, or I residues (lower panel, blue contours) showing two populations. The upper 
panels (red) are the corresponding regions for the U-15N labeled pPLNAFA. U-15N 
labelled spectra were acquired at higher signal-to-noise to observe the second 
population. C. Structures of the T (PDB 2KB7[386]) and R (PDB 2LPF[394]) states 
for PLNAFA. D. 19F NMR spectra of TFMB-tagged SERCA reconstituted into 
anisotropic (q = 4) bicelles at variable temperatures. E. 2D [15N-1H] SE-SAMPI4 
spectra of uniformly 15N labeled PLNAFA (blue, lower panel) and pPLNAFA (red, 
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upper panel) bound to SERCA in the absence of Ca2+ (E2 state). Spectra are 
overlaid with PLNAFA or pPLNAFA in their free forms (grey). PISA wheels are 
overlaid, showing assigned residues (black points) used to fit helical tilt and 
rotation angles. Ambiguous assignments are shown in parentheses. The region 
corresponding to domain Ib is expanded to show peak broadening (asterisk) 
following the transition of PLN's cytoplasmic region to the B state. F. Selected 
structure of the SERCA/PLNAFA complex. Expanded region shows visible (green 
spheres, labelled) and broadened (red spheres) residues mapped onto domain II 
of PLNAFA (left) and pPLNAFA (right, form a structure of the SERCA/PLNAFA 
complex). 
Since monomeric PLN is the functional form [395], we utilized a monomeric mutant 
of PLN devoid of TM cysteine residues [396]. Both unphosphorylated (PLNAFA) and 
phosphorylated (pPLNAFA) variants of PLN were expressed recombinantly, while 
SERCA was purified from mammalian tissues [397]. Since lipid bicelles orient 
spontaneously with the normal of the membrane (?⃑⃗?) perpendicular to B0, we doped 
the sample with Yb3+ ions to change the magnetic susceptibility and orient the lipid 
membranes with ?⃑⃗? parallel to B0. This expedient doubles the values of CSs and 
DCs and increases the resolution of the NMR spectra [398, 399]. Fig. 5.1A. shows 
the 2D [15N-1H] sensitivity-enhanced (SE)-SAMPI4 [400] separated local field 
(SLF) spectra of free PLNAFA and pPLNAFA. Due to PLN's intrinsic conformational 
dynamics, the SLF spectra visualize only its TM region. The spectra display the 
typical wheel-like pattern diagnostic of a helical conformation for both the TM 
domains of PLNAFA and pPLNAFA. Residue-specific assignments were carried out 
on free PLNAFA using a combination of a 3D SE-SAMPI4-PDSD spectrum [401], 
selective 15N labeled samples, and predictions from MD simulations [402] (Table 
5.1; Fig. 5.1–fig. supp. 5.1-3). To obtain PLN’s topology in lipid bilayer, the 
assigned resonances were fit to idealized Polar Index Slant Angle (PISA) models 
extracting whole-body tilt () and rotation or azimuthal (ρ) angles [145, 403], which 
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for free PLNAFA was  = 37.5 ± 0.7° and ρL31 = 201 ± 4°, and for pPLNAFA  = 34.8 ± 
0.5° and ρL31 = 201 ± 4°, where ρL31 is the rotation angle referenced to Leu31. 
Notably, the high resolution of the oriented SLF spectra of PLNAFA show two 
distinct sets of peaks (Figure 5.1B.), with populations unevenly distributed. The 
average population of the minor state estimated from the normalized peak 
intensities is approximately 30 ± 9 %. Remarkably, the resonances of the minor 
population overlap almost entirely with those of pPLNAFA (Fig. 5.1B.), revealing a 
topological equilibrium in which the TM region of PLN interconverts between two 
energetically different orientations. We previously showed that PLN 
phosphorylation shifts the conformational equilibrium toward the R state [184], 
releasing the interactions with the lipid membranes of domain Ia (Fig 5.1C.). Our 
OS-ssNMR data show that these phosphorylation-induced effects propagate to the 
TM domains, shifting the topological equilibrium toward the less populated state. 
 
5.2.2 PLN phosphorylation by PKA signals a rearrangement of the SERCA/PLN 
binding interface 
To investigate how Ser16 phosphorylation allosterically affects the inhibitory 
TM binding interface, we reconstituted the SERCA/PLN complex in lipid bicelles 
and studied it by OS-ssNMR. The alignment of mammalian SERCA in bicelles was 
confirmed by cross-linking the most reactive cysteines with a trifluoromethylbenzyl 
(TFMB)-methanethiosulfonate (MTS) tag to probe its alignment by 19F NMR (Fig. 
5.1D.; Fig. 5.1–fig. supp. 4). Five of the twenty-four cysteines of SERCA were 
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uniquely labeled as monitored by solution NMR in isotropic bicelles (q = 0.5). In 
anisotropic bicelles (q = 4.0) and at low temperature, the ssNMR spectrum of 19F-
SERCA consists of a single unresolved 19F resonance due to the rapid 
reorientation of the enzyme in the isotropic phase. Upon increasing the 
temperature, the 19F-SERCA/bicelle complex orients with ?⃑⃗? perpendicular to B0, 
and the 19F resonance becomes anisotropic as a triplet with 1.3 kHz dipolar 
coupling [404]. Fig.5.1E. shows the 2D SLF spectra of PLNAFA and pPLNAFA in 
complex with SERCA. To maintain a functional and stable complex, we used a 
lipid-to-complex molar ratio of 2000:1, with PLN concentration 10 times less than 
in the SERCA free samples. Therefore, the signal-to-noise ratio in the oriented 
spectra is significantly reduced relative to the free forms. Nonetheless, the SLF 
spectra of both SERCA/PLNAFA and SERCA/pPLNAFA complexes show the wheel-
like patterns typical of the α-helical domains with selective exchange broadening 
for resonances located at the protein-protein binding interface (Fig. 5.1F.). The 
assigned peaks associated with the helical domain II were fit to the ideal PISA 
model, yielding = 33.2 ± 1.2° and ρL31 = 193 ± 7°. Therefore, upon binding 
SERCA, PLNAFA requires a distinguishable -4.3 ± 1.4° change in tilt (p = 4.3 × 10-
15) and a less significant -8 ± 8° change in rotation (p = 0.00027). These error 
bounds factor the linewidths and variation associated with substituting ambiguous 
assignments into the PISA fitting (parentheses of Figure 5.1E.). Similarly, the PISA 
model for pPLNAFA was fit to  = 30.4 ± 1.1° and ρL31 of 197 ± 4°, suggesting that 
the topology of the TM domain requires adjustments of -3.4 ± 1.2° (p = 2.9 × 10-14) 
and -4 ± 6° (p = 0.0013) to form a complex with the ATPase. 
124 
Reductions in the TM helix tilt angle, which accompanied phosphorylation 
and complex formation, also coincided with a dramatic broadening of peaks in the 
cluster of isotropic resonances around 140 ppm (Fig. 5.1E.). These resonances 
are attributed to the dynamic domain Ib residues, and their disappearance is 
consistent with SERCA binding, which requires the unwinding of the 
juxtamembrane region, and a concomitant reduction of the tilt angle to re-establish 
hydrophobic matching with the thickness of the lipid bilayer [184, 381]. Therefore, 
for free and bound PLN, we find that communication between cytoplasmic and 
intramembrane environments is transduced via domain Ib dynamics. Analysis of 
the SLF spectra also shows that phosphorylation of PLN at Ser16 restores the 
intensities of most resonances except for those at the upper binding interface (i.e., 
Asn30, Leu31, Asn34, and Phe41). These spectral changes suggest a 
reorganization of PLN-SERCA packing interactions, rather than a complete 
dissociation of the complex, consistent with prior MAS-ssNMR, EPR, and FRET 
measurements [184, 381, 405, 406]. 
 
5.2.3 Dynamic structural refinement of the SERCA-PLN complexes 
To determine the structural ensembles of the SERCA/PLNAFA and 
SERCA/pPLNAFA complexes, we incorporated the data from our experimental 
measurements into RAOR-MD samplings [201, 385]. This dynamic refinement 
methodology employs full atomic MD simulations in explicit lipid membranes and 
water and utilizes restraints from sparse datasets to generate experimentally-
125 
driven structural ensembles. As starting coordinates for our samplings, we used 
the X-ray structure of E2-SERCA/PLN, where a super-inhibitory mutant of PLN 
was used to stabilize the complex for crystallization [384]. We docked the TM 
domains of PLNAFA using restraints obtained from chemical cross-linking 
experiments for both cytoplasmic and luminal sites [382, 407, 408] (Fig. 5.2–fig. 
supp. 5.1A.).  
 
Figure 5.2: Conformational ensembles and energy landscapes of the 
SERCA/PLNAFA and SERCA/pPLNAFA complexes 
A. and B. Depiction of headpiece movements associated with the first A. and 
second B. principal components. Structures with the highest PC values are shown 
as transparent black. (C, D) PCA histograms of SERCA/PLNAFA C. and 
SERCA/pPLNAFA D. structural ensembles with projections of crystal structures in 
various states: Ca2E1-ATP[409, 410], Ca2E1~P-ADP[410-412], Ca2E1[2], E1-
SLN[413], E2-PLN[384], E2P[411, 414], E2~P[411, 414, 415], and E2[416]. 
Clusters are numbered. E. and F. Top 20 most representative structures of PLNAFA 
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(E., cluster 1) and pPLNAFA (F., cluster 2) bound to SERCA from the most 
representative state. 
The dynamic cytoplasmic region (loop and domain Ia), which was not resolved in 
the crystal structure, was held in proximity to the nucleotide-binding (N) and 
phosphorylation (P) domains of SERCA using upper boundary restraints from 
paramagnetic relaxation enhancements (PRE) obtained from MAS-ssNMR [184]. 
Additionally, CSs and DCs from OS-ssNMR were applied to the TM region as 
ensemble-averaged restraints across eight replicas. The resulting structural 
ensembles were in excellent agreement with all the available experimental data 
for both complexes. The overall profile of the average pairwise distances for 
residues in domain Ia and loop to the spin-label at Cys674 matches the PRE 
measurements, with the minimal distance (i.e., maximum PRE effect) observed for 
PLN-Tyr6 (Fig. 5.2–fig. supp. 5.1B., C.). Similarly, back-calculated CS and DC 
values for PLNAFA and pPLNAFA were in excellent agreement with experiments 
(Fig. 5.2–figure supp. 5.1D.). Average back-calculated tilt angles of 32.8° and 
30.4° for PLNAFA and pPLNAFA, respectively, matched PISA fits to experimental 
values (Fig. 5.2–fig. supp. 5.1E., 2). All pairwise distances between previously 
reported cross-linkable positions [382, 407, 408, 417] were distributed within 
acceptable ranges (Fig. 5.2–fig. supp. 5.1F.). Although not used as an initial 
docking restraint, cytoplasmic residues PLN Lys3 and SERCA Lys397 were also 
partially distributed within a distance consistent with previously reported cross-
linking [418]. 
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To assess the SERCA/PLN complexes' conformational landscape, we used 
principal component analysis (PCA). PCA identified a combined opening of the 
cytoplasmic headpiece involving a hinge-like displacement of the N domain and 
rotation of the A domain away from the P domain (PC1) and planar rotations 
separating the N and A domains (PC2) (Fig. 5.2A., B.; Fig. 5.2–fig. supp. 5.3-5). 
These motions differentiate the E1 and E2 states of SERCA, as shown by the 
projections of crystal structures onto the PCA map (Fig. 5.2C., D.). The 
SERCA/PLNAFA complex spans four distinct clusters, while the SERCA/pPLNAFA 
complex spans eight (see Fig. 5.2–figure supp. 5.6 for representative structures). 
When bound to PLNAFA, SERCA mostly retains the compact E1-like headpiece 
present in the crystal structure and interconverts with equal frequency between a 
highly compact cluster (3) resembling nucleotide-bound E1 states and a cluster (1) 
intermediate toward the E2 states, which exhibits a partial opening of the A and N 
domains caused by breaking of the salt bridges involving Arg139-Asp426/Glu435 
and Lys218-Asp422. Albeit biased along the E1 coordinate of PC2, similar states 
were present for pPLNAFA, but the interaction of pSer16 with Arg604 weakens the 
Asp601-Thr357 and Arg604-Leu356 hydrogen bonds at the hinge of the N and P 
domains, leading to four additional open states (clusters 5 to 8). Separate clusters 
correspond to successive breakages of interdomain hydrogen bonds in the 
headpiece. Salt bridges between PLN-Ser16 to SERCA-Arg460 and PLN-Arg14 
to SERCA-Glu392 were also found to stabilize these open states (Fig. 5.2–fig. 
supp. 5.7). These open states resemble off-pathway crystal structures solved for 
the Ca2E1 state observed in the absence of nucleotide[2, 375, 419]. For all 
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clusters, the binding interactions near the Ser16 position were more persistent for 
pPLNAFA than PLNAFA (Fig. 5.2E., F.; Fig. 5.2–fig. supp. 5.6). 
 
Figure 5.3: Mechanism for reversal of PLN inhibition by phosphorylation 
A. Ensemble-averaged per-residue structural analysis (upper panel) and 
intermolecular contact profiles (lower panel). A contact is defined when any PLN 
atom comes within 3.5 Å of any SERCA atom for any given frame. B. Spider plot 
of pairwise electrostatic interactions between cytoplasmic residues and SERCA in 
RAOR-MD conformational ensembles. C. and D. 2D Histograms correlating the 
distances between the cytoplasmic binding interfaces, defined by the center of 
masses of Arg14 to Ser16 of PLN and Arg604 to Glu606 of SERCA, to the 
inhibitory intermolecular contacts of PLN Lys27 for the SERCA/PLNAFA C. and 
SERCA/pPLNAFA D. ensembles. E. and F. Corresponding 1D histograms for Lys27 
contacts E. and binding of the cytoplasmic domain F.. G. Disruption of the inhibitory 
TM pairwise interactions detected in the RAOR-MD conformational ensembles. 
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Linewidths of the interhelical contacts are scaled to average contacts per frame for 
the non-phosphorylated complex and colored by the relative change observed with 
phosphorylation. Directions of the purple arrows exemplify clockwise or 
counterclockwise rotations of the TM domain of PLN during the trajectories. 
From the analysis of the structural ensembles of the two complexes, it 
emerges that the relief of inhibition (i.e., activation) occurs via a rearrangement of 
the intramembrane contacts between the TM region of pPLNAFA and SERCA, with 
a reconfiguration of electrostatic interactions near the phosphorylation site and a 
disruption of packing at the protein-protein interface (Fig. 5.3A., B.). The 
interactions between the cytoplasmic regions are transient and highly dynamic, 
resembling the conformational ensembles of intrinsically disordered complexes 
[420]. For both complexes, we observe persistent interactions between PLN-Glu2 
and SERCA-Lys365, PLN-Glu19, and SERCA-Lys328, and to a lesser extent PLN-
Lys3 and SERCA-Asp399 and PLN-Tyr6 and SERCA-Asp557. For PLNAFA, 
however, the arginine residues (Arg9, Arg13, and Arg14) interact transiently with 
SERCA-Glu606, while for pPLNAFA, the phosphate group at Ser16 interacts 
strongly with SERCA-Arg604 and SERCA-Lys605. Interestingly, we detected the 
formation of intramolecular salt-bridges between the phosphate of Ser16 and PLN-
Arg9, PLN-Arg13, and PLN-Arg14, causing domain Ia to adopt a compact 
conformation as previously suggested by fluorescence data [421, 422] (Table 5.2, 
6.3). These cytoplasmic protein-protein interactions destabilized PLN’s domain Ib 
and consequently severed inhibitory intermolecular contacts with SERCA’s TM 
helices involving Gln23-Leu321/Arg325 (M4), Lys27-Phe809 (M6) and Asn30-
Trp107 (M2), while the intermolecular contacts involving domain II are mostly 
retained (Fig. 5.3A and Fig. 5.3–fig. supp. 5.1). In fact, hydrophobic substitutions 
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within domain Ib have been identified as hotspots for engineering super-inhibitory 
PLN mutants (i.e., Asn/Lys27Ala and Asn30Cys), which exhibit stable helical 
structure well into the loop domain [384, 423, 424]. Importantly, these structural 
ensembles capture the order-disorder dynamics of domain Ib resonances 
observed in the OS-ssNMR spectra and suggested by previous NMR and EPR 
studies[425]. Destabilization and detachment of this region is consistent with the 
reappearance of exchange-broadened interfacial resonances of domain II 
paralleled by broadening of the resonances of the dynamic domain Ib in the SLF 
spectra of the SERCA/pPLNAFA complex (Fig. 5.1E.). The interactions of domain 
Ia (Arg13-Ser16) and inhibitory contacts of domain Ib (at Lys27) with SERCA 
appear to be mutually exclusive (Fig. 5.3C.-F.). In both complexes, the 
electrostatic interactions of PLN-Arg13, PLN-Arg14, or PLN-pSer16 with the 
SERCA’s Arg604-Glu606 stretch cause the detachment of PLN’s domain Ib and 
the consequent weakening of the inhibitory interaction (Fig. 5.3C.-G.). This 
illustrates the regulatory role of the B state of PLN for relieving inhibition and the 
superinhibitory activity of domain Ia-truncated PLN [184]. 
 
5.2.4 Phosphorylation disrupts correlated motions between PLNAFA and SERCA’s 
Ca2+ binding sites 
To assess the effects of PLN’s phosphorylation on Ca2+ transport, we 
calculated the topological correlations of the TM’s tilt angle fluctuations between 
PLN's and SERCA’s TM helices (Fig. 5.4A.-D.). When PLNAFA is bound to SERCA,  
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Figure 5.4: PLN topological transitions are allosterically 
coupled to SERCA's Ca2+ binding sites 
A. and B. Correlation maps of motions between the TM topology 
of PLNAFA A. or pPLNAFA B. with the topology of the 10 TM 
domains of SERCA. C. and D. Corresponding spider plots 
showing the density of correlations are displayed below. Green 
spheres mark positions of the calcium-binding sites. E. and F. 
Snapshots of the SERCA/PLNAFA E. and SERCA/pPLNAFA F. 
complexes highlighting the transient interactions with the 




binding sites' geometry, possibly reducing SERCA's Ca2+ binding affinity. In 
contrast, the analysis of the trajectories of the SERCA/pPLNAFA complex displays 
only correlated motions between the TM of pPLNAFA and the most proximal SERCA 
helices, with only a sparse network of correlations involving TM4, TM5, TM6, and 
TM8. Phosphorylation of PLN at Ser16 increases the electrostatic interactions with 
the cytoplasmic domain of SERCA (R to B state transition, i.e., disorder to order) 
[184], and simultaneously weakens intramembrane protein-protein interactions to 
uncouple the dynamic transitions of PLN from SERCA. The latter removes the 
structural hindrance of PLN’s TM domain and augments Ca2+ transport (Fig. 5.4E., 
F.). 
 
5.2.5 Effects of Ca2+ ion binding to SERCA on PLN’s topology 
To assess the effects of Ca2+, we performed SLF experiments on 
SERCA/PLNAFA and SERCA/pPLNAFA complexes in the E1 state (Fig. 5.5A., B.). 
The addition of Ca2+ to the SERCA/PLNAFA complex did not cause significant 
changes to the PLN topology (= 32.9 ± 1.4° and ρL31 = 199 ± 4°; p = 0.29 and p = 
0.0025 compared to the E2 complex). However, the reappearance (i.e., 
sharpening) of several resonances in the spectra (e.g., Phe32, Phe35/Leu42, and 
Ala36) indicates a rearrangement of the binding interface between the two proteins 
similar to phosphorylation's effect on the E2 complex. A small topological change, 
however, was observed for the SERCA/pPLNAFA complex, for which Ca2+-binding 
induced a decrease of both tilt and rotational angles of 1.8 ± 1.3° and 10 ± 7°, 
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respectively (= 28.6 ± 0.7° and 
ρL31 = 187 ± 6°, p = 1.9 × 10-6 and 
p = 4.2 × 10-7 compared to the E2 
complex). Due to the lack of X-ray 
structures, we were unable to 
carry out dynamic modeling of 
these complexes. However, these 
experimental results agree with 
our E2-SERCA models 
suggesting that a loss of 
inhibition, either from 
phosphorylation or Ca2+ binding, 
does not require an extensive 
structural and topological 
reconfiguration of PLN’s domain II 




OS-ssNMR spectroscopy revealed that the TM helix of PLN undergoes a 
topological equilibrium that is shifted upon phosphorylation, providing direct 
evidence of the allosteric coupling between the outer membrane regulatory and 
 
Figure 5.5: Effects of Ca2+ binding to 
SERCA on the topology of PLN and 
pPLN 
A. and B. 2D [15N-1H] SE-SAMPI4 spectrum 
of PLNAFA A. and pPLNAFA B. bound to 
SERCA in the E1 form reconstituted into 
aligned lipid bicelles. PISA wheels for an 
ideal are superimposed. Equivalent spectra 




TM inhibitory regions. Our dynamic modeling of the SERCA/PLN complexes using 
experimental restraints shows that the structural disorder of the juxtamembrane 
domain Ib following Ser16 phosphorylation of PLN signals a slight topological 
change in the TM region that is sufficient to relieve its inhibitory function. This event 
involves allosteric effects between the inhibitory interactions of domain II of PLN 
and SERCA’s core helices harboring the Ca2+ binding sites. In addition to the 
localized disruption of PLN domain Ib interactions with SERCA, phosphorylation 
and Ca2+-binding signal a collective switch of PLN's TM domain from an inhibitory 
to a non-inhibitory topology. The tilt angle reductions of PLN accompanying the 
relief of inhibition are easily identifiable from the OS-ssNMR spectra, while 
rotations are more subtle; nonetheless these topological changes are sufficient to 
disrupt critical inhibitory interactions. 
Recent X-ray investigations and extensive computational studies showed 
that SERCA undergoes significant rocking motions throughout its enzymatic cycle 
[426-428]. These conformational transitions analyzed in the absence of PLN are 
highly concerted and cooperative, i.e., the dynamics of the cytoplasmic headpiece 
of SERCA correlates with its TM domains [427, 428]. PLN (and other regulins) 
[370] wedges into the ATPase's binding groove and either correlate with the 
topological changes of SERCA’s TM domains or interfere with its rocking motions 
leading to uncoupling of ATP hydrolysis and Ca2+ transport. PLN experiences 
significant changes in tilt angle (ranging from 28.6° to 37.5°), depending on both 
the conformational state of PLN and enzymatic state of SERCA. Therefore, these 
dynamic and topological transitions provide the mechanism to modulate TM 
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protein-protein interactions, which can be tuned by posttranslational 
phosphorylation, O-glycosylation [429], and binding of ancillary proteins [430, 431]. 
The structural and dynamic changes of PLN, detected by OS-ssNMR, 
resolves an ongoing controversy about the subunit vs. dissociative models 
proposed for SERCA regulation [377, 405, 406, 432, 433]. The latter model 
speculates that the reversal of the inhibitory function of PLN is due to a complete 
dissociation of this regulin from the ATPase; but this is not supported by 
spectroscopic data either in vitro or in cell [184, 381, 405, 406, 433]. On the other 
hand, the subunit model agrees well with all spectroscopic measurements, but it 
does not explain the reversal of inhibition caused by phosphorylation or the 
elevation of Ca2+ concentration. Our ssNMR-driven dynamic calculations clearly 
shows that topological and structural changes modify the interactions at the 
interface and are propagated to the distal Ca2+ binding sites.  
Fig. 5.6 summarizes our proposed mechanistic model for allosteric control 
of SERCA by PLN’s topological changes. We previously showed that PLN’s 
cytoplasmic domain undergoes a three-state equilibrium (T, R, and B) in which the 
T and R states are inhibitory, while the B state is non-inhibitory.[184] Our new data 
show that, when bound to the E2-SERCA state, the TM region of PLN (domains Ib 
and II) remains locked into the ATPase’s binding groove. An increase of Ca2+ 
concentration drives SERCA into the E1 state and reconfigures the intramembrane 
binding interface augmenting Ca2+ transport without significant topological 
changes to PLN. On the other hand, detectable topological changes occur upon 
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PLN’s phosphorylation both at low and high Ca2+ concentrations, shifting the 
equilibrium toward the non-inhibitory B state of PLN [434] and transmitting changes 
across the SERCA/PLN interface that increase Ca2+ transport. In this framework, 
it is possible to explain how single-site disease mutations or deletion in domains 
Ia and Ib may lead to perturbations of the protein-protein electrostatic network of 
interactions, resulting in 
dysfunctional Ca2+ transport 
[423, 435, 436]. 
In conclusion, the 
structural dynamics and 
topological allostery identified 
for PLN may explain how 
bitopic miniproteins, despite 
their simple architecture, can 
fulfill diverse regulatory roles 
and how posttranslational 
modification at cytoplasmic 
sites may constitute switches 
for signal transduction across 
cellular membranes operated 




Figure 5.6: Regulatory model of SERCA by 
PLN’s phosphorylation and Ca2+ 
PLN’s cytoplasmic domain exists in equilibrium 
between three distinct populations in the 
presence of SERCA. The increase of Ca2+ ions 
causes significant shifts SERCA’s conformation 
toward the E1 state, while the topology of PLN 
is only slightly affected (top equilibrium). 
Phosphorylation of PLN at Ser16 signals more 
extensive topological changes with a 
reconfiguration of SERCA/PLN TM interactions 
both at low and high Ca2+ concentrations 
(bottom equilibrium), augmenting Ca2+ 
transport. Note that the T and R populations are 
not represented for clarity. 
 
137 
membrane proteins regulate membrane-embedded enzymes or receptors [369]. 
In the heart, phospholemman [438-440], a member of the FXYD family, regulates 
the Na+/K+-ATPase interacting via its transmembrane domain, with its regulatory 
interactions modulated by protein kinases A and C. Several regulins have also 
been recently found to control SERCA's isoforms in other tissues [370] and share 
similar topologies to PLN. They all bind at distal locations from the active sites 
(e.g., ATP or ion channels) of enzymes, revealing possible hotspots for allosteric 
control by small molecules. Therefore, the characterization of the topological 
allosteric control of SERCA by PLN represents a first step in understanding how 
and why evolution has preserved these small polypeptides as a means to regulate 
the function of ATPases [439, 441] or other membrane transporters [442]. 
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5.5.1 Expression, purification, and phosphorylation of PLNAFA 
Uniformly 15N-labelled PLNAFA was expressed as a soluble fusion with 
maltose binding protein (MBP) as reported previously [443], with minor 
modifications. Freshly transformed E. coli Codon Plus (Invitrogen) cells were used 
to inoculate overnight LB cultures, which were subsequently centrifuged and 
resuspended into M9 minimal media (15NH4Cl as the sole nitrogen source) at an 
OD600 of ~0.7. Cultures were grown at 30°C to OD600 1.0 then induced with 1 mM 
IPTG over 20 h to a final OD600 of 5. Cells (~6 g/L of M9) were stored at -20 °C. 
Selectively 15N-labelled PLN was expressed from M9 media (free of NH4Cl) with 
125 mg/L of the respective 15N-amino acid, 300 mg/L of non-scrambling and 450 
mg/L scrambling-prone 14N-amino acids [444]. Reverse-labeled PLN was 
expressed in M9 minimal media (15NH4Cl) with 1 g/L of the respective 14N-labeled 
amino acid. Induction times for selective and reverse labeling growths were 
reduced to 3 to 4 h to reduce scrambling. 
For purification, cells were homogenized (Sorvall Omni Mixer) and lysed by 
sonification in 200 mL lysis buffer (20 mM sodium phosphate, 120 mM NaCl, 2 mM 
DTT, 1 mM EDTA, 0.1 mg/mL lysozyme, 0.5 % glycerol, 0.5% Tween 20 and 
protease inhibitors, pH 7.3). The lysate was centrifuged (17,500 rpm, JA25.50 
rotor, 4 C, 40 min) and supernatant loaded onto 30 mL bed volume of amylose 
resin. The resin was washed with buffer (20 mM sodium phosphate, 120 mM NaCl, 
pH 7.3) and eluted into 100 mL buffer including 50 mM maltose. Elution volumes 
were concentrated to ~50 mL and dialyzed overnight against 3 L of cleavage buffer 
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(50 mM Tris-HCl, 2 mM -mercaptoethanol, pH 7.3). All purification steps were 
done at 4°C and yielded up to 120 mg of fusion protein from 1 L M9 media. 
To phosphorylate PLNAFA at Ser16 (pPLNAFA), the MBP fusion was dialyzed 
into 30 mM Tris-HCl, pH 7.5, followed by addition of 11x reaction buffer to reach 
50 mM Tris-HCl, 10 mM MgCl2, 0.05 mM PMSF, 1 mM NaN3, 1 mM EDTA). The 
catalytic subunit of protein kinase A (PKA) was added at 1:1000 ratio to fusion 
protein, with 2 mM DTT, and the reaction started by addition of 2 mM ATP and 
incubation at 30C for 3 h with gentle agitation. 
MBP-PLN, either phosphorylated or non-phosphorylated, was cleaved with 
TEV protease and 2 mM DTT for 3 h at 30 C to liberate insoluble PLN (Fig. 5.7A.), 
which was pelleted by centrifugation and dissolved into 10% SDS and 50 mM DTT 
at approximately 10 mg/mL then stored at -20 C. PLN was further purified by 
HPLC using a Vydac 214TP10154 C4 column heated at 60 °C and eluted using 
H2O/0.1% trifluoroacetic acid (TFA) and a linear gradient of isopropanol/0.1% TFA 
from 10 to 40% over 10 mins then to 80% over 50 min (2 mL/min flow rate). The 
protein was lyophilized. Complete phosphorylation of pPLNAFA was confirmed by 
MALDI-MS (Fig. 5.7B.). The inhibitory activity of PLNAFA against SERCA, and 
relieved inhibition of pPLNAFA, in the DMPC/POPC (4:1) lipid bilayer composition 




5.5.2 Preparation of oriented bicelle samples 
Long-chain lipids DMPC (37.0 mg), POPC (10.4 mg) and PE-DTPA (0.9 
mg; i.e., 79.25:19.75:1.0 molar ratio) were aliquoted together from chloroform 
stocks (Avanti Polar Lipids), dried to a film with N2 and residual solvent removed 
under high vacuum. The film was resuspended into 1 mL ddH2O, freeze-thawed 
three times between liquid N2 and a 40 C water bath then lyophilized. DHPC (7.7 
mg; 1:4 molar ratio, or q = 4, to long chain lipids) was prepared separately from a 
chloroform stock, dried and lyophilized from ddH2O. 
 For bicelles containing only PLN, DHPC was dissolved into 250 L sample 
buffer (20 mM HEPES, 100 mM KCl, 1 mM NaN3, 2.5% glycerol, pH 7.0), then 
used to solubilize PLN (2.5 mg) by vortex. Separately, long-chain lipids were 
suspended into 250 L of buffer. PLN in DHPC and long-chain lipids, both pre-
chilled in ice, were combined and vortexed while allowing the sample to reach 
room temperature, then placed back on ice. The process was repeated at least 
three times to fully solubilize long-chain lipids, which produced a completely 
transparent liquid at cold temperature (micelle phase) and transparent solid gel at 
room temperature (bicelle phase). The sample was placed on ice, brought to pH 
4.2 with KOH, then concentrated to ~180 L using a 0.5 mL 10 kDa MWCO 
centrifugal filter (Amicon) at 4°C. The solubility of PLNAFA and pPLNAFA was 
significantly diminished at higher pH. The sample was doped with 0.8 L of 1 M 
YbCl3, corrected back to pH 4.2 with KOH, then loaded into a 5 mm flat bottom 
sample cell (New Era). 
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 For bicelles containing the SERCA/PLNAFA complexes, SERCA1a was 
purified from rabbit skeletal muscle as previously described [397]. SERCA was 
eluted from Reactive Red affinity resin at ~0.5 mg/mL in SERCA, 0.1% C12E8, 1 
mM CaCl2, 1 mM MgCl2, 20 mM MOPS, 20% glycerol, 8 mM ADP, 0.25 mM DTT, 
pH 7.00 and stored at -80°C. Protein concentration was determined by Pierce BCA 
Assay (Thermo Scientific) and activity confirmed by coupled-enzyme assays [317]. 
Immediately prior to use, SERCA (4 mg) was thawed at 4°C and combined with 
long-chain lipids (prepared as above, except with 1.5% molar PE-DTPA chelating 
lipid) solubilized into 1 mL of 4% C12E8 in sample buffer. The mixture was diluted 
to ~30 mL with sample buffer and stirred at 4°C for 30 min prior removal of C12E8 
by adding 4 g of Bio-Beads SM-2 (Bio-Rad) in stages of 0.5, 0.5, 1 and 2 g with 15 
min stirring between additions. Stirring continued overnight at 4°C. Bio-Beads were 
removed by a 25G syringe and the cloudy suspension of proteoliposomes 
centrifuged at (12,000 rpm, JA25.50 rotor, 4°C, 30 min). The pellet was 
resuspended into ~40 mL sample buffer and centrifuged once more to wash out 
residual elution buffer. The final pellet was resuspended with 250 L sample buffer 
and fully solubilized by adding a 250 L mixture of PLNAFA, or pPLNAFA (0.23 mg), 
in DHPC (adjusted to pH 7.0) with several cooling/heating cycles under vortex. The 
bicelle mixture (~1 mL) was centrifuged (13,400 rpm, Eppendorf F45-12-11 rotor, 
4 °C, 30 sec) to remove insoluble debris and the supernatant concentrated to ~200 
L using a 0.5 mL 10 kDa MWCO centrifugal filter (Amicon) at 4 °C. The sample 
was doped with 1.6 L of 1 M YbCl3 in four stages, correcting pH back to 7.0 with 
KOH at each addition. Sample buffer included 20 mM HEPES, 100 mM KCl, 1 mM 
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NaN3, 5 mM MgCl2, 2 mM DTT, 2.5% glycerol, pH 7.0 with 4 mM EGTA or 5 mM 
CaCl2 to stabilize E2 or E1 states, respectively. SDS-PAGE confirmed co-
reconstitution of SERCA and PLN in the bicelles (Fig. 5.7D.). 
 
Figure 5.7: Activity and confirmation of PLNAFA 
A. SDS-PAGE gel of the expression and purification of PLNAFA as an MBP-fusion: 
ladder (L), pre-induced (PI) and induced (I) expression, lysate supernatant (Lys.), 
purified MBP-PLNAFA eluted from amylose resin (E), MBP-PLNAFA after cleavage 
with TEV protease (C),and HPLC-purified PLNAFA. B. MALDI-MS spectra of HPLC-
purified 15N PLNAFA and pPLNAFA. C. Coupled-enzyme ATPase activity assays of 
SERCA reconstituted into DMPC/POPC (4:1; lipid-to-protein ratio of 700:1) 
liposomes with a 5-fold excess of either PLNAFA or pPLNAFA. Assays consisted of 
50 mM HEPES, 100 mM KCl, 5 mM MgCl2, 0.2 mM NADH, 0.5 mM PEP, 10 U/mL 
pyruvate kinase, 10 U/mL lactate dehydrogenase, and 7 μM calcium ionophore 
A23187 at pH 7.0. ATPase activity was measured by the rate of reduction in NADH 
absorbance at 340 nm at EGTA-buffered calcium concentrations between 10-7 and 
10-4 M, initiated by addition of 0.5 mM ATP. Activity as a function of calcium 
concentration was fitted to a Hill function to extract the pKCa values (calcium 
concentration at half Vmax) shown. Errors indicate the standard deviation from 3 
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replicate measurements. Statistical significance was determined by unpaired t-test 
(Microsoft Excel 365 Version 2002). D. SDS-PAGE gel of SERCA and PLN 
reconstituted into bicelles for OS-ssNMR: bicelle sample freshly solubilized by 
DHPC (B), supernatant after centrifugation (S) and pellet formed from a small non-
solubilized component (P). 
 
5.5.3 Synthesis of TFMB and tagging of SERCA 
Trifluoromethylbenzyl (TFMB)-methanethiosulfonate (MTS) was 
synthesized analogously to our method previously reported for synthesizing a 13C-
ethylmethanethiosulfonate tag[306, 445] with minor modifications. Briefly, 4-
(trifluoromethyl)benzyl bromide (5 mmole), MTS (5 mmole) and KI (0.03 mmole) 
were dissolved into 2 mL of dimethylformamide and stirred under nitrogen for 16 h 
at 40°C. 
For TFMB tagging, SERCA (8 mg) was thawed and dialyzed into 1 L of E1-
state sample buffer (as above, but without DTT and including 0.25 mM C12E8) 
overnight at 4 °C. DMPC (25.2 mg) and POPC (7.1 mg), solubilized in 500 μL of 
5% C12E8, was then added to dialyzed SERCA. Detergent was removed by stirring 
with 1 g Bio-Beads SM-2 for 1.5 h at 4°C and a further 30 min at room temperature. 
Proteoliposomes were removed from Bio-Beads with a 25G syringe and 
centrifuged (18,000 rpm, JA25.50 rotor, 4 °C, 40 min). The pellet was suspended 
into 120 L buffer and solubilized by adding DHPC (q = 4 for oriented or q = 0.5 
for isotropic bicelles). TFMB-MTS (200 mM in DMSO) was added to the bicelles at 
5:1 molar excess and incubated at room temperature for 1 hour prior to 
concentrating to ~250 with a 0.5 mL 10 kDa MWCO centrifugal filter (Amicon) and 
loading into a Shigemi NMR tube for 19F NMR measurement. 
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 19F NMR spectra of TFMB-tagged SERCA were acquired on a solution state 
Bruker 600 MHz Avance NEO spectrometer equipped with a TCI HCN cryoprobe. 
1D single-pulse experiments were acquired using a 90° pulse of 12 µs and recycle 
delay of 0.4 s. Spectra in isotropic bicelles were acquired with 1 k scans and 4 k 
scans for oriented bicelles. Spectra were processed using NMRPipe [321]. 
 
5.5.4 Oriented solid-state NMR spectroscopy 
All 15N spectra were acquired on a Varian VNMRS spectrometer equipped with a 
low-E static bicelle probe[446] operating at a 1H frequency of 700 MHz. 1D [1H-
15N]-cross-polarization (CP)-based experiments used 90° pulse length of 5 μs, or 
50 kHz radiofrequency (RF) field, on 1H and 15N channels; contact time of 500 μs 
with a 10% linear ramp on 1H centered at 50 kHz; and an acquisition time of 10 ms 
under 50 kHz SPINAL64 heteronuclear proton decoupling [327]. For all 
experiments, 15N was set to 166.3 ppm and externally referenced to 15NH4Cl at 
39.3 ppm [447]; and detected using a spectral width of 100 kHz. 
2D separated local field (SLF) spectra were collected using a signal-
enhanced (SE)-SAMPI4 experiment [400, 448, 449]. The indirect dipolar 
dimension utilized complex points and a spectral width of 20.8 kHz. The t1 evolution 
period utilized 1H homonuclear decoupling with an RF field of 50 kHz and 48 μs 
dwell time, and a phase-switched spin-lock pulses on 1H and 15N of 62.5 kHz RF 
field. The sensitivity enhancement block used a τ delay of 75 μs and three cycles 
of phase-modulated Lee-Goldberg (PMLG) homonuclear decoupling [450] with an 
effective RF field of 80 kHz. 
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 3D SE-SAMPI4-PDSD spectra [401] were acquired with 15 increments in 
both indirect dimensions; spectral widths of 20.8 kHz and 10 kHz in the dipolar 
coupling and indirect 15N dimensions, respectively; and 3 s mixing time for 15N-15N 
diffusion [451]. Total acquisition times for PLNAFA samples were typically 1 h for a 
1D [1H-15N] CP spectra (1 k scans), 5 h for 1D [1H-15N] WE-CP spectra (5 k scans), 
24 h for 1D [1H-15N] rINEPT spectra (25 k scans), 40 h for 2D SE-SAMPI4 spectra 
(1 k scans) and 2 weeks for 3D SE-SAMPI4-PDSD spectra (2 experiments added 
with 0.25 k scans each). For the SERCA/PLNAFA complexes, 2D SE-SAMPI4 
spectra were acquired over 4.5 days at 25 °C (4 k scans, 15 indirect points) and 
1D [1H-15N] CP spectra for 4 h (4 k scans). A recycle delay of 3 sec was used for 
all experiments. All spectra were processed using NMRPipe [321] and analyzed 
using NMRFAM-SPARKY [452] and Nmrglue [453]. 
 
5.5.5 PISA wheel simulations and fitting 
Polar Index Slant Angle (PISA) wheels [145, 403] were fitted to 2D SE-
SAMPI4 spectra using the PISA-SPARKY plugin in the NMRFARM-SPARKY 
package [454]. Default parameters were used to describe ideal helix structure and 
15N chemical shift (CS) and 15N-1H dipolar coupling (DC) tensors. The Cα-N-H 
bond angle was modified from 116° to 119° to best fit PLNAFA spectra. CSs and 
DCs were fit by exhaustively searching tilts (θ), rotations (ρL31, i.e., referenced to 
residue Leu31) and order parameters (S) in increments of 0.1°, 1.0° and 0.01, 
respectively, for the lowest RMSD between calculated and experimental values 
[454]. The parameter S, which factors scaling due to rigid-body helical fluctuations 
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and imperfect alignment [455], was determined as 0.80 ± 0.05 and 0.81 ± 0.03 for 
PLNAFA and pPLNAFA, respectively, alone in bicelles. Due to the sparsity of peaks 
assigned for spectra of PLN in complex with SERCA, S was fixed to 0.80 to reduce 
fitting errors. Errors in tilt θ, ρL31 and S were determined by repeating fitting 20 
times with peak positions randomly adjusted at each iteration. Random 
adjustments were taken from a Gaussian distribution having a standard deviation 
equal to average FWHM peak linewidths (3 ppm for CS and 0.8 kHz for DC 
dimensions). The statistical significance of topological comparisons made 
throughout the text were determined using an unpaired t-test (Microsoft Excel 365 
Version 2002) on tilt and azimuthal angles from the 20 repeat fits. 
 
5.5.6 Unrestrained molecular dynamics 
      A simulation of truncated PLNAFA (M20 to L52; PDB 2LPF [394]) in 97 DMPC 
and 32 POPC, 150 mM KCl and 4927 waters was constructed using the CHARMM-
GUI webserver [4, 5] and CHARMM36 forcefield[456]. Production runs were done 
using the AMBER18 [457, 458] package at 10 Å cutoff and 8 Å force-based 
switching and default configuration files provided by the CHARMM-GUI webserver. 
For example, using the Langevin thermostat [459] (310 K), Monte Carlo barostat 
[460] (1 bar, semi-isotropic coupling) and the SHAKE algorithm [461] for 
constraining hydrogens. The simulation was run for 1 µs. The final 900 ns of 
trajectory was used to predict 15N chemical shifts and 15N-1H dipolar couplings, as 
previously reported [402]. 
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5.5.7 NMR-restrained refinement of the SERCA/PLN complex 
The initial conformation of SERCA in the E2 state was obtained from the 
crystal structure of the SERCA/PLN complex (PDB 4Y3U) [384]. Missing loops in 
the structure of SERCA were introduced using MODELLER software [462]. The 
interface between SERCA and PLNAFA (human sequence with a single Asn27Lys 
substitution) was then refined in silico by introducing information from our cross-
linking data. Specifically, the transmembrane section of PLNAFA was docked onto 
SERCA in vacuo, maintaining backbone positional restraints on the pump and 
restraining the dihedral angles of PLNAFA to retain the helical structure. Docking 
was guided by cross-linking data [382, 407, 408], performing short MD runs (500 
ps) with an harmonic upper wall potential applied to restrain the distances between 
cross-linked residues to below 5 Å. 100 such runs were performed starting from 
different orientations of PLNAFA, and the resulting docked complexes were 
clustered according to the backbone RMSD of the proteins. The center of the most 
highly populated cluster was picked as the most representative structure and used 
to continue the modelling. The N-terminal segment of PLNAFA, not present in the 
original structure, was built as a random coil detached from SERCA. Ser16 was 
modelled both with and without the phosphorylation, generating two different 
PLNAFA/SERCA complexes. 
 The structures of the PLNAFA/SERCA and pPLNAFA/SERCA complexes 
were then embedded in DMPC:POPC bilayers, mimicking the experimental 
conditions, and solvated with TIP3P water [463]. The systems were equilibrated 
for 1 µs with positional restraints using the coarse-grained model MARTINI[464] 
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and then re-converted to full-atom descriptions using the Backward approach 
[465]. The full-atomic systems were equilibrated for 50 ns at 300 K and a further 
50 ns after releasing the positional restraints. Eight equally spaced structures were 
extracted from the final 20 ns of sampling. These eight structures were used as 
starting points for ssNMR-restrained replica-averaged sampling (RAOR-MD). The 
final equilibrated box (of dimensions 10.8 x 10.8 x 15.9 nm3) contains 247 DMPC 
lipids, 82 POPC molecules, 39,017 TIP3P waters and 23 Na+ ions to neutralize the 
system (~174,000 atoms). 
 15N chemical shift (CS) and 15N-1H dipolar coupling (DC) restraints were 
incorporated into the sampling using replica-averaged restrained MD, as 
previously described [201, 385] (code available at 
https://github.com/maximosanz/modelSSNMR), composed of eight replicas 
evolving simultaneously. The restraining forces were gradually incorporated during 
an initial equilibration phase of 20 ns, where the forces were linearly increased to 
a maximum of 50 J/(mol·ppm2) and 800 J/(mol·kHz2) for CSs and DCs, 
respectively. 
 In order to enhance the conformational sampling of the disordered domain 
Ia of PLNAFA, we implemented a sampling based on annealing cycles, whereby the 
PLNAFA N-terminus periodically binds and detaches from the SERCA surface. The 
experimental PRE measurements [184] were incorporated in order to drive each 
binding event. At the beginning of each cycle, the domain Ia of PLNAFA is fully 
detached from SERCA by introducing a lower-wall harmonic potential that pushes 
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PLNAFA residues away from SERCA residues present in the cytoplasmic domains 
of the pump. The lower wall potential pushes PLNAFA residues 0 to 10 at least 50 
Å away from Ile140 (SERCA A domain), Thr430 (SERCA N domain) and Cys674 
(SERCA P domain). Residues 11 to 14 were pushed at least 25 ̊A away from those 
residues and in addition the interfacial SERCA residues Thr742, Ala327 and 
Leu119. The detachment occurs gradually, by linearly increasing the force of the 
lower-wall potential to a maximum of 5 J/(mol · nm2) after 500 ps. During this time, 
the temperature is also linearly increased to 370 K to enhance the conformational 
sampling space of the disordered domain Ia. CS and DC force constants were 
linearly decreased to half their value to avoid instabilities during this high-energy 
phase of the cycle. This detachment step yields a fully detached PLNAFA domain 
Ia with no SERCA contacts and enough surrounding free space to explore its 
unbound disordered conformational space. This step is followed by another 500 
ps of sampling at 370 K, where the detached PLNAFA domain Ia is allowed to 
fluctuate.  Subsequently, a binding stage follows, whereby the lower-wall potential 
is linearly removed over 1 ns of sampling. The PRE-derived distance restraints 
were gradually incorporated over this time as an upper-wall potential at 30 
Angstrom with a maximum force of 5 J/(mol·nm2). During this step the force 
constants of CS and DC are also restored to their full value, and the temperature 
is linearly decreased to 300 K. After the binding phase, the PLNAFA N-terminus 
adopts a SERCA-bound conformation. This step leads onto the sampling phase of 
the cycle, where the restraint forces and the temperature are kept constant for 2 
ns. The structures sampled during these 2 ns are the ones included in the final 
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conformational ensembles 
of SERCA/PLNAFA.  This 
annealing cycle sampling 
approach is illustrated in 
Fig. 5.8. 
We performed 25 
annealing cycles per replica 
for both PLNAFA and 
pPLNAFA, resulting in a total 
simulation time of 0.8 µs for 
each ensemble. 10,000 
equally separated structures 
(400 ns) in the sampling part 
of the cycles were extracted 
to perform the analyses 
described in the main text. All samplings were performed using a previously 
described version of GROMACS [466], modified to include the CS and DC 
restraints [385]. The CHARMM36 force field [456] was used. Temperature was 
coupled using the v-rescale algorithm [467] and pressure was coupled at 1 bar 
using the semi-isotropic Berendsen method[468]. All simulations were carried out 
under periodic boundary conditions. The integration timestep was set to 2 fs and 
the LINCS algorithm was used for constraints [469]. Electrostatic interactions were 
accounted for using the Particle Mesh Ewald method [470]. Ensembles were 
 
Figure 5.8: Annealing cycle used in the 
sampling of the SERCA/PLNAFA complex 
During the first nanosecond of the simulation, the 
N-terminus of PLN is detached from SERCA and 
the temperature is raised to 370 K to randomize 
its conformation. Then the system is cooled back 
down to 300 K over 1 ns, during which time the 
CS, DC and PRE restraints are re-introduced. 
























analyzed using CPPTraj [471] for principle component analyses (PCA); VMD [472] 
for contact, hydrogen bond and distance measurements; custom Python scripts 
for computing helical tilt (θ) and rotation (ρ) angles; and GROMACS energy tool 
for electrostatic interactions.  
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5.6 Supplementary Figures 
Table 5.1: O-ssNMR assignments 
Summarized 15N CS and 15N-1H DC assignments of PLNAFA and pPLNAFA 
reconstituted alone in bicelles or in complex with SERCA in either E2 (Ca2+-free) 
or E1 (5 mM Ca2+) states. 
Res. 
PLNAFA pSer16-PLNAFA 
PLNAFA + SERCA 
(E2) 
pSer16-PLNAFA 
+ SERCA (E2) 
PLNAFA + SERCA 
(E1) 
pSer16-PLNAFA 
+ SERCA (E1) 
CS DC CS DC CS DC CS DC CS DC CS DC 
N27 117.6* 1.19* 118.1 0.90 - - - - - - - - 
N30 117.6* 1.19* 121.5 3.10 - - - - - - - - 
L31 152.8 0.94 155.2 0.74 - - 164.3 1.26 - - - - 
F32 167.7 2.46 177.9 3.38 - - 187.6 4.07 181.6 3.78 186.6 4.56 
N34 125.8 1.36 132.4 2.71 - - - - - - - - 
F35 164.7 1.17 166.2* 1.36* - - 179.1 2.86 176.4 2.30 - - 
A36 176.5 4.74 184.3 5.28 186.5 5.72 191.0 6.37 190.4 5.91 192.8 6.76 
L37 123.9 4.89 132.2 5.71 136.5 6.66 146.0 6.57 146.1 4.73 151.7 5.87 
I38 140.8 1.03 146.5 1.40 156.9 1.86 160.3 2.54 156.4 2.11 164.9 2.14 
L39 181.7* 2.31* 185.7* 2.86* 190.3 3.88 194.4 3.99 194.5 3.76 198.5 4.75 
I40 155.7 6.19 163.5* 6.88* 164.0 7.04 171.5 6.87 166.7 6.99 169.9 7.25 
F41 127.8 3.39 134.6 4.19 - - 150.0 4.46 - - 148.4 4.33 
L42 160.5 0.91 166.2* 1.36* 175.5 1.74 179.1 2.86 - - 181.1 2.63 
L43 187.5* 4.17* 190.9* 4.46* 192.8 5.77 198.3 5.76 196.5 5.89 - - 
L44 138.0 6.02 145.6 6.19 149.9 6.22 155.5 6.26 156.0 5.19 155.1 6.65 
I45 139.2 1.80 144.5 2.64 152.7 2.74 160.3 2.54 - - 162.1 3.57 
A46 181.7* 2.31* 185.7* 2.86* - - 191.4 2.84 - - - - 
I47 170.5 6.35 175.9 6.65 - - 181.8 7.23 179.5 6.74 181.9 7.99 
I48 132.7 4.88 139.2 5.39 145.5 5.16 154.3 6.03 151.2 4.94 - - 
V49 157.1 1.75 160.1 2.26 - - - - - - - - 
M50 187.5* 4.17* 190.9* 4.46* - - 198.0 5.14 202.5 4.80 199.9 5.94 
L51 158.3 7.06 163.5* 6.88* - - - - - - - - 
* These peaks are overlapped.  
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Table 5.2: Pairwise inter- and intramolecular hydrogen bond summary for 
PLNAFA/SERCA REMD PCA clusters 
Parentheses report the average number hydrogen bonds to a charged residue of 
SERCA or PLN (bold font) observed over all frames assigned to the respective 
clusters. Hydrogen bonds were defined with a donor -acceptor distance less than 
3 Å and a donor-H-acceptor angle less than 20°. 
Cluster 
Average hydrogen bonds per frame 







































Table 5.3: Pairwise inter- and intramolecular hydrogen bond summary for 
pSer16-PLNAFA/SERCA REMD PCA clusters 
Hydrogen bonds were measured according to Table 2. 
Cluster 
Average hydrogen bonds per frame 


















































































































































Figure 5.9: Figure 1 supplement 1. Assignment by 3D OS-ssNMR 
A. 2D projection and B. strip plot of [15N-15N-1H] 3D SE-SAMPI4-PDSD spectrum 
of pPLNAFA in bicelles showing sequential 15N-15N correlations.  
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Figure 5.10: Figure 1 supplement 2. Assignment of OS-ssNMR spectra by 
selective labeling and un-labeling experiments 
2D [15N-1H] SE-SAMPI4 spectra of uniformly 15N-labelled PLNAFA (blue) and 
pPLNAFA (red) overlaid with recombinant residue-specific uniformly labeled (U) and 
uniformly unlabeled (UL) preparations (black). Circles indicate theoretical peak 
positions based on PISA fitting and labels in italics are residues missing from 
experimental spectra.  
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Figure 5.11: Figure 1 supplement 3. Prediction of assignments from 
unrestrained MD simulation of truncated PLN 
A. Back-calculated SLF spectrum of domain Ib (red) and II (blue) residues 
computed as previously described[402]. B. PLNAFA domain II tilt angle throughout 
the simulation and C. the corresponding histogram.  
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Figure 5.12: Figure 1 supplement 4. Synthesis and oriented NMR of the 
trifluoromethylbenzyl (TFMB)-methanethiosulfonate (MTS) tag 
A. Synthesis of the TFMB-MTS tag. Lettering specifies carbon and proton 
assignments in B. 1H and C. 13C NMR spectra of the tag in CDCl3. Values in 
parenthesis specify peak multiplicity (s = singlet, d = doublet, q = quartet). D. 19F 
NMR of TFMB-tagged SERCA in isotropic bicelles. E. 19F NMR of TFMB-tagged 
SERCA (black) and free tag (red) in oriented bicelles. Spectra show that the tag 
partitions into bicelles, but with considerably reduced dipolar coupling compared 





Figure 5.13: Figure 2 supplement 1. Restraints for RAOR-MD structural 
refinement 
A. Schematic of crosslinking restraints[382, 407, 408] used for docking and 
paramagnetic relaxation enhancements previously observed by MAS-ssNMR[184] 
between methanethiosulfonate spin-labeled (MTSSL) Cys674 and cytoplasmic 
residues of PLNAFA and pPLNAFA. B. Averaged pairwise distances between 
cytoplasmic residues (at Cβ) of PLNAFA and Cys674-Sγ show qualitative 
agreement with C. prior [13C-13C] DARR MAS-ssNMR PRE measurements 
(reproduced with permission from [184]). D. Wave plots comparing 15N chemical 
shifts and 15N-1H dipolar couplings obtained experimentally (blue or red circles) 
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and back-calculated (green triangles) from RAOR-MD ensembles. Wave lines 
were taken from a PISA fits to the experimental points. E. Tilt (θ) and azimuthal 
angles (ρ31) back-calculated from RAOR-MD ensembles of PLNAFA (blue) and 
pPLNAFA (red). F. REMD pairwise distance distributions (Cβ-Cβ) of crosslinking 
residues[382, 407, 408, 417, 418]. Histograms encased in dotted lines relate to 
residue-pairs restrained during initial docking. Shaded regions show a typical 4 to 
15 Å crosslinking range. The residue pair Asn30 – Cys318, outside of this range, 
has optimal crosslinking with longer (15 Å) reagents[417].  
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Figure 5.14: Figure 2 supplement 2. Experimental and back-calculated 
RAOR-MD SLF spectra of the PLNAFA/SERCA complex 
Comparison of cross-peak positions observed from experimental SE-SAMPI4 
spectra (blue or red) and back-calculated from RAOR-MD ensembles (green; 
assumes 200 Hz and 800 Hz linewidths in CSA and DC dimensions, respectively). 
PISA fits were performed using only residues (solid circles) conforming closely to 
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ideal helicity in experimental spectra (i.e. Ile38, Leu39, Ile40 and Leu43 for PLNAFA; 
and Phe35, Ile38, Ile40, Leu43, Ile47 and Met50 for pPLNAFA).  
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Figure 5.15: Figure 2 supplement 3. Headpiece dynamics of SERCA in RAOR-
MD 
A. Inter-domain headpiece distances distributions from RAOR-MD of SERCA in 
complex with PLNAFA (blue) and pPLNAFA (red). B. SERCA headpiece distance as 
a function of the two largest components (PC1 and PC2) from Principal 
Component Analysis (PCA) of the two RAOR-MD calculations. Center of masses 
were determined using only backbone atoms with the Actuator (A) domain defined 
by residues 1 to 48 and 111 to 253, the Nucleotide-binding (N) domain by 360 to 
602 and the Phosphorylation (P) domain by 314 to 359 and 602 to 757.  
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Figure 5.16: Figure 2 supplement 6. RAOR-MD clustering. Top 20 most 
representative structures of each cluster extracted from PCA 
Structures were aligned by TM residues of SERCA. Only the most representative 
structure of SERCA is shown for each cluster.  
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Figure 5.17: Figure 2 supplement 7 
Example open state snapshot (PCA cluster 6) of SERCA stabilized by electrostatic 




Figure 5.18: Figure 3 supplement 1. Summary of inhibitory TM contacts 
Per-residue ensemble-averaged intermolecular contacts for TM helices of SERCA. 
A single contact by SERCA to PLNAFA (blue) or pPLNAFA (red) in RAOR-MD 
simulations is defined when any SERCA atom comes within 3.5 Å of any PLN atom 
for any given frame. PLNAFA residues responsible for the most contacts are 
designated at local maxima. 
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Abstract 
Hematopoietic-substrate-1 associated protein X-1 (HAX-1) is a 279 amino acid 
protein expressed ubiquitously. In cardiac muscle, HAX-1 was found to modulate 
the sarcoendoplasmic reticulum calcium ATPase (SERCA) by shifting its apparent 
Ca2+ affinity (pCa). It has been hypothesized that HAX-1 binds phospholamban 
(PLN), enhancing its inhibitory function on SERCA. HAX-1 effects are reversed by 
cAMP-dependent protein kinase A that phosphorylates PLN at Ser16. To date, the 
molecular mechanisms for HAX-1 regulation of the SERCA/PLN complex are still 
unknown. Using enzymatic, in cell assays, circular dichroism, and NMR 
spectroscopy, we found that in the absence of a binding partner HAX-1 is 
essentially disordered and adopts a partial secondary structure upon interaction 
with lipid membranes. Also, HAX-1 interacts with the cytoplasmic region of 
monomeric and pentameric PLN as detected by NMR and in cell FRET assays, 
respectively. We propose that the regulation of the SERCA/PLN complex by HAX-
1 is mediated by its interactions with lipid membranes, adding another layer of 
control in Ca2+ homeostatic balance in the heart muscle.  
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6.1 Introduction 
The hematopoietic-substrate-1 associated protein X-1 (HAX-1) is a 
multifunctional, intracellular protein discovered over two decades ago [97]. HAX-1 
is localized in many different tissues and regulates a variety of cellular targets 
[112]. Specifically, HAX-1 is involved in critical cellular functions such as apoptosis 
[104, 473-479], cell migration [107, 480, 481], endocytosis [482, 483], and mRNA 
transport [484-486], and interacts with several targets including viral proteins [102, 
487-490], ABC-transporters [491] and potassium channels [479]. Aberrant 
expression of HAX-1 has been linked to severe diseases, including cancer, 
psoriasis, and congenital neutropenia (Kostmann syndrome) in addition to 
neurodevelopmental delays and abnormalities [112]. 
 
Figure 6.1: HAX-1 secondary structure predictions based on s2D software 
[492] 
Random coil regions are indicated in black, alpha-helix in red, and beta-strand in 
blue. The domains that are responsible for the function of HAX-1 are indicated on 
top of the graph: PEST sequence [97], caspase 9 binding site [475], SERCA/PLN 
binding region [88, 90], and the putative membrane binding region [97]. 
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Recently, HAX-1 was identified as a novel regulator of Ca2+ transport in 
cardiomyocytes [91]. Specifically, it was found that HAX-1 interacts with 
phospholamban (PLN), an endogenous inhibitor of the sarcoplasmic reticulum 
(SR) Ca2+-ATPase (SERCA) [88]. SERCA is part of the primary signaling 
mechanism in cardiomyocytes as it transports Ca2+ from the cytosol into the SR, 
thereby controlling contraction and relaxation of the heart muscle [493]. 
Abnormalities in Ca2+ cycling are linked to the progression of heart failure [494-
497]. The activity of SERCA is mainly regulated by PLN, a bitopic membrane 
protein embedded in the SR [498]. In the healthy heart, unphosphorylated PLN 
inhibits SERCA by reducing its apparent affinity for Ca2+, while phosphorylated 
PLN at Ser16 reverses its inhibitory function in response to β-adrenergic 
stimulation [498]. A growing body of evidence indicates that HAX-1 binds SERCA 
either independently or in conjunction with PLN [88, 89, 91, 95, 96, 499]. To date, 
however, there are only sparse structural studies on HAX-1, limiting our 
understanding of the molecular mechanism and biological function of this protein. 
Theoretical predictions suggest that HAX-1 is likely to be intrinsically disordered 
(Fig. 6.1), which may explain its functional versatility. Cellular localization studies 
suggest that HAX-1 may also interact with lipid membranes as it chiefly interacts 
with proteins localized around organelle membranes [112].  
To gain insights on the function and molecular mechanism of action, we studied 
full-length HAX-1 in its free form and in the presence of lipid membranes and PLN 
using a combination of enzymatic and in cell assays, circular dichroism (CD), and 
NMR spectroscopy. When free in solution, HAX-1 is mostly disordered and 
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becomes partially ordered upon interacting with lipid membranes. Our solid-state 
NMR (ssNMR) experiments show that HAX-1 interacts with the cytoplasmic region 
of monomeric PLN when both proteins are functionally reconstituted in lipid 
bilayers, while FRET measurements show that HAX-1 is able to interact with the 
cytoplasmic region of PLN in its pentameric assembly. Our results support the 
theoretical predictions on HAX-1 structure and demonstrate its ability to interact 
with both lipid membranes and PLN, confirming its role in Ca2+ cycling. 
 
6.2 Methods 
6.2.1 Expression and purification of HAX-1 
The full length HAX-1 (279 amino acid) was expressed either as a fusion 
protein with a histidine-tagged maltose binding protein (MBP) for soluble, native 
expression or with a histidine-tagged SUMO protein for inclusion body expression 
in the BL21(DE3) strain of E. coli. For the SUMO fusion construct, we used a pE-
SUMO vector, containing a T7 promoter and ampicillin resistance. The E. coli 
bacteria were grown at 24°C and overnight protein expression was induced at 
OD600 of 0.8. The cells were resuspended in 20 mM PBS, 150 mM NaCl, 0.5% 
Triton X-100, 0.5% glycerol, 75ug/mL EDTA, 1mM DTT, at pH 7.3 and lysed with 
a French press in the presence of lysozyme. After lysis, the suspension was 
centrifugated at 17,500 rpm for 45 minutes at 4°C with His-SUMO-HAX-1 
contained in insoluble inclusion bodies in the resulting pellet. Inclusion bodies were 
homogenized using a Potter-Elvehjem pestle and glass tube in 20 mM PBS, 2% 
Triton X-100, at pH 7.3 with three plunging cycles. A final washing step without 
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detergent was used to remove excess Triton X-100. The inclusion bodies were 
solubilized in 10 mM Tris, 100 mM NaH2PO4, and 6M urea at pH 8.0. His-SUMO-
HAX-1 was purified by affinity chromatography using Ni-NTA under denaturing 
conditions. Washing and elution steps were carried out at pH 7.0 and 4.0, 
respectively. His-SUMO-HAX-1 was then diluted in 20 mM PBS and 0.01% C12E8 
15 times and cleaved with ULP1 at 4°C. The cleavage reaction was dialyzed into 
ddH2O allowing HAX-1 to precipitate from solution, which was collected by 
centrifugation at 17,500 RPM for 45 minutes. The resulting pellet was solubilized 
in 10% SDS prior to purification using reversed-phase high performance liquid 
chromatography (RP-HPLC). The purified protein was then lyophilized overnight 
to a white powder. The correct sequence was confirmed by trypsin digestion, 
where 6 fragments matched the expected result. One of the fragments showed a 
clear propensity for oxidation at M175 (Figs. 6.11A. and B.), a post-translational 
modification that may emphasize the anti-apoptotic role of HAX-1 in oxidative 
stress [94, 96, 478]. Note that to avoid oxidation of the purified HAX-1 we carried 
out the studies in the presence of DTT. The correct molecular weight was further 
confirmed by LC-MS, which detected peaks at Mw of 31620.52, 32018.52, and 
33416.52 Da for unlabeled, 15N-labeled, and 15N-13C-labeled HAX-1 (Fig. 6.11C.). 
Approximately 99% labelling efficiency was estimated for the subsequent NMR 
experiments. 
We also expressed HAX-1 fused to Maltose Binding Protein (MBP) (Fig. 6.12). 
For the MBP fusion the E. coli bacteria were grown at 24°C with overnight protein 
expression induced with 0.5 mM IPTG once the OD600 reached 0.8. Harvested cell 
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pellets were stored at -20°C. For purification of HAX-1, cells were resuspended in 
20 mM PBS, 150 mM NaCl, 0.5% Tween-20, 0.5% glycerol, 75ug/mL EDTA, 1mM 
DTT, at pH 7.3 and lysed by French press in the presence of lysozyme. After lysis, 
the suspension was centrifugated at 17,500 rpm for 45 minutes at 4°C and the 
fusion protein was purified from the resulting supernatant by affinity 
chromatography with amylose resin (New England Biolab). The fusion protein was 
then purified by size exclusion chromatography (SEC) with a superdex 75 column 
(GE Healthcare). Subsequent cleavage by the tobacco etch virus (TEV) protease 
required 0.1% Tween 20 for optimal cleavage. Finally, the cleavage mixture was 
purified by affinity once more with TALON resin (Takara) resulting in purified 
protein in detergent. 
 
6.2.2 Expression and purification of PLNAFA 
Expression and purification of a monomeric, functional variant of PLNWT, 
PLNAFA, where the cysteines in the transmembrane domain (C36, C41, and C46) 
were mutated into alanine, phenylalanine, and alanine, respectively [396], was 
carried out as previously described [500]. Briefly, unlabeled and uniformly (U) 15N-
labeled PLNAFA and U-13C,15N-labeled PLNAFA was expressed in E. coli bacteria 
with maltose binding protein (MBP) as a fusion protein at 30°C with overnight 
induction. Cells were resuspended in 20 mM PBS, 150 mM NaCl, pH 7.3 and lysed 
by French press. Purification was performed using affinity chromatography using 
amylose resin. The purified fusion construct was cleaved using TEV protease over 
~3 hours at 34°C. After the cleavage reaction was complete, MBP and uncleaved 
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fusion protein were removed from PLNAFA via centrifugation at 17,500 RPM for 45 
minutes at 4°C. The resulting pellet was resuspended in 10% SDS and further 
purified by reversed phase HPLC using water as buffer A and isopropanol as buffer 
B with 0.1% trifluoroacidic acid (TFA) in both buffers. The purified protein was then 
lyophilized overnight to a white powder. 
 
6.2.3 SERCA isolation and purification 
SERCA1a isoform was used in this study due to the robust purification protocol 
and high yields. Note SERCA1a has been proven structurally and functionally 
similar to SERCA2a (heart isoform) [501]. SERCA1a was extracted from rabbit 
skeletal muscle as previously described [502]. Briefly, skeletal muscle from a New 
Zealand white rabbit was harvested and the crude sarcoplasmic reticulum (SR) 
was extracted through centrifugation. The crude SR was stored in sucrose buffer 
at -80°C (20 mM MOPS, 0.3 M sucrose, 1 mM NaN3, pH 7.0). The stored SR was 
then thawed, where SERCA was solubilized into octaethylene glycol monododecyl 
ether (C12E8) from the SR membrane and purified by affinity to Reactive Red resin. 
Purified SERCA was stored in aliquots of elution buffer (0.8 mg/mL SERCA, 0.1% 
C12E8, 1 mM CaCl2, 1 mM MgCl2, 20 mM MOPS, 20% glycerol, 8 mM ADP, pH 
7.00) at -80°C. This preparation was thawed again at 4°C and activity was 
measured by ATP/NADH coupled enzymatic assays prior to use [503]. 
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6.2.4 ATP/NADH coupled enzymatic assays 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE) were purchased from Avanti Polar 
Lipids. SERCA, HAX-1 and PLNAFA were co-reconstituted in DOPC and DOPE 
(4:1) reaching a final ratio of 700:1:m:n lipid:SERCA:HAX-1:PLNAFA, where m and 
n are the selected molar ratios for each experiment. Lipids solubilized in chloroform 
were dried under a flux of N2 for ~30 minutes and kept under vacuum overnight. 
The lipid film was then resuspended into 0.1 mM KCl, 5 mM MgCl2, 10% (v/v) 
glycerol, and C12E8 at 4:1 (w/w) C12E8:lipid ratio. 40 ng of SERCA1a was added to 
the mixture. The lipid/detergent mixed micelles were stirred in the presence of 30 
mg of biobeads ® at 4°C for 3 hours to remove residual detergent and form 
proteoliposomes. The reconstituted system was then resuspended in sucrose 
buffer. SERCA activity was measured in a final buffer containing 5 mM ATP, Ca2+ 
(pCa 5.0 – 8.0 for a 12 point curve),100 mM MOPS, 200 mM KCl, 10 mM MgCl2, 
0.4 mM NADH, 1.0 mM phosphoenolpyruvic acid (PEP), 20 IU/mL lactate 
dehydrogenase (LDH), 20 IU/mL pyruvate kinase (PK), and 0.00712 mg/mL Ca2+ 
ionophore A23187(A.G. Scientific). Assays were incubated at 25°C prior to 
carrying out the ATP/NADH coupled enzyme assay as a function of [Ca2+]. The 
rate of reaction (ATP hydrolysis) was monitored by the decrease of absorption at 
340 nm due to the consumption of NADH by LDH to convert pyruvate into lactate. 






Where Vmax is maximum 
activity, n is the Hill coefficient, 
and [Ca2+] at half Vmax is KCa. 
 
6.2.5 Circular dichroism (CD) 
For the CD measurements 
with different lipid mixtures, a 
solution of 5 μM HAX-1 was 
prepared in 20 mM KH2PO4 
and 50 mM KCl (Fig. 6.15). 
For DMPC titrations, a 5 μM 
HAX-1 solution was prepared 
in 10 mM KH2PO4 at pH 7.0 
(Fig. 6.3). Lipid suspensions in 
CHCl3 were first dried under 
N2 flux overnight and then 
resuspended in acqueous 
buffer. The lipid suspension 
was extruded 10 times through a 0.1 μm polycarbonate filter prior to addition of 
HAX-1 to reach a total lipid-to-protein ratio of 200:1 (Fig. 6.15). For the DMPC 
titrations, a series of lipid-to-protein ratios were used ranging from 10:1 to 800:1 
(Fig. 6.3). The CD spectra were recorded on a Jasco J-815 spectropolarimeter. 
 
Figure 6.2: HAX-1 augments the inhibitory 
potency of PLN 
A. Normalized SERCA activity assays in the 
presence of PLNAFA (blue) at a molar ratio of 
1:5. B. Bar graph representing the changes in 
the apparent calcium affinity of SERCA alone 
and in complex with PLNAFA and HAX-1 at 
varying molar ratios. 
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The acquisition parameters are reported in Table 3.1. The partition constant, Kx, 









Where c is the y-intercept and the sum of a and c is the asymptote at saturation 
[504-506]. 
6.2.6 Solution-state NMR experiments 
Lyophilized HAX-1 was prepared by solubilizing into 20 μL of 100 mM KOH. 
140 μL of ddH2O was then added and the sample placed on ice. 20 μL of 10x 
buffer (200 mM KH2PO4, 500 mM KCl, pH 6.20) was added to the solution and 
vortexed. The pH was adjusted to 7.0 and 19 μL of D2O and 5 μM DSS were added 
for a total of 200 μL. Isotropic bicelles were prepared by mixing DMPC and DHPC 
at a q-ratio of 0.33 (5% w/v lipids) and added at a lipid-to-protein ratio of 240:1 in 
lyophilized powder form. The [1H,15N]-HSQC experiments were carried out on a 
900 MHz Bruker spectrometer and performed at 45 °C, with the exception of urea 
denaturation at 25 °C, using 8 scans per 256 increments. The [1H,15N]-TRACT 
experiments were carried out on a 600 MHz spectrometer and performed at 25 °C. 
To record the relaxation of the α and β spins, 31 delay times were used. These 
data were fit with an exponential decay curve (SciPy library, Python 3.7) and τc 
was calculated using 160 ppm for the difference of the two principal components 
of the 15N chemical shift tensor (ΔδN), 1.02 Å for the 15N-1H inter-nuclear distance 
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(rHN) and 17° for the angle between the unique axis of 15N chemical shift tensor 
and the 15N-1H bond (ϴ) [507]. Spectra were processed with NMRPipe [508] and 
analyzed with NMRFAM-SPARKY [509]. 
 
6.2.7 Solid-state NMR experiments 
Magic angle spinning (MAS) solid-state NMR experiments were carried out on 
a 700 MHz spectrometer using a 3.2 mm probe. All spectra were acquired at 25°C 
with a MAS rate set to 10 or 12 kHz using a 15 ms acquisition time and 3 s recycle 
delay. For these samples, 0.5 mg U-15N,13C PLNAFA was reconstituted in 12 mg 
 
Figure 6.3: Circular dichroism spectroscopy shows that HAX-1 undergoes 
structural rearrangement upon interacting with DMPC LUVs 
Wavelength circular dichroism spectra for increasing lipid:protein ratios of 
DMPC:HAX-1. The inset shows the exponential decay toward saturation in the 
increasingly negative values at the alpha-helical indicative 208 nm. 
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d54-DMPC vesicles (L/P ratio = 100) in 20 mM HEPES, 100 mM KCl, 1 mM NaN3, 
1 mM Mg2+, 2.5% glycerol, pH 7.0. For the HAX-1 sample, 2.5 mg HAX-1 was 
added to the same sample. The one-dimensional cross polarization (CP) and 
rINEPT spectra were acquired using 2,048 and 10,000 scans for HAX-1 and 
PLN/HAX-1 samples, respectively. 2D [13C,13C]-DARR experiments were recorded 
using 256 scans and 120 increments in the indirect dimension with a mixing time 
of 100 ms. 
 
6.2.8 Fluorescence resonance energy transfer (FRET) experiments 
Wild-type PLN labeled with N-terminal Cerulean (Cer) and yellow 
fluorescent protein (YFP) fusion tags were co-expressed in AAV-293 cells with or 
without HAX-1. Cells were cotransfected at a plasmid molar ratio of 1:5:10 for Cer-
PLN:YFP-PLN:HAX-1. Intrapentameric FRET was quantified as previously 
described [73]. Briefly, FRET was quantified from acceptor sensitization by 
fluorescence microscopy. Images were acquired with a 40 × 0.75 NA objective, 
with 50 ms exposure time for Cer, YFP, and FRET (Cer excitation, YFP emission) 
imaging conditions. FRET efficiency was calculated according to E = G/(G + 3.2× 
FCer), where G=FFRET−a×FYFP−d×FCer [510], where FFRET, FYFP, and FCer are the 
matching fluorescence intensity from FRET, YFP, and Cer images, respectively, 
and G represents FRET intensity corrected for the bleed-through of the channels. 
The parameters a and d are bleed-through constants calculated as a =FFRET/FCer 
for a control sample transfected with only YFP-SERCA and d=FFRET/FYFP for a 
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control sample transfected with only Cer-SERCA. These values were determined 
to be G=4.74 a=0.075 and b=0.88. The FRET efficiency of each cell was compared 
to that cell’s fluorescence intensity in the YFP channel, which was taken as an 
index of protein expression level. The relationship between FRET and protein 
expression ([PLN]) yielded estimates of PLN oligomerization affinity and the 
intrinsic FRET efficiency of the PLN pentamer. The data were analyzed with a 
hyperbolic fit of the form FRET=(FRETmax)([PLN])/(KD+[PLN]), where FRETmax is 
the intrinsic FRET of the PLN pentamer (FRETmax) and KD is the apparent 
dissociation constant of oligomerization [511]. 
 
6.3 Results 
6.3.1 HAX-1 acts synergistically with PLN to increase SERCA inhibition 
HAX-1 was expressed using His-MBP and His-SUMO fusion constructs and 
purified under native and denatured conditions, respectively. A similar strategy was 
used to assess the intrinsically disordered nature of -synuclein [512]. Under both 
experimental conditions, HAX-1 was fully functional as established by SERCA 
inhibition assays. Expression as a His-SUMO fusion protein was preferred as the 
purification from inclusion bodies eliminated the need of Tween 20 and resulted in 
higher purity, avoiding degradation. Fig. 6.10 shows the characterization of the 
recombinant HAX-1 using mass spectrometry. Fig. 6.11 shows the expression gels 
and the superposition of the [1H,15N]-HSQC experiments of the amide regions of 
HAX-1 purified using both native and denatured conditions. The two NMR spectra 
of HAX-1 are essentially superimposable, showing that the protein behaves like an 
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IDP in both preparations [513]. As expected for disordered proteins, the chemical 
shift breadth of amide resonances is narrower than a globular protein. To assess 
the protein’s monodispersity, we analyzed [1H,15N]-TRACT experiments [507]. 
From these relaxation data, we estimated a correlation time (τc) of 15.1 ± 0.9 ns 
(Fig. 6.12), confirming that HAX-1 in the NMR samples is monodispersed [514]. 
To determine the activity of HAX-1, we carried out ATP-coupled assays on SERCA 
in the presence and absence of PLN and with HAX-1 at various molar ratios. As 
previously reported [91, 95], HAX-1 augmented the inhibitory effects of PLN at 
SERCA:PLN:HAX-1 in a 1:1:1 ratio (Fig. 6.2). Note that at higher concentrations 
of HAX-1 the results are no longer reliable, probably due to protein aggregation. 
 
6.3.2 HAX-1 is an intrinsically disordered protein 
Previous studies suggested that truncated HAX-1 is intrinsically disordered 
and adopts a partial secondary structure only upon binding Ca2+ [98]. Additionally, 
using computational approaches, Balcerak et al. predicted that HAX-1 is largely 
disordered [99]. To confirm these predictions, we used a combination of CD and 
NMR spectroscopy. The CD spectra suggest that HAX-1 adopts partial secondary 
structures, with a dichroic profile containing less than 30% α-helical structures (Fig. 
6.3) [515]. The NMR amide fingerprint from the [1H,15N]-HSQC experiments 
features a narrow dispersion in the 1H chemical shifts that further confirmed the 
disordered nature of HAX-1 (Fig. 6.4). Upon chemical denaturation with urea (Fig. 
6.13), the [1H,15N]-HSQC of HAX-1 displays sharper peaks in conjunction with a 
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few additional peaks. Also, the spectrum has a higher signal-to-noise (S/N) ratio, 
i.e., 37 versus 141 for native and denatured conditions, respectively. 
 
6.3.3 HAX-1 undergoes a partial ordering upon interaction with model lipids 
membranes 
It has been hypothesized that HAX-1 exists as a membrane-associated 
protein with the C-terminal tail interacting with lipid bilayers [97, 473, 485, 516-
518]. To determine whether HAX-1 undergoes structural transitions in the 
presence of membrane mimetic environments, we used a combination of CD and 
solution and ssNMR spectroscopy. The CD spectra of HAX-1 upon titration with 
DMPC large unilamellar vesicles (LUV) show that this protein undergoes a partial 
ordering upon interaction with this membrane mimetic system in a concentration-
dependent manner (Fig. 6.3). Increasing the LUV concentration, the CD spectra 
show a sequential decrease of molar ellipticity at 208 nm, indicating an increase 
of the secondary structure content, which is modulated by the interaction with lipids 
(Fig. 6.3). Fitting the changes in molar ellipticity resulted in a partition constant Kx 
of 1.1 ± 0.2 mM, suggesting a weak interaction of this polypeptide with the DMPC 
LUV [504-506]. A higher effect was obtained by adding DHPC:DMPC mixtures in 
3:1 molar ratios, which shows a significant increase in alpha-helical structure. More 
importantly, negatively charged lipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphate (POPA) and 1-palmoitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
(POPS) show more pronounced changes in HAX-1 secondary structure (Fig. 6.14. 
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The latter suggests that the nature of the lipid membrane modulates the secondary 
structure of HAX-1. 
 
Figure 6.4: NMR fingerprinting of HAX-1 free and upon interactions with 
isotropic bicelles 
A. [1H,15N]-HSQC spectrum of HAX-1 in 50 mM KCl, 100 mM KH2PO4, pH 7.0. B. [1H,15N]-
HSQC spectrum of HAX-1 in 50 mM KCl, 100 mM KH2PO4, pH 7.0 with DMPC/DHPC 
isotropic bicelle (q = 0.33). C. Overlay of A. and B. 
Finally, we determined the effects of membrane mimetic systems on the 
structure of HAX-1 using both solution and solid-state NMR spectroscopy. In Fig. 
6.4, we report the HAX-1 fingerprints in the absence and presence of DHPC:DMPC 
isotropic bicelles (3:1 molar ratio). It is apparent that upon addition of isotropic 
bicelles, the breadth of the 1H chemical shift increases slightly and each resonance 
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in the spectra becomes 
significantly sharper and 
more resolved, an effect 
that is probably caused 
by the increase in the 
secondary structure 
content in accordance to 
the CD spectra. Since 
isotropic bicelles are a 
mere approximation of physiological lipid membranes [519], we carried out ssNMR 
spectroscopy on HAX-1 reconstituted with DMPC LUVs. We first performed CP-
based experiments, which rely on polarization transfer via dipolar couplings to 
detect the most rigid domains of a protein [520]. For HAX-1, these experiments 
show an envelope of resonances corresponding to residues that interact with the 
lipid membranes (Fig. 6.5A.). In addition, the rINEPT experiments, whose 
polarization transfer occurs via through-bond J-couplings, revealed the presence 
of several resonances, corresponding to the most mobile residues of HAX-1 as 
well as those residues that do not interact with the membrane bilayer (Fig. 6.5B.). 
These data demonstrate that HAX-1 interacts with the membranes only partially 
and there is a significant portion of the protein that remains dynamic and does not 
interact with lipid membranes. 
 
 
Figure 6.5: Interactions of HAX-1 with DMPC 
vesicles by ssNMR spectroscopy 
A. CP and B. rINEPT spectra acquired on the same 
HAX-1 sample in DMPC LUVs. 
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6.3.4 HAX-1 binds the 
cytoplasmic domain of 
monomeric PLN 
Using yeast-two-
hybrid analysis and pull 
down assays, it was found 
that HAX-1 interacts with the 
cytoplasmic region of PLN, 
increasing its inhibitory 
potency for SERCA [88-91, 
95, 96]. In particular, these 
researchers found that 
residues 203-245 of HAX-1 
constitute the minimal 
binding sequence targeting 
residues 16-22 of PLN, 
which include the two 
phosphorylation sites, 
Ser16 and Thr17, for protein 
kinase A and CaMKII, 
respectively [88]. To assess 
the physical interactions between these two proteins, we reconstituted U-13C,15N 
 
Figure 6.6: HAX-1 interacts with the 
cytoplasmic domain of PLNAFA 
A. Structures of PLN in the T (left, Protein Data Bank 
(PDB) ID code 2KB7) and R (right, PDB ID code 
2LPF) states. Each domain is color-coded with the 
more flexible domains (Ia and loop) in green and 
orange, respectively and the more rigid 
transmembrane domains (Ib and II) in red and blue, 
respectively. B. CP and rINEPT spectra of PLNAFA in 
DMPC vesicles. C. CP and rINEPT spectra of 
PLNAFAand HAX-1 in DMPC vesicles. 
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PLN with unlabeled HAX-1 in DMPC lipid vesicles and carried out MAS ssNMR 
experiments. 
Previously, we characterized the structure of PLNAFA in lipid membranes 
and found that this bitopic membrane protein contains two regions 
(transmembrane and cytoplasmic) that can be divided into four dynamic domains: 
the N-terminal amphipathic helix (domain Ia), a mobile loop, a juxtamembrane helix 
(domain Ib), and a more rigid and hydrophobic helix embedded in the hydrocarbon 
region of the membrane (domain II) [172]. Also, our laboratory [16, 160, 207, 434, 
521] and others [211, 522-525] discovered that PLN’s cytoplasmic region exists in 
equilibrium between two inhibitory conformations: an ordered T (tense) state 
(helical and membrane bound) and a disordered R (relaxed) state (dynamic and 
membrane detached, Fig. 6.6A.), the latter of which is characterized by a flexible 
cytoplasmic domain available for a putative, non-inhibitory SERCA-bound B state 
[207]. The two inhibitory states, the R state and the T state, manifest as separate 
resonances in the [13C,13C]-DARR spectra for selected residues [160, 207] and 
can be discriminated using either CP or rINEPT experiments [159, 213]. Fig. 6.6B. 
and C show CP and rINEPT experiments for U-13C,15N PLNAFA and U-13C,15N 
PLNAFA/HAX-1 complex, respectively. The CP experiment shows an envelope of 
resonances corresponding to the most rigid residues of PLNAFA, including the 
transmembrane domain (residue 34-52) and the juxtamembrane region (domain 
Ib, residues 21-33). In contrast, the rINEPT spectrum displays weaker peak 
intensities corresponding to the loop and domain Ia resonances, which are more 
dynamic. Moreover, the population of the dynamic region of PLNAFA can be tuned 
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(i.e., increased or decreased) by single-site mutations engineered in the dynamic 
loop [521]. The increase in the population of the R state shifts PLN toward the non-
inhibitory B state, increasing Ca2+ transport [521]. These results were confirmed 
by analyzing the dynamics of naturally occurring mutations (R9C and R25C) in 
lipid membranes by ssNMR [74]. 
 
Figure 6.7: 2D [13C,13C]-DARR spectra of PLN in the presence and absence 
of HAX-1 
A. [13C,13C]-DARR overlay of PLNAFA (black) and PLNAFA with HAX-1 (red). B. inset 
of A. showing the most dramatic chemical shifts upon addition of HAX-1 C. inset 
of A. demonstrating the A11/15 of PLNAFA chemical shift in the presence of HAX-
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1. D. Further confirmation of PLNAFA interaction with HAX-1 with the appearance 
of peaks at 35 ppm in the ω1 dimension and 65 ppm in the ω2 dimension. 
In the rINEPT spectrum of the PLNAFA/HAX-1 complex (Fig. 6.6C.), we 
observed a decrease of the dynamic population compared to PLNAFA (~2%) (Fig. 
6.6B.), which indicates that the cytoplasmic region of PLNAFA is more rigid in the 
presence of HAX-1. The decreased dynamic population is comparable to the 
population of the R state present in PLNR9C (~1%) [213]. We also registered a 2D 
[13C,13C]-DARR experiment of U-13C,15N PLNAFA bound to HAX-1 (Fig. 6.7). As 
reporter for PLNAFA conformational equilibrium, we selected the resonances of the 
Ala residues [160, 526]. The resonances of these residues are essentially 
overlapped; however, the 13Cαchemical shifts of the resonances associated with 
the R state of Ala11 and Ala15 are resolved as they fall in the random coil region 
of the spectrum [160, 207]. Upon addition of HAX-1, there is a slight chemical shift 
change of the R state, and more importantly, a decrease of the population of the 
R state consistent with the rigidification of PLN (Fig. 6.7C.). The appearance of 
new resonances further confirms the interaction between HAX-1 and monomeric 
PLNAFA (Fig. 6.7B. and D.). Taken together, these MAS ssNMR data support the 
physical interactions between monomeric PLNAFA and HAX-1, which causes a shift 
in the conformational equilibrium of PLN from a dynamic to a rigid state. 
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6.3.5 HAX-1 binds the cytoplasmic domain of pentameric PLN 
Finally, we investigated the interactions between HAX-1 and PLN in living 
cells. For these experiments, we utilized wild-type PLN that is in equilibrium 
between a pentameric assembly (storage) and monomeric form in cell membranes 
[527]. First, we quantified intra-pentameric 
FRET for PLNWT labeled with genetically 
encoded fluorescent tags [511]. Co-expression 
of HAX-1 slightly decreased the intrinsic FRET 
of the pentamer (FRETmax) from 45.4 ± 0.9% to 
38.2 ± 2.2%, consistent with a change in the 
overall architecture of the pentamer. Student’s 
T-test comparison of 6 independent groups of 
3 technical replicates yielded a p-value of 
0.0003. Decreased intrinsic FRET indicates 
that the N-terminal fluorescent tags of PLN are 
more widely separated from one another, 
increasing the FRET distance (Fig. 6.8). These 
data indicate that HAX-1 binding to PLN increases the association of PLN 
cytoplasmic domains with the surface of the membrane, supporting the hypothesis 
that HAX-1 interacts with both PLN and the lipid membrane. 
6.4 Discussion 
HAX-1 belongs to a family of proteins that that are ubiquitously expressed and 
play various roles in health and disease [112]. Given their relatively small size and 
 
Figure 6.8: In cell FRET 
experiments show that HAX-
1 changes the architecture 
of pentameric PLNWT 
Coexpression of a 
stoichiometric excess of HAX-
1 decreases the intrinsic FRET 
(FRETmax) of the pentameric 
form of PLN, consistent with 




remarkable biological importance, it is surprising that these proteins have not lured 
structural biologists. To date, there are only sparse structural reports on HAX-1, 
and they suggest that this protein is essentially disordered. Hirosaka et al. [98] 
expressed and labeled truncated HAX-1 for NMR studies. The amide signature of 
their construct as analyzed by [1H,15N]-HSQC experiments displays a poor 
chemical shift dispersion in the 1H dimension, suggesting a relatively uniform 
chemical environment for each residue and supporting the unfolded nature of HAX-
1. Furthermore, these authors showed that addition of Ca2+ slightly changes the 
amide chemical shifts, suggesting that HAX-1 can bind Ca2+ ions. Independently, 
Balcerak et al. [99] showed that HAX-1 is indeed able to bind Ca2+ ions and 
provided a computational model of the protein featuring ~40% of disordered 
domains. 
Moreover, initial studies suggested that HAX-1 is a mitochondrial membrane 
protein with residues 261-273 in the C-terminal tail acting as a membrane anchor 
[97]. More recent studies have shown that HAX-1 isoform A localizes in the ER 
and lamellipodia, while isoform B has been found in the nuclear matrix with claims 
that HAX-1 is a cytosolic protein [528]. What is known, however, is that HAX-1 
primarily interacts with proteins localizing around organelle membranes. Only 
recently, Kranias and co-workers reported the involvement of HAX-1 in the 
regulatory cycle of SERCA, suggesting a direct interaction with PLN [88]. To verify 
these predictions, we probed the interactions of HAX-1 with both lipid mimetic 
environments and PLN. We found that HAX-1 adopts partial folding upon binding 
to membranes and accentuated preference for negatively charged lipids. NMR 
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experiments in lipid membranes show that upon binding, HAX-1 restricts the 
motion of the cytosolic region of monomeric PLN, shifting its conformational 
equilibrium. In conjunction with decreasing FRETmax measurements of pentameric 
PLN in the presence of HAX-1, these data might explain the function of HAX-1 
which could ‘sequester’ the cytoplasmic region of PLN while simultaneously 
anchoring it to the membrane as seen in Fig. 6.9. Without the cytoplasmic region 
available to bind SERCA, only the inhibitory intramolecular interactions between 
the transmembrane domain of PLN and SERCA would be preserved. Our results 
are in agreement with the proposed model of allosteric regulation of SERCA, 
where the cytoplasmic region, upon binding the Ca2+-ATPase, ‘activates’ its 
function (i.e., PLN becomes less inhibitory) [207]. Under physiological conditions, 
PLN inhibits SERCA adopting three different states: the inhibitory T and R, where 
the inhibition is elicited via intramembrane interactions, and the non-inhibitory B 
state. Phosphorylation shifts the equilibrium toward the B state, ‘activating’ the 
enzyme, which increases its apparent affinity for Ca2+. HAX-1 binding, on the other 
hand, shifts the equilibrium towards the inhibitory T state interacting with both 
membrane bilayers and PLN (Fig. 6.9). This model agrees with the activity assays 




Figure 6.9: Proposed mechanism for HAX-1 synergistic inhibition of SERCA 
with PLN 
PLN in complex with SERCA (PDB ID code 4Y3U) is in equilibrium between a T 
and R state. PKA recognizes and phosphorylates the R state preferentially, shifting 
the equilibrium toward a non-inhibitory state [434]. In contrast, HAX-1 (modeled by 
I-TASSER) traps the cytoplasmic domain of PLN in the T state and shifts the 




In summary, our studies demonstrate that HAX-1 is an intrinsically disordered 
protein with the ability of interacting with model membranes to adopt a partially 
ordered structure. We showed that full-length HAX-1 is able to regulate the 
inhibitory potency of PLN by interacting with the cytoplasmic domain of PLN and 
shifting the conformational equilibrium toward a more inhibitory state. This adds a 
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6.7 Supplementary Figures 
 
Figure 6.10: Figure S1. Mass spectrometry of recombinant HAX-1 
A. Trypsin digest peptide fragments matched to HAX-1 primary amino acid 
sequence with a -10log(P) score above 24. (Blue bars are matched peptides, Red 
O indicates an oxidized state for Met). B. MS/MS data derived from the oxidized 






Figure 6.11: Figure S2. NMR spectra and corresponding SDS-PAGE gels of 
recombinant U-15N HAX-1 expressed in native conditions and in inclusion 
bodies 
A. Overlay of the [1H,15N]-HSQC spectra for MBP-HAX-1 fusion protein purification 
and SUMO-HAX-1 fusion inclusion body purification (IB-HAX-1). The MBP-fusion 
purified HAX-1 [1H,15N]-HSQC spectrum was recorded on a 900 MHz Bruker 
spectrometer. The sample consisted of 100 μM HAX-1, 50 mM KCl, 20 mM MOPS, 
0.1% Tween 20. The number of scans was 16 for 128 increments. Temperature 
was held constant at 25 oC. The SUMO-fusion purified HAX-1 [1H,15N]-HSQC 
spectrum was recorded on a 900 MHz Bruker spectrometer. The sample consisted 
of 300 μM HAX-1, 50 mM KCl, 20 mM MOPS. The number of scans was 8 for 128 
increments. The temperature was held at 25 oC. Boxed resonances of the blue 
spectrum appear in the spectra of samples purified from inclusion bodies recorded 
in isotropic bicelles and samples subject to higher temperatures. B. SDS-PAGE 
gel of purified HAX-1 from inclusion bodies. C. SDS-PAGE gel of purified HAX-1 




Figure 6.12: Figure S3. TRACT NMR data and corresponding exponential 
decay fits 
An overlay of the relaxation data and the relaxation rates for the α- and β-spin 
states (Rα and Rβ, respectively). 31 time points were recorded from 0 to 0.070 
seconds (2.3 ms increments starting from 0.1 ms) for the relaxation period (Δ). 
Least-squares fitting with Monte Carlo error analysis was used for the estimation 




Figure 6.13: Figure S4. Amide fingerprints of HAX-1 under native and 
denaturing conditions 
Superposition of [1H,15N]-HSQC spectra of HAX-1 in native solution conditions 
(red) and in 6M urea (black). The spectra were referenced with 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS). 
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Figure 6.14: Figure S5. Circular Dichroism spectroscopy shows that HAX-1 
undergoes structural rearrangement upon interacting with different 
membrane mimetics 
CD spectra of HAX-1 interacting with various lipid mimetic compositions. 
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Table 6.1: Table S1 Circular Dichroism Collection Parameters 
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Conclusions and Perspectives 
The preceding chapters (2 through 6) are the culmination of my work to answer 
the questions I posed for myself: 
• How can HAX-1 be expressed, purified, and functionally assayed for in vitro 
biophysical characterization? 
• What is the structure of HAX-1 in solution and in the presence of lipid 
membranes?  
• How is SERCA function and PLN regulation affected by HAX-1 and how 
can a SERCA/PLN/HAX-1 complex be formed to perform NMR studies 
under fully functional conditions? 
Chapter 2 is a reprint of a solid-state NMR review publication that I was a 
collaborator on. Aside from formatting and editing this publication, I contributed 
previously unpublished data on the effects of HAX-1 binding to the PLN 
cytoplasmic domain, as well as MAS RI-HSQC, HSQC, and MAS 13C-13C DARR 
data. This paper and these data highlight the idea of combining solution- and 
solid-state NMR (both MAS and OS) that was the backbone of my research on 
the peripheral membrane protein HAX-1. 
Chapter 3 is a reprint of a review paper that I authored on the CCLS-HSQC pulse 
sequence. This was the first, first-author paper that I published and served as a 
tool to learn the NMR theory necessary to progress through my Ph.D. In addition, 
this pulse sequence was used to partially assign HAX-1 in the presence of 
isotropic bicelles; a strategy that we had previously not used before in the 
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assignment of solution-state spectra. The assignment proved necessary to 
determine the location of HAX-1 that associates with lipid membranes 
experimentally. 
Chapter 4 is a reprint of a book chapter describing the methods for synthetic 
ethyl labeling of SERCA. I contributed to this paper primarily through the 
extraction of SERCA from New Zealand White Rabbit skeletal muscle. Aside 
from providing the technical skill for purification of SERCA used in activity assays 
and ssNMR experiments for question number three, tagging SERCA in this way 
is a future perspective for the HAX-1 project now that there is a foundational 
understanding of the HAX-1/PLN interaction. This tagging strategy will be used to 
study the structure function relationships of the ternary SERCA/PLN/HAX-1 
complex. 
Chapter 5 is a reprint of an eLife research paper describing the structure-function 
relationship of phosphorylated and unphosphorylated PLN binding to SERCA. My 
work on this paper consisted of reproducing each spectrum published to ensure 
not only that this work was correct, but that we could move forward with OS-
ssNMR for the PLN/HAX-1 complex. From this work, we discovered that the 
interactions of domain Ib are essential for PLN binding of SERCA, setting the 
foundations for my research on HAX-1/PLN interactions. 
Chapter 6 is a reprint of a BBA Biomembranes research paper describing the 
purification methods and structure of HAX-1 as an IDP; these data answered the 
first objective. HAX-1 interactions with lipid membranes as well as the PLN 
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cytoplasmic domain were explored, however with this initial paper, I felt I had 
only scratched the surface of the latter two objectives. My final research paper 
investigates the lipid/HAX-1 interactions and fully describes the effects HAX-1 
binding has on not only the cytoplasmic domain of PLN, but the transmembrane 
domain as well. From this manuscript, we learn that HAX-1 interacts with the 
membrane via its C-terminal putative membrane binding region. Importantly, we 
discovered that HAX-1 does not only affect the cytoplasmic domain of PLN, but 
results in the stabilization of the SERCA binding residues of PLN. Through a 
collaboration with Seth Robia at Loyola, Chicago, we confirm this effect in vivo, 
demonstrating a decrease in Kd and a decrease in FRETmax. These data prove 
that HAX-1 increases PLN inhibition by increasing the stability of SERCA binding 
residues while pulling the cytoplasmic domain of PLN away from the non-
inhibitory SERCA bound state. 
In summary, we have developed a method with which to purify HAX-1 for in vitro 
studies. We have demonstrated that HAX-1 is an intrinsically disordered protein 
that interacts with lipid membranes via its C-terminal membrane binding domain. 
The membrane binding domain was found to be essential for binding the 
cytoplasmic domain of PLN and stabilizing the SERCA binding residues of PLN, 
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